# EDGAR Filing Document

**Accession Number:** 0001571123
**File Stem:** 0001571123-26-000069
**Filing Date:** 2026-4
**Character Count:** 447648
**Document Hash:** 50fa13cc77310c57fbeb5eff2269ca17
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001571123-26-000069.hdr.sgml**: 20260422

**ACCESSION NUMBER**: 0001571123-26-000069

**CONFORMED SUBMISSION TYPE**: DEF 14A

**PUBLIC DOCUMENT COUNT**: 93

**CONFORMED PERIOD OF REPORT**: 20260603

**FILED AS OF DATE**: 20260422

**DATE AS OF CHANGE**: 20260422

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Science Applications International Corp
- **CENTRAL INDEX KEY:** 0001571123
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN [7373]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 461932921
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0130

**FILING VALUES:**
- **FORM TYPE:** DEF 14A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-35832
- **FILM NUMBER:** 26883919

**BUSINESS ADDRESS:**
- **STREET 1:** 12010 SUNSET HILLS ROAD
- **CITY:** RESTON
- **STATE:** VA
- **ZIP:** 20190
- **BUSINESS PHONE:** 703-676-4300

**MAIL ADDRESS:**
- **STREET 1:** 12010 SUNSET HILLS ROAD
- **CITY:** RESTON
- **STATE:** VA
- **ZIP:** 20190

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SAIC Gemini, Inc.
- **DATE OF NAME CHANGE:** 20130305

?xml version='1.0' encoding='ASCII'? saic-20260422

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, DC 20549**

**SCHEDULE 14A**

Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934

Filed by the Registrant ☒

Filed by a Party other than the Registrant ☐

Check the appropriate box:

☐Preliminary Proxy Statement

☐**Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))**

☒Definitive Proxy Statement

☐Definitive Additional Materials

☐Soliciting Material Pursuant to § 240.14a-12

**Science Applications International Corporation**

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒No fee required

☐Fee paid previously with preliminary materials

☐Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11

![27-0013-Proxy_Statement_2026_Cover.jpg](saic-20260422_g1.jpg)

![SAIC_Glance@300x-100.jpg](saic-20260422_g2.jpg)

SAIC<sup>®</sup> is a premier Fortune 500 mission integrator focused on advancing

the power of technology and innovation to serve and protect our world.

Our robust portfolio of offerings across the defense, space, civilian and

intelligence markets includes secure high-end solutions in mission IT,

enterprise IT, engineering services and professional services. We integrate

emerging technology, rapidly and securely, into mission critical operations

that modernize and enable critical national imperatives.

We are approximately 23,000 strong; driven by mission, united by purpose,

and inspired by opportunities. Headquartered in Reston, Virginia, SAIC

has annual revenues of approximately $7.3 billion. For more information,

visit saic.com. For ongoing news, please visit our newsroom.

![](saic-20260422_g3.gif)

**PURPOSE**

Advance the power of

technology and

innovation to serve and

protect our world

**VISION**

We will be our nation's

most trusted solutions

integrator to secure and

digitally evolve U.S.

critical missions with our

customers

**MISSION**

Partner with our

customers to transform

government, by creating

and integrating digital

solutions that address

national imperatives with

our diverse talent and

innovative tech

![](saic-20260422_g3.gif)

**VALUES**

![Innovation_1@300x-100.jpg](saic-20260422_g4.jpg)

![Inclusion_1@300x-100.jpg](saic-20260422_g5.jpg)

![Integrity @300x-100.jpg](saic-20260422_g6.jpg)

**Integrity**

Demand unwavering

honesty, ethics and

authenticity in yourself

and others

**Innovation**

Empower our people to

take appropriate risks

and leverage emerging

technology to solve our

customers' most complex

problems

**Inclusion**

Respect and value

our people and

passionately partner

with our customers

and our communities

![SAIC_1@300x-100.jpg](saic-20260422_g7.jpg)

**Letter to Our Shareholders**

![Fellow SAIC Shareholders_1@1.5x-100.jpg](saic-20260422_g8.jpg)

![JimReagan_ShareholderLetter copy.jpg](saic-20260422_g9.jpg)

As SAIC's new Chief Executive Officer, I write this letter with great humility

and even greater excitement. I am honored and grateful to the Board of

Directors for the faith they have placed in me to lead this organization.

Together with our leadership team and employees we are sharpening our

focus on execution, advancing innovative technologies for our customers,

and driving sustained profitable growth for our investors.

Fiscal year 2026 was challenging on several fronts. Government

shutdowns, efficiency measures, and customer workforce impacts

were a few of the headwinds that our company navigated. Our financial

results reflected these challenges and did not live up to our – and your –

expectations.

As revenue contracted by 3% to $7.3B, we focused on disciplined cost

management and strong operational execution to deliver an 18% increase

in adjusted diluted earnings per share. Fiscal 2026 free cash flow of $577

million was a 16% increase from the prior year and we returned $492

million of capital to shareholders, consisting of $422 million of share

repurchases and $70 million of dividends. We also continued to invest for

future growth, restructuring our growth oriented organizational structure,

and spending $203 million to acquire SilverEdge Government Solutions.

For more than 50 years, SAIC has solved our nation's most complex

challenges with speed and precision. We've recently taken the same

approach to improve results by:

• streamlining our go-to-market business units to better align to evolving

customer mission priorities while pivoting to high-growth markets.

• increasing our business development investment to include adding a

Chief Growth Officer, strengthening our differentiated technology-

enabled solutions, and aggressively leveraging artificial intelligence

(AI) to help ourselves and our customers efficiently and rapidly solve

real-world complexities.

• expanding our go-fast commercial-like technology offerings, to include

our acquisition of SilverEdge to enhance our capabilities across digital

transformation, generative AI, and new business models to innovate

along with our national security and intelligence customers.

**James C. Reagan**

SAIC Chief Executive Officer

![New Quotes@300x-100.jpg](saic-20260422_g10.jpg)

I'm enthusiastically

optimistic about where we

are headed. We have a clear

path forward and a motivated

organization. The alignment to

customer priorities, commitment

to execution excellence,

development of innovative

mission-focused technologies

and commercial solutions, and

the passion of our employees is

how we will create value.

![New Quotes@300x-100.jpg](saic-20260422_g10.jpg)

**Letter to Our Shareholders**

• launching a bottoms-up enterprise review to improve our business

processes, enhance our speed and efficiency, and most importantly,

create capacity for investment.

These recent actions build on SAIC's strong foundation to deliver

meaningful results to all of our stakeholders, and we're poised to accelerate

our momentum in the year ahead and beyond. In Fiscal 2027, we are

committed to focus on where we can differentiate and win by:

• deploying our resources more efficiently to drive growth.

• sharpening execution excellence to increase capacity for investment in

the business.

• prioritizing yield and bid quality across our business development

function.

• leaning into our pursuit of opportunities where we have a greater right

to win and higher rates of customer retention.

I'm enthusiastically optimistic about where we are headed. We have a clear

path forward and a motivated organization. The alignment to customer

priorities, commitment to execution excellence, development of innovative

mission-focused technologies and commercial solutions, and the passion of

our employees is how we will create value.

SAIC is building a faster, more focused company that is positioned to

compete and win. On behalf of our Board of Directors, our Executive

Leadership Team, and our 23,000 employees, we thank you for your

support and faith in SAIC. We are acutely aware of the responsibility

entrusted to us and we have a sense of urgency to deliver for you.

James C. Reagan

![Jim Reagan Signature@1.5x-100.jpg](saic-20260422_g11.jpg)

**NOTICE OF VIRTUAL ANNUAL MEETING** 

**OF STOCKHOLDERS**

![SAIC_logo_RGB_DarkBlue.jpg](saic-20260422_g12.jpg)

The annual meeting of stockholders of

Science Applications International

Corporation ("SAIC"), a Delaware

corporation, will be held on Wednesday,

June 3, 2026 at 9:00 a.m. (ET) as a

virtual meeting at

www.virtualshareholdermeeting.com/

SAIC2026. We believe that a virtual

annual meeting of stockholders provides

greater access to those who may want to

attend and, therefore, have chosen this

over an in-person meeting. In addition,

our Proxy Statement and our Annual

Report on Form 10-K for our fiscal year

ended January 30, 2026, are available at

www.proxyvote.com. Information on

these websites, other than these

materials, is not a part of the proxy

solicitation materials.

The foregoing items of business are fully

described in our Proxy Statement made

available on the Internet and, upon

request, in paper copy. Our Board of

Directors has set the close of business

on April 6, 2026 as the record date for

the determination of stockholders who

are entitled to notice of and to vote at the

annual meeting and at any and all

adjournments, postponements or

continuations thereof. A list of

stockholders entitled to vote at the

meeting will be available for inspection

for at least 10 days prior to the meeting.

If you are a stockholder and want to

inspect the stockholder list, please send

a written request to our Corporate

Secretary at Legal-

Department@saic.com to arrange for

electronic access to the stockholder list.

12010 Sunset Hills Road

Reston, Virginia 20190

---

| | | |
|:---|:---|:---|
| **Meeting information** | **Ways to vote** |  |
| ![Date and Time@300x-100.jpg](saic-20260422_g13.jpg)<br>**Date and time**<br>June 3, 2026<br>9:00 a.m. (ET)<br>| ![Internet icon_3@300x-100.jpg](saic-20260422_g14.jpg)<br>**Internet**<br>| ![Virtual Icon_3@300x-100.jpg](saic-20260422_g15.jpg)<br>**Virtual Annual** <br>**Meeting** <br>|
| ![Location@300x-100.jpg](saic-20260422_g16.jpg)<br>**Location**<br>www.virtualshareholdermeeting.com/<br>SAIC2026<br>| ![Phone Icon_3@300x-100.jpg](saic-20260422_g17.jpg)<br>**Telephone**<br>|  |
| ![Record Date@300x-100.jpg](saic-20260422_g18.jpg)<br>**Record date**<br>April 6, 2026<br>| ![Mail Icopn_3@300x-100.jpg](saic-20260422_g19.jpg)<br>**Mail**<br>|  |
| **Your vote is important**<br>For specific instructions regarding how to vote, please refer to the questions and <br>answers beginning on page 6 of this Proxy Statement or the instructions on the <br>proxy and voting instruction card. Submitting a proxy or voting instructions will not <br>prevent you from attending the virtual annual meeting and voting at the meeting if <br>you so desire but will help us secure a quorum and reduce the expense of additional <br>proxy solicitation.  | **Your vote is important**<br>For specific instructions regarding how to vote, please refer to the questions and <br>answers beginning on page 6 of this Proxy Statement or the instructions on the <br>proxy and voting instruction card. Submitting a proxy or voting instructions will not <br>prevent you from attending the virtual annual meeting and voting at the meeting if <br>you so desire but will help us secure a quorum and reduce the expense of additional <br>proxy solicitation.  | **Your vote is important**<br>For specific instructions regarding how to vote, please refer to the questions and <br>answers beginning on page 6 of this Proxy Statement or the instructions on the <br>proxy and voting instruction card. Submitting a proxy or voting instructions will not <br>prevent you from attending the virtual annual meeting and voting at the meeting if <br>you so desire but will help us secure a quorum and reduce the expense of additional <br>proxy solicitation.  |

---

---

| | |
|:---|:---|
| **Items of business** | **Items of business** |
| **1** | To elect ten directors |
| **2** | To conduct a non-binding, advisory vote to approve the compensation of our <br>named executive officers ("Say-on-Pay") |
| **3** | To conduct a non-binding, advisory vote on the frequency of future Say-on-Pay <br>votes |
| **4** | To approve an amendment to our 2023 Equity Incentive Plan to increase the total <br>number of authorized shares |
| **5** | To ratify the appointment of Ernst & Young LLP as our independent registered <br>public accounting firm for the fiscal year ending January 29, 2027 |

---

By Order of the Board of Directors

**Hilary L. Hageman** \| Corporate Secretary \| Reston, Virginia \| April 22, 2026

![Hilary Hagman Signature.jpg](saic-20260422_g20.jpg)

 **saic.com** \| 1<br>

**SUMMARY INFORMATION**

This summary highlights information contained elsewhere in this Proxy Statement. It does not contain all the information that you

should consider, and you should carefully read the entire Proxy Statement as well as our Annual Report on Form 10-K for our

fiscal year ended January 30, 2026, before voting.

Annual Meeting of Stockholders

---

| | |
|:---|:---|
| • Time and Date: | 9:00 a.m. (ET) on June 3, 2026 |
| • Website: | www.virtualshareholdermeeting.com/SAIC2026 |
| • Record Date: | April 6, 2026 |
| • Voting: | Stockholders as of the close of business on the record date are entitled to vote. |
| • Attendance: | All stockholders and their duly appointed proxies may attend the virtual meeting. |

---

Meeting Agenda and Voting Recommendations

&nbsp;&nbsp;&nbsp;&nbsp;

---

| | | |
|:---|:---|:---|
| **Agenda Item** | **Board Recommendation** | **Page** |
| **Proposal 1:** Election of ten directors. | **FOR** <br>each nominee<br>| <u>[10](#ifa3fbb5066a84569873a8446686510e8_28)</u> |
| **Proposal 2:** Approval of a non-binding, advisory vote to approve the compensation of our <br>named executive officers ("Say-on-Pay").<br>| **FOR** | <u>[37](#ifa3fbb5066a84569873a8446686510e8_82)</u> |
| **Proposal 3:** Approval of a non-binding, advisory vote on the frequency of future Say-on-<br>Pay votes.<br>| **ONE YEAR** | <u>[40](#ifa3fbb5066a84569873a8446686510e8_1725)</u> |
| **Proposal 4:** Approval of an amendment to the 2023 Equity Incentive Plan to increase the <br>total number of authorized shares.<br>| **FOR** | <u>[79](#ifa3fbb5066a84569873a8446686510e8_1649267443663)</u> |
| **Proposal 5:** Ratification of the appointment of Ernst & Young LLP as our independent <br>registered public accounting firm for the fiscal year ending January 29, 2027.<br>| **FOR** | <u>[89](#ifa3fbb5066a84569873a8446686510e8_124)</u> |

---

Board Nominees

The following table provides summary information about each director nominee. Each director nominee is elected annually by a

majority of votes cast by our stockholders, except in cases of contested elections.

---

| | | | | |
|:---|:---|:---|:---|:---|
| | **Age** | **Director** <br>**Since**<br>| **Principal Occupation** | **Committees** |
| **Paul Eremenko**<sup>(1)</sup> | 46 | 2026 | CEO and Co-Founder of P-1 AI | • Audit<br>• Technology<br>|
| **Carolyn B. Handlon** | 68 | 2022 | Former Financial Executive and Treasurer for Marriott <br>International, Inc.<br>| • Audit<br>• Nominating<br>|
| **Katharina G. McFarland** | 66 | 2019 | Private Consultant and former Assistant Secretary of <br>Defense (Acquisition), Dept. of the Army<br>| • Nominating (Chair)<br>• Technology (Chair)<br>|
| **Milford W. McGuirt** | 69 | 2021 | Former Managing Partner at KPMG, LLP | • Audit (Chair)<br>• Nominating <br>|
| **Donna S. Morea** | 71 | 2013 | Chair of SAIC's Board; former President of U.S., Europe, <br>and Asia for CGI Group<br>| • Compensation<br>• Nominating<br>|
| **James C. Reagan** | 67 | 2023 | Chief Executive Officer of SAIC; Former Chief Financial <br>Officer at Leidos Holdings, Inc.<br>| • Technology |
| **Adm. Michael S. Rogers** <br>**(USN Ret.)**<sup>(2)</sup><br>| 66 | 2026 | Retired four-star Admiral with the U.S. Navy | • Audit<br>• Technology<br>|
| **Steven R. Shane** | 68 | 2013 | Former partner at Accenture PLC | • Compensation (Chair)<br>• Technology<br>• Audit<br>|
| **John K. Tien, Jr.** | 62 | 2024 | Former Deputy Secretary of the U.S. Department of <br>Homeland Security <br>| • Nominating<br>•Compensation<br>|
| **David J. Urban**<sup>(3)</sup> | 62 | 2025 | Managing Director at BGR Group | • Compensation<br>• Nominating<br>|

---

(1)Mr. Eremenko was appointed to the Board of Directors effective as of April 8, 2026.

2 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**SUMMARY INFORMATION**<br>

(2)Adm. Rogers was appointed to the Board of Directors effective as of April 8, 2026.

(3)Mr. Urban was appointed to the Board of Directors effective as of September 15, 2025.

Corporate Governance Highlights

---

| | |
|:---|:---|
| ![Corporate_Governance_Highlights-2025.jpg](saic-20260422_g21.jpg) | **Board of Directors Independence** <br>**✓** Twelve of thirteen current Directors Qualify as Independent Directors <br>**✓** Donna S. Morea is the Independent, Non-Executive Chair of the Board of Directors<br>**✓** Mandatory Retirement Age for Independent Directors is 75 years  |
| ![Corporate_Governance_Highlights-2025.jpg](saic-20260422_g21.jpg) | **Director Elections** <br>**✓** Annual Board of Directors Elections <br>**✓** Directors Elected by a Majority of Votes Cast When Uncontested |
| ![Corporate_Governance_Highlights-2025.jpg](saic-20260422_g21.jpg) | **Board of Directors Meetings in Fiscal 2026** <br>**✓** Seven Full Board of Directors Meetings <br>**✓** Ten Independent Director-Only Sessions  |
| ![Corporate_Governance_Highlights-2025.jpg](saic-20260422_g21.jpg) | **Evaluating and Improving Board of Directors Performance** <br>**✓** Annual Board of Directors Self-Evaluation Required <br>**✓** Annual Review of Independence of Board of Directors<br>**✓** Committee Self-Evaluations Required <br>**✓** Board of Directors Orientation/Education Programs  |
| ![Corporate_Governance_Highlights-2025.jpg](saic-20260422_g21.jpg) | **Aligning Director and Stockholder Interests** <br>**✓** Director and Executive Stock Ownership Guidelines <br>**✓** Annual Equity Grant to Non-Employee Directors  |
| ![Corporate_Governance_Highlights-2025.jpg](saic-20260422_g21.jpg) | **Published Governance Policies and Practices (available at** <br>**investors.saic.com)** <br>**✓** Corporate Governance Guidelines <br>**✓** Code of Conduct<br>**✓** Charters for Committees of Board of Directors<br>**✓** Position Description of Chair of Board of Directors |

---

 **saic.com** \| 3<br>

**TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  | **Information About the Annual Meeting of Stockholders** | <u>[5](#ifa3fbb5066a84569873a8446686510e8_25)</u> |
| **Proposal 1** | **Proposal 1 - Election of Directors** | <u>[10](#ifa3fbb5066a84569873a8446686510e8_28)</u> |
| **Proposal 1** | Majority Voting Standard in Uncontested Director Elections | <u>[12](#ifa3fbb5066a84569873a8446686510e8_31)</u> |
| **Proposal 1** | Recommendation of the Board of Directors | <u>[12](#ifa3fbb5066a84569873a8446686510e8_34)</u> |
| **Proposal 1** | Nominees for Election to the Board of Directors | <u>[13](#ifa3fbb5066a84569873a8446686510e8_37)</u> |
| **Corporate** <br>**Governance** | **Corporate Governance** | <u>[20](#ifa3fbb5066a84569873a8446686510e8_40)</u> |
| **Corporate** <br>**Governance** | Corporate Governance Guidelines | <u>[21](#ifa3fbb5066a84569873a8446686510e8_43)</u> |
| **Corporate** <br>**Governance** | Proxy Access | <u>[21](#ifa3fbb5066a84569873a8446686510e8_46)</u> |
| **Corporate** <br>**Governance** | Code of Conduct | <u>[21](#ifa3fbb5066a84569873a8446686510e8_49)</u> |
| **Corporate** <br>**Governance** | Director Independence | <u>[21](#ifa3fbb5066a84569873a8446686510e8_52)</u> |
| **Corporate** <br>**Governance** | Criteria for Board Membership | <u>[22](#ifa3fbb5066a84569873a8446686510e8_55)</u> |
| **Corporate** <br>**Governance** | Board Leadership Structure | <u>[23](#ifa3fbb5066a84569873a8446686510e8_58)</u> |
| **Corporate** <br>**Governance** | The Board's Role in Risk Oversight | <u>[23](#ifa3fbb5066a84569873a8446686510e8_61)</u> |
| **Corporate** <br>**Governance** | Corporate Responsibility  | <u>[24](#ifa3fbb5066a84569873a8446686510e8_64)</u> |
| **Corporate** <br>**Governance** | Board of Directors Meetings and Committees | <u>[25](#ifa3fbb5066a84569873a8446686510e8_67)</u> |
| **Corporate** <br>**Governance** | Board of Directors Compensation | <u>[33](#ifa3fbb5066a84569873a8446686510e8_70)</u> |
| **Corporate** <br>**Governance** | Related Party Transactions | <u>[35](#ifa3fbb5066a84569873a8446686510e8_73)</u> |
| **Corporate** <br>**Governance** | Communication with the Board of Directors | <u>[36](#ifa3fbb5066a84569873a8446686510e8_79)</u> |
| **Proposal 2** | **Proposal 2 - Advisory (Non-Binding) Vote on** <br>**Executive Compensation**<br>| <u>[37](#ifa3fbb5066a84569873a8446686510e8_82)</u> |
| **Proposal 2** | Vote Required | <u>[39](#ifa3fbb5066a84569873a8446686510e8_85)</u> |
| **Proposal 2** | Recommendation of the Board | <u>[39](#ifa3fbb5066a84569873a8446686510e8_88)</u> |
| **Proposal 3** | **Proposal 3 - Advisory (Non-Binding) Vote on Frequency of Vote on** <br>**Executive Compensation**<br>| <u>[40](#ifa3fbb5066a84569873a8446686510e8_1725)</u> |
|  | Vote Required | <u>[41](#ifa3fbb5066a84569873a8446686510e8_1839)</u> |
|  | Recommendation of the Board | <u>[41](#ifa3fbb5066a84569873a8446686510e8_1860)</u> |
| **Compensation** <br>**Discussion and** <br>**Analysis** |  |  |
| **Compensation** <br>**Discussion and** <br>**Analysis** | **Compensation Discussion and Analysis** | <u>[42](#ifa3fbb5066a84569873a8446686510e8_91)</u> |
| **Compensation** <br>**Discussion and** <br>**Analysis** | Human Resources and Compensation Committee Report | <u>[58](#ifa3fbb5066a84569873a8446686510e8_94)</u> |
| **Compensation** <br>**Discussion and** <br>**Analysis** |  |  |

---

4 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**TABLE OF CONTENTS**<br>

---

| | | |
|:---|:---|:---|
| **Executive** <br>**Compensation** | **Executive Compensation** | <u>[59](#ifa3fbb5066a84569873a8446686510e8_97)</u> |
| **Executive** <br>**Compensation** | Summary Compensation Table | <u>[60](#ifa3fbb5066a84569873a8446686510e8_100)</u> |
| **Executive** <br>**Compensation** | Grants of Plan-Based Awards | <u>[62](#ifa3fbb5066a84569873a8446686510e8_103)</u> |
| **Executive** <br>**Compensation** | Outstanding Equity Awards at Fiscal Year-End | <u>[64](#ifa3fbb5066a84569873a8446686510e8_106)</u> |
| **Executive** <br>**Compensation** | Options Exercised and Stock Vested | <u>[65](#ifa3fbb5066a84569873a8446686510e8_109)</u> |
| **Executive** <br>**Compensation** | Nonqualified Deferred Compensation  | <u>[66](#ifa3fbb5066a84569873a8446686510e8_112)</u> |
| **Executive** <br>**Compensation** | Potential Payments upon Termination or a Change in Control | <u>[67](#ifa3fbb5066a84569873a8446686510e8_115)</u> |
| **Executive** <br>**Compensation** | CEO Pay Ratio | <u>[73](#ifa3fbb5066a84569873a8446686510e8_118)</u> |
| **Executive** <br>**Compensation** | Pay Versus Performance | <u>[74](#ifa3fbb5066a84569873a8446686510e8_121)</u> |
| **Proposal 4** | **Proposal 4 - Approval of an Amendment to the 2023 Equity Incentive** <br>**Plan to Increase the Total Number of Authorized Shares**<br>| <u>[79](#ifa3fbb5066a84569873a8446686510e8_1649267443663)</u> |
| **Proposal 4** | Vote Required | <u>[88](#ifa3fbb5066a84569873a8446686510e8_1649267443675)</u> |
| **Proposal 4** | Recommendation of the Board | <u>[88](#ifa3fbb5066a84569873a8446686510e8_1649267443687)</u> |
| **Proposal 5** | **Proposal 5 - Ratification of Appointment of Independent** <br>**Registered Public Accounting Firm**<br>| <u>[89](#ifa3fbb5066a84569873a8446686510e8_124)</u> |
| **Proposal 5** | Vote Required | <u>[90](#ifa3fbb5066a84569873a8446686510e8_127)</u> |
| **Proposal 5** | Recommendation of the Board | <u>[90](#ifa3fbb5066a84569873a8446686510e8_130)</u> |
| **Audit Matters** | **Audit Matters** | <u>[91](#ifa3fbb5066a84569873a8446686510e8_133)</u> |
| **Audit Matters** | Audit Committee Report | <u>[92](#ifa3fbb5066a84569873a8446686510e8_136)</u> |
| **Audit Matters** | Independent Registered Public Accounting Firm | <u>[93](#ifa3fbb5066a84569873a8446686510e8_139)</u> |
| **Audit Matters** | Audit and Non-Audit Fees | <u>[93](#ifa3fbb5066a84569873a8446686510e8_142)</u> |
| **Other Information** | **Other Information** | <u>[94](#ifa3fbb5066a84569873a8446686510e8_145)</u> |
| **Other Information** | Stock Ownership of Certain Beneficial Owners | <u>[95](#ifa3fbb5066a84569873a8446686510e8_148)</u> |
| **Other Information** | Stock Ownership of Directors and Officers | <u>[96](#ifa3fbb5066a84569873a8446686510e8_151)</u> |
| **Other Information** | Delinquent Section 16(a) Reports | <u>[97](#ifa3fbb5066a84569873a8446686510e8_154)</u> |
| **Other Information** | Stockholder Proposals and Director Nominations for the 2027 Annual <br>Meeting<br>| <u>[97](#ifa3fbb5066a84569873a8446686510e8_157)</u> |
| **Other Information** | Annual Report on Form 10-K | <u>[98](#ifa3fbb5066a84569873a8446686510e8_160)</u> |
|  | **Appendices** | <u>[99](#ifa3fbb5066a84569873a8446686510e8_163)</u> |
|  | Appendix A: Non-GAAP Financial Measures | <u>[100](#ifa3fbb5066a84569873a8446686510e8_166)</u> |
|  | Appendix B: SAIC's 2023 Equity Incentive Plan | <u>[102](#ifa3fbb5066a84569873a8446686510e8_2406)</u>  |

---

 **saic.com** \| 5<br>

**INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS**<br>

![SectionDividers.jpg](saic-20260422_g22.jpg)

6 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS**<br>

**INFORMATION ABOUT THE** 

**ANNUAL MEETING OF STOCKHOLDERS**

Proxy Statement

This Proxy Statement is being furnished to the stockholders of Science Applications International Corporation ("SAIC"), a

Delaware corporation, in connection with the solicitation of proxies by our Board of Directors ("Board") for use at our annual

meeting of stockholders to be held on Wednesday, June 3, 2026, at 9:00 a.m. (ET) as a virtual meeting via webcast at

www.virtualshareholdermeeting.com/SAIC2026, and at any and all adjournments, postponements or continuations thereof. This

Proxy Statement and the proxy and voting instruction card are first being sent or made available to our stockholders on or about

April 22, 2026.

---

| | |
|:---|:---|
| **FOUR DIFFERENT WAYS TO VOTE YOUR SHARES**  | **FOUR DIFFERENT WAYS TO VOTE YOUR SHARES**  |
| ![Internet icon_3@300x-100.jpg](saic-20260422_g14.jpg) | **By Internet** <br>You may submit a proxy or voting instructions <br>over the Internet by going to <br>www.proxyvote.com or by scanning the QR <br>code on your proxy and voting instruction card <br>with a smart phone and following the <br>instructions.<br>|
| ![Mail Icopn_3@300x-100.jpg](saic-20260422_g19.jpg) | **By Mail** <br>If you received your proxy materials in the mail, <br>you may complete, sign and return the <br>accompanying proxy and voting instruction card <br>in the postage-paid envelope provided.<br>|

---

---

| | |
|:---|:---|
| ![Phone Icon_3@300x-100.jpg](saic-20260422_g17.jpg) | **By Telephone** <br>You may submit a proxy or voting instructions by <br>calling 1-800-690-6903 and following the <br>instructions.<br>|
| ![Virtual Icon_3@300x-100.jpg](saic-20260422_g15.jpg) | **At The Virtual Annual Meeting** <br>If you are a stockholder of record you may <br>electronically attend the virtual annual <br>meeting and vote your shares at <br>www.virtualshareholdermeeting.com/SAIC2026 <br>during the meeting. You will need to provide <br>your 16-digit control number that is on your <br>Notice of Internet Availability of Proxy Materials <br>or your proxy card if you receive a printed copy <br>of the proxy materials by mail. <br>|

---

Information About Voting Rights and Solicitation of Proxies

**Who is entitled to vote at the annual meeting?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

Only stockholders of record of our common stock as of

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

the close of business on our record date of April 6, 2026,

are entitled to notice of, and to vote at, the annual

meeting. As of April 6, 2026, there were 43,102,387

shares of common stock outstanding. We have no other

class of capital stock outstanding.

**Who may attend the annual meeting?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

All stockholders as of our record date of April 6, 2026, or

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

their duly appointed proxies, may attend the virtual

annual meeting as well as vote and submit questions

during the webcast of the meeting by visiting

www.virtualshareholdermeeting.com/SAIC2026 and

entering the 16-digit control number included in our

Notice of Internet Availability of Proxy Materials or on

your Proxy card (if you received a printed copy of the

proxy materials).

**Why hold a virtual annual meeting?**

![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

We believe that a virtual stockholder meeting provides

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

greater access to those who may want to attend our

annual meeting and, therefore, have chosen this over an

in-person meeting. We ensure that at our virtual annual

meeting, all attendees are afforded the same rights and

opportunities to participate as they would at an in-person

meeting. These procedures include the ability for

stockholders to ask questions during the course of the

meeting, post appropriate questions received during the

meeting for review by other participants, review our

corresponding answers to such questions on our

Investor Relations website at investors.saic.com as soon

as possible after the meeting and access technical

support staff during the meeting in the event of

difficulties arising from the use of the virtual meeting

platform. We continue to receive positive feedback from

our stockholders as we adopt best practices and new

technologies for our annual meeting, Proxy Statement

and related materials. We evaluate annually the method

 **saic.com** \| 7<br>

**INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS**<br>

of holding the annual meeting, taking into consideration

the above factors as well as business and market

conditions and the proposed agenda items. We continue

to believe that holding our annual meeting virtually over

the internet is the right approach for our company, as it

enables more of our geographically diverse base of

stockholders to participate in our annual meeting.

**What constitutes a quorum?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

The presence, either in person or by proxy, of the

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

holders of a majority of the total voting power of the

shares of common stock outstanding as of April 6, 2026,

is necessary to constitute a quorum and to conduct

business at the annual meeting. Abstentions and broker

"non-votes" will be counted as present for purposes of

determining the presence of a quorum.

**What is a broker "non-vote"?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

A broker "non-vote" occurs when a broker, bank or other

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

nominee holding shares for a beneficial owner does not

vote on a particular proposal because the nominee does

not have discretionary voting power with respect to that

matter and has not received voting instructions from the

beneficial owner. In tabulating the voting results for a

particular proposal, broker "non-votes" are not

considered entitled to vote on that proposal. Broker

"non-votes" will not have an effect on the outcome of any

matter being voted on at the meeting, assuming a

quorum is present.

Unless you provide voting instructions to any broker

holding shares on your behalf, your broker may not use

discretionary authority to vote your shares on any of the

matters to be considered at the annual meeting other

than the ratification of our independent registered public

accounting firm. Please vote your shares or provide

voting instructions to your broker so your vote can be

counted.

**How many votes am I entitled to?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

Each holder of common stock will be entitled to one vote

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

per share, in person or by proxy, for each share of

common stock held in the stockholder's name as of

April 6, 2026, on any matter submitted to a vote of

stockholders at the annual meeting.

**How do I vote my shares?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

Shares of common stock represented by a properly

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

executed and timely proxy will, unless it has previously

been revoked, be voted in accordance with its

instructions. In the absence of specific instructions, the

shares represented by a properly executed and timely

proxy will be voted in accordance with the Board's

recommendations as follows:

• **FOR** all of the company's nominees to the Board;

• **FOR** the approval, on a non-binding, advisory basis, of

the compensation of our named executive officers

("Say-on-Pay");

• **ONE YEAR** as the frequency of future Say-on-Pay

votes;

• **FOR** the approval of an amendment to our 2023

Equity Incentive Plan to Increase the Total Number of

Authorized Shares; and

• **FOR** the ratification of the appointment of Ernst & Young

LLP as our independent registered public accounting

firm for our fiscal year ending January 29, 2027.

No other business is expected to come before the

annual meeting; however, should any other matter

properly come before the annual meeting, the proxy

holders intend to vote such shares in accordance with

their best judgment on any additional matter.

You may revoke a previously delivered proxy by

delivering written notice of revocation to Hilary L.

Hageman, our Corporate Secretary, or by executing a

later dated proxy and giving written notice of the

revocation to our Corporate Secretary at any time before

the proxy is voted at the annual meeting. If you

submitted your proxy by Internet or by telephone, you

can vote again by voting over the Internet or by

telephone. We will honor the latest vote received. Proxy

holders will vote shares represented by written proxies, if

properly signed and returned to our Corporate Secretary,

in accordance with instructions of the stockholders.

**What are the voting deadlines?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

For shares not held in the Science Applications

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

International Corporation Retirement Plan (the "SAIC

Retirement Plan"), the deadline for submitting a proxy

using the internet or the telephone is 11:59 p.m. (ET) on

June 2, 2026. For shares held in the SAIC Retirement

Plan, the deadline for submitting voting instructions

using any of the allowed methods is 11:59 p.m. (ET) on

May 31, 2026.

**How are the shares held by the SAIC Retirement**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

**Plan voted?** 

Each participant in the SAIC Retirement Plan has the

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

right to instruct Vanguard Fiduciary Trust Company

("Vanguard"), as trustee of the SAIC Retirement Plan

(the "SAIC Trustee"), on a confidential basis, how to vote

his or her proportionate interests in all shares of

common stock held in the SAIC Retirement Plan. The

SAIC Trustee will vote all shares held in the SAIC

Retirement Plan for which no voting instructions are

received in the same proportion as the shares for which

voting instructions have been received by participants in

8 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS**<br>

the SAIC Retirement Plan. The SAIC Trustee's duties

with respect to voting the shares of common stock in the

SAIC Retirement Plan are governed by the fiduciary

provisions of the Employee Retirement Income Security

Act of 1974, as amended ("ERISA"). The fiduciary

provisions of ERISA may require in certain limited

circumstances that the SAIC Trustee override the votes

of participants with respect to the shares of common

stock held by the SAIC Trustee.

**How are the shares held by the SAIC Stock Plans**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

**voted?** 

Under the terms of our Management Stock

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

Compensation Plan and Key Executive Stock Deferral

Plan (collectively, the "SAIC Stock Plans"), Newport

Trust Company ("NTC"), as trustee of the SAIC Stock

Plans, has the power to vote the shares of common stock

held in the SAIC Stock Plans. NTC will vote all those

shares in the same proportion that our other stockholders

collectively vote their shares of common stock. If you are

a participant in any of the SAIC Stock Plans, you do not

have the right to instruct NTC how to vote or to otherwise

vote your proportionate interests in the shares of

common stock held in such SAIC Stock Plan.

**What is the difference between a "stockholder of**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

**record" and a "beneficial" holder?** 

These terms describe how the ownership of your shares

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

is reflected on the books of our transfer agent,

Computershare. If your shares are registered directly

with Computershare as a transfer agent, then you are a

"stockholder of record" of these shares. If your shares

are held in an account at a broker, bank, trust or other

similar organization, then you are a "beneficial" holder of

these shares. The organization holding your account is

considered the stockholder of record for purposes of

voting at the annual meeting. As a beneficial owner, you

have the right to instruct the organization on how to vote

the shares held in your account. If you wish to vote in

person at the virtual annual meeting, you must obtain a

valid proxy from the organization holding the shares.

**Who is soliciting these proxies?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

We are soliciting these proxies and the cost of the

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

solicitation will be borne by us, including the charges and

expenses of persons holding shares in their name as

nominee incurred in connection with forwarding Proxy

Materials to the beneficial owners of those shares. We

have retained Morrow Sodali LLC to assist in the

solicitation of proxies for the annual meeting for a fee of

approximately $10,000 plus reimbursement of out-of-

pocket expenses. In addition to the distribution of the

Proxy Materials by mail and through the Notice of

Internet Availability of Proxy Materials described below

under the caption "Internet Availability of Proxy

Materials," proxies may be solicited by our officers,

directors and employees in person, by telephone or by

email. These individuals will not be additionally

compensated for such solicitation but may be

reimbursed for reasonable out-of-pocket expenses

incurred in connection with such solicitation.

**What is "householding" and how does it affect me?**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

We have adopted a procedure approved by the

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

Securities and Exchange Commission ("SEC") called

"householding." Under this procedure, we send only one

Proxy Statement and one annual report to eligible

stockholders who share a single address, unless we

have received instructions to the contrary from any

stockholder at that address. This practice is designed to

reduce our printing and postage costs. Stockholders who

do not participate in householding will continue to

receive separate proxy and voting instruction cards. We

do not use householding for any other stockholder

mailings.

If you are a registered stockholder residing at an

address with other registered stockholders and wish to

receive a separate copy of the Proxy Statement or

annual report, or if you do not wish to participate in

householding and prefer to receive separate copies of

these documents in the future, please contact our

mailing agent, Broadridge, either by calling toll-free

at (866) 540-7095, or by writing to Broadridge,

Householding Department, 51 Mercedes Way,

Edgewood, New York 11717. If you own shares through

a bank, broker or other nominee, you should contact the

nominee concerning householding procedures. We will

promptly deliver a separate copy of the Proxy Statement

or annual report to you upon request.

If you are eligible for householding, but you and other

stockholders of record with whom you share an address

currently receive multiple copies of the Proxy Statement

or annual report and you wish to receive a single copy of

each of these documents for your household, please

contact our mailing agent, Broadridge, at the telephone

number or address indicated above to bring this to our

mailing agent's attention.

**Where can I find the voting results of the annual**![Round Question @300x-100.jpg](saic-20260422_g23.jpg)

**meeting?** 

We intend to announce preliminary voting results at the

![Round Answer@300x-100.jpg](saic-20260422_g24.jpg)

annual meeting and publish final results in a Current

Report on Form 8-K to be filed with the SEC within four

business days of the annual meeting.

 **saic.com** \| 9<br>

**INFORMATION ABOUT THE ANNUAL MEETING OF STOCKHOLDERS**<br>

Internet Availability of Proxy Materials

As permitted by the rules and regulations of the SEC, we are using the Internet as a means of furnishing proxy materials to our

stockholders. We believe this method makes the proxy distribution process more efficient, lowers costs and helps in conserving

natural resources.

On or about April 22, 2026, we mailed to our stockholders a Notice of Internet Availability of Proxy Materials containing

instructions on how to access our proxy materials, including the proxy statement and annual report. The Notice of Internet

Availability of Proxy Materials also instructs you on how to access your proxy and voting instruction card to be able to vote

through the Internet or by telephone. Other stockholders, in accordance with their prior requests, and employees with regular

access to email through their company email address have received email notification of how to access our proxy materials

and vote via the Internet or by telephone or have been mailed paper copies of our proxy materials and a proxy and voting

instruction card.

The Proxy Statement and Annual Report are available at www.proxyvote.com.

10 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

![SectionDividers2.jpg](saic-20260422_g25.jpg)

 **saic.com** \| 11<br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

**PROPOSAL 1 -** 

**ELECTION OF DIRECTORS** 

The Board unanimously

recommends a vote **FOR** 

each nominee.

![Check in Box-01.jpg](saic-20260422_g26.jpg)

At the annual meeting, ten directors are to be elected to serve for one-year terms and to hold such position until each director's

successor is elected and qualified unless any of the directors resign or are removed prior to the end of their respective term. All

nominees have been nominated by the Board based on the recommendation of the Nominating and Corporate Governance

Committee thereof. To the best knowledge of the Board, all of the nominees are able and willing to serve. Each nominee has

consented to be named in this Proxy Statement and to serve if elected. Each nominee listed below is currently a director of the

company and, other than Mr. Eremenko, Adm. Rogers, and Mr. Urban, each was elected by the stockholders at our 2025 annual

meeting of stockholders. Mr. Urban was elected to serve as a director by the Board effective as of September 15, 2025, and is

standing for election by our stockholders as a director of the company for the first time at this year's annual meeting. Mr. Urban

was first identified as a potential director candidate by one of our current non-executive directors. Mr. Eremenko and Adm.

Rogers were each elected to serve as directors by the Board effective as of April 8, 2026, and each are standing for election by

our stockholders as a director of the company for the first time at this year's annual meeting. Mr. Eremenko and Adm. Rogers

were both first identified by an external search firm. All three candidates went through the company's rigorous vetting process,

including full background checks, and were selected based on their excellent credentials and financial acumen. Mr. Eremenko,

Adm. Rogers, and Mr. Urban were then evaluated by the Nominating and Corporate Governance Committee in advance of its

recommendation of their respective service as directors. In addition to the director nominees below who served as members of

the Board during our fiscal year ended January 30, 2026, Dr. Garth Graham, Ms. Yvette Kanouff, and Mr. Timothy J. Mayopoulos

each also served as members of the Board during our fiscal year ended January 30, 2026. Dr. Graham, Ms. Kanouff, and Mr.

Mayopoulos are not standing for re-election at this year's annual meeting of stockholders and, as a result, the size of the Board

will be decreased from thirteen to ten directors.

![Election of Directors_v10.jpg](saic-20260422_g27.jpg)

12 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

Majority Voting Standard in Uncontested Director Elections

We have adopted majority voting procedures for the election of directors in uncontested elections. In an uncontested election,

nominees must receive more "for" than "against" votes to be elected without further action. Abstentions and broker non-votes are

not counted as votes cast. As provided in our bylaws, a "contested election" is one in which the number of nominees exceeds the

number of directors to be elected. The election of directors at the 2026 annual meeting of stockholders is an uncontested election.

If an incumbent director receives more "against" than "for" votes, he or she is expected to tender his or her resignation in

accordance with our Corporate Governance Guidelines. The Nominating and Corporate Governance Committee will consider the

offer of resignation and recommend to the Board the action to be taken. The Board will promptly disclose its decision as to

whether to accept or reject the tendered resignation in a press release, Current Report on Form 8-K or other public

announcement.

Shares of common stock represented by properly executed, timely received and unrevoked proxies will be voted as instructed in

the proxy. In the absence of specific instructions, the shares represented by properly executed, timely received and unrevoked

proxies will be voted "for" each nominee. If any of the nominees listed below becomes unable to stand for election at the annual

meeting, the proxy holders intend to vote for any person designated by the Board to replace the nominee unable to serve.

Recommendation of the Board of Directors

The Board unanimously recommends a vote FOR each nominee.

 **saic.com** \| 13<br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

Nominees for Election to the Board of Directors

Set forth below is a brief biography of each nominee for election as a director and a brief discussion of the specific experience,

qualifications, attributes or skills that led to the Board's conclusion that the nominee should serve as a director of our company.

The Board evaluates each individual in the context of the Board as a whole, with the objective of recommending to stockholders

a group of nominees with complementary skills and a diverse mix of backgrounds, perspectives and expertise beneficial to the

broad business diversity of the company. Our board membership criteria and director nomination process are described in the

"Corporate Governance" section of this Proxy Statement.

**Paul Eremenko** 

---

| | |
|:---|:---|
| ![Eremenko.jpg](saic-20260422_g28.jpg) | **Select Qualifications and Skills:**<br>**Leadership and Executive Experience:** Mr. Eremenko is the Chief Executive <br>Officer and Co Founder of P-1 AI, a company focused on developing agentic <br>artificial intelligence for complex systems engineering. From 2020 to 2024 he <br>served as CEO of Universal Hydrogen Co. a hydrogen aviation company <br>which built and flew the world's largest fuel cell-powered passenger airliner. <br>From 2018 to 2019, Mr. Eremenko was Senior Vice President and Chief <br>Technology Officer (CTO) of United Technologies Corporation (UTC), where he <br>led the 30,000-person engineering function and spearheaded research, <br>technology, and innovation initiatives, and played a key role in the technical <br>due diligence for the merger of UTC's aerospace businesses with Raytheon to <br>form Raytheon Technologies (NYSE: RTX). He also served as CTO of Airbus <br>SE, the world's leading maker of commercial aircraft, and was the founding <br>CEO of Acubed, Airbus' Silicon Valley innovation center. <br>**Industry Experience:** From 2013 to 2015, Mr. Eremenko served as Director of <br>Engineering at Google's Advanced Technology and Projects organization, and <br>prior to that at Motorola Mobility. Mr. Eremenko currently serves on the Board <br>of Directors of Eve Holding Inc. (NYSE: EVEX), an aerospace company. Mr. <br>Eremenko worked at DARPA, the Defense Advanced Research Projects <br>Agency, from 2009 – 2013, first as a Program Manager, and later as the <br>Deputy Director and Acting Director of the Tactical Technology Office, the <br>agency's large systems and platforms office. For his work at DARPA, Mr. <br>Eremenko was awarded the Distinguished Public Service Medal by the Office <br>of the Secretary of Defense. <br>Mr. Eremenko earned his undergraduate and Master's degrees in aeronautics <br>from the Massachusetts Institute of Technology (MIT) and California Institute of <br>Technology (Caltech), respectively. Mr. Eremenko also holds a J.D. from <br>Georgetown University. His leadership and expertise in AI, aerospace <br>research and development, and managing advanced technology <br>organizations, as well as his experience in the government sector, position him <br>as a pioneer in driving technological transformation, providing the board with <br>invaluable insights to guide strategic decisions and foster innovation-led <br>growth**.** |
| **Age:** 46<br>**Director since:** 2026<br>**Independent**<br>**Committees:**<br> Audit; Technology | **Select Qualifications and Skills:**<br>**Leadership and Executive Experience:** Mr. Eremenko is the Chief Executive <br>Officer and Co Founder of P-1 AI, a company focused on developing agentic <br>artificial intelligence for complex systems engineering. From 2020 to 2024 he <br>served as CEO of Universal Hydrogen Co. a hydrogen aviation company <br>which built and flew the world's largest fuel cell-powered passenger airliner. <br>From 2018 to 2019, Mr. Eremenko was Senior Vice President and Chief <br>Technology Officer (CTO) of United Technologies Corporation (UTC), where he <br>led the 30,000-person engineering function and spearheaded research, <br>technology, and innovation initiatives, and played a key role in the technical <br>due diligence for the merger of UTC's aerospace businesses with Raytheon to <br>form Raytheon Technologies (NYSE: RTX). He also served as CTO of Airbus <br>SE, the world's leading maker of commercial aircraft, and was the founding <br>CEO of Acubed, Airbus' Silicon Valley innovation center. <br>**Industry Experience:** From 2013 to 2015, Mr. Eremenko served as Director of <br>Engineering at Google's Advanced Technology and Projects organization, and <br>prior to that at Motorola Mobility. Mr. Eremenko currently serves on the Board <br>of Directors of Eve Holding Inc. (NYSE: EVEX), an aerospace company. Mr. <br>Eremenko worked at DARPA, the Defense Advanced Research Projects <br>Agency, from 2009 – 2013, first as a Program Manager, and later as the <br>Deputy Director and Acting Director of the Tactical Technology Office, the <br>agency's large systems and platforms office. For his work at DARPA, Mr. <br>Eremenko was awarded the Distinguished Public Service Medal by the Office <br>of the Secretary of Defense. <br>Mr. Eremenko earned his undergraduate and Master's degrees in aeronautics <br>from the Massachusetts Institute of Technology (MIT) and California Institute of <br>Technology (Caltech), respectively. Mr. Eremenko also holds a J.D. from <br>Georgetown University. His leadership and expertise in AI, aerospace <br>research and development, and managing advanced technology <br>organizations, as well as his experience in the government sector, position him <br>as a pioneer in driving technological transformation, providing the board with <br>invaluable insights to guide strategic decisions and foster innovation-led <br>growth**.** |

---

14 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

**Carolyn B. Handlon**

---

| | |
|:---|:---|
| ![Carolyn_Handlon.jpg](saic-20260422_g29.jpg) | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Served in various <br>financial leadership roles for over 35 years, including 17 years as Executive <br>Vice President, Finance and Treasurer, with Marriott International, Inc. Prior to <br>joining Marriott, Ms. Handlon worked for the Overseas Private Investment <br>Corporation and for the Continental Illinois National Bank and Trust. <br>**Financial Expertise:** Over 40 years of financial experience in the areas of <br>global capital markets, global investment and real estate lending, financial <br>strategy and risk management, global cash operations, mergers and <br>acquisitions, and corporate finance.<br>**Director Experience:** Ms. Handlon currently serves on the Board of Directors <br>for Invesco Mortgage Capital and Apple Hospitality REIT, Inc. (Nasdaq: APLE).<br>Ms. Handlon's extensive background in the financial and global market <br>industry along with her senior leadership experience provide significant value <br>to our Board. |
| **Age:** 68<br>**Director since:** 2022<br>**Independent**<br>**Committees:**<br> Audit; Nominating | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Served in various <br>financial leadership roles for over 35 years, including 17 years as Executive <br>Vice President, Finance and Treasurer, with Marriott International, Inc. Prior to <br>joining Marriott, Ms. Handlon worked for the Overseas Private Investment <br>Corporation and for the Continental Illinois National Bank and Trust. <br>**Financial Expertise:** Over 40 years of financial experience in the areas of <br>global capital markets, global investment and real estate lending, financial <br>strategy and risk management, global cash operations, mergers and <br>acquisitions, and corporate finance.<br>**Director Experience:** Ms. Handlon currently serves on the Board of Directors <br>for Invesco Mortgage Capital and Apple Hospitality REIT, Inc. (Nasdaq: APLE).<br>Ms. Handlon's extensive background in the financial and global market <br>industry along with her senior leadership experience provide significant value <br>to our Board. |

---

**Katharina G. McFarland** 

---

| | |
|:---|:---|
| ![Katherina_McFarland.jpg](saic-20260422_g30.jpg) | **Select Qualifications and Skills:**<br>**Leadership Experience:** With over 30 years of government service, <br>Katharina McFarland is widely recognized as a leading subject-matter expert <br>on government procurement, science and technology (as prior Co-Chair of the <br>Army Science Board and prior Chair of the Board of Army Research and <br>Development at the National Academies of Science), IT, cyber, and AI as <br>Commissioner of the National Security Commission on Artificial Intelligence, and <br>Procurement as a Director on the Procurement Round Table. She also serves as <br>a member of the NASA Aerospace Safety Advisory Council. Ms. McFarland was <br>previously the Assistant Secretary of Defense for Acquisition (2012 to 2017) and <br>acting Assistant Secretary of the Army (Acquisition, Logistics & Technology) <br>(2016 to 2017). She was President of the Defense Acquisition University from <br>2010 to 2012. From 2006 to 2010, Ms. McFarland was the Director of <br>Acquisition, Missile Defense Agency. <br>**Director Experience**: Ms. McFarland has extensive public and private Board <br>experience and served as a Director for Engility from 2017 to January 2019. <br>She has served on the Board of Directors for Transphorm Inc. from January <br>2021 to July 2024, and served on the Board of Directors for Virgin Orbit from <br>November 2021 to August 2023. In addition, Ms. McFarland has served on a <br>number of various advisory boards and council positions, including those at <br>Rafael Systems Global Sustainment Group, Skylo, and Gambit.<br>Ms. McFarland brings substantial experience in defense acquisition, program <br>management, logistics and technology. In particular, her experience with the <br>U.S. Department of Defense, Department of the Army, and Intelligence <br>Community procurement provides valuable insight to the Board. |
| **Age:** 66<br>**Director since:** 2019<br>**Independent**<br>**Committees:** <br>Nominating (Chair); Technology (Chair) | **Select Qualifications and Skills:**<br>**Leadership Experience:** With over 30 years of government service, <br>Katharina McFarland is widely recognized as a leading subject-matter expert <br>on government procurement, science and technology (as prior Co-Chair of the <br>Army Science Board and prior Chair of the Board of Army Research and <br>Development at the National Academies of Science), IT, cyber, and AI as <br>Commissioner of the National Security Commission on Artificial Intelligence, and <br>Procurement as a Director on the Procurement Round Table. She also serves as <br>a member of the NASA Aerospace Safety Advisory Council. Ms. McFarland was <br>previously the Assistant Secretary of Defense for Acquisition (2012 to 2017) and <br>acting Assistant Secretary of the Army (Acquisition, Logistics & Technology) <br>(2016 to 2017). She was President of the Defense Acquisition University from <br>2010 to 2012. From 2006 to 2010, Ms. McFarland was the Director of <br>Acquisition, Missile Defense Agency. <br>**Director Experience**: Ms. McFarland has extensive public and private Board <br>experience and served as a Director for Engility from 2017 to January 2019. <br>She has served on the Board of Directors for Transphorm Inc. from January <br>2021 to July 2024, and served on the Board of Directors for Virgin Orbit from <br>November 2021 to August 2023. In addition, Ms. McFarland has served on a <br>number of various advisory boards and council positions, including those at <br>Rafael Systems Global Sustainment Group, Skylo, and Gambit.<br>Ms. McFarland brings substantial experience in defense acquisition, program <br>management, logistics and technology. In particular, her experience with the <br>U.S. Department of Defense, Department of the Army, and Intelligence <br>Community procurement provides valuable insight to the Board. |

---

 **saic.com** \| 15<br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

**Milford W. McGuirt** 

---

| | |
|:---|:---|
| ![Milford_McGuirt.jpg](saic-20260422_g31.jpg) | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Served as Managing <br>Partner of the Atlanta office and Mid-South Area of KPMG from January 2015 <br>until his retirement in September 2019. During a 33-year career at KPMG, <br>Mr. McGuirt held a number of leadership positions, including as a senior <br>partner and the National Audit Sector Leader and National Industry Leader for <br>the firm's higher education practice. Prior to joining KPMG, Mr. McGuirt served <br>as an audit manager with Coopers & Lybrand. <br>**Financial Expertise:** Over 41 years of financial experience in the areas of <br>public accounting and auditing with Big 4 international and consulting firms, <br>including 29 years as a Partner at KPMG. <br>**Director Experience**: Mr. McGuirt served on the board of HD Supply as an <br>independent director and member of the audit and nominating and corporate <br>governance committee from July to December of 2020, and currently serves <br>on the board of Oxford Industries, Inc. since July of 2020, and private company <br>Chick-fil-A, Inc. since October 2021. In addition, Mr. McGuirt also previously <br>served on KPMG's Nominating Committee of the Board of Directors as well as <br>the KPMG Diversity Advisory Board and KPMG Foundation.<br>Mr. McGuirt's decades of extensive experience in the financial industry, <br>specifically in the accounting and auditing fields, as well as over 30 years of <br>leadership roles, make him a great asset to the Board and his financial insight <br>will be greatly beneficial to our company. |
| **Age:** 69<br>**Director since:** 2021<br>**Independent**<br>**Committees:** <br>Audit (Chair); Nominating | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Served as Managing <br>Partner of the Atlanta office and Mid-South Area of KPMG from January 2015 <br>until his retirement in September 2019. During a 33-year career at KPMG, <br>Mr. McGuirt held a number of leadership positions, including as a senior <br>partner and the National Audit Sector Leader and National Industry Leader for <br>the firm's higher education practice. Prior to joining KPMG, Mr. McGuirt served <br>as an audit manager with Coopers & Lybrand. <br>**Financial Expertise:** Over 41 years of financial experience in the areas of <br>public accounting and auditing with Big 4 international and consulting firms, <br>including 29 years as a Partner at KPMG. <br>**Director Experience**: Mr. McGuirt served on the board of HD Supply as an <br>independent director and member of the audit and nominating and corporate <br>governance committee from July to December of 2020, and currently serves <br>on the board of Oxford Industries, Inc. since July of 2020, and private company <br>Chick-fil-A, Inc. since October 2021. In addition, Mr. McGuirt also previously <br>served on KPMG's Nominating Committee of the Board of Directors as well as <br>the KPMG Diversity Advisory Board and KPMG Foundation.<br>Mr. McGuirt's decades of extensive experience in the financial industry, <br>specifically in the accounting and auditing fields, as well as over 30 years of <br>leadership roles, make him a great asset to the Board and his financial insight <br>will be greatly beneficial to our company. |

---

**Donna S. Morea** 

---

| | |
|:---|:---|
| ![Donna_Morea.jpg](saic-20260422_g32.jpg) | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Served as President of <br>CGI, one of the largest independent information technology firms in North <br>America, from May 2004 until her retirement at the end of 2011. Ms. Morea also <br>served as a Board Director for CGI from February 2012 to May 2013. Ms. Morea <br>currently serves on the Board of Directors of Truist (NYSE:TFC) and is an <br>Operating Executive of The Carlyle Group, where she focuses on technology <br>and business services. Ms. Morea is also a member of the Advisory Board of <br>Blue Delta Capital Partners.<br>**Industry Knowledge and Experience: *Information and Technology*** <br>***Expertise:*** Over 40 years of experience; nationally recognized executive in IT <br>software and professional services; and led CGI's IT and business process <br>services in the U.S., EMEA and Asia Pacific for large enterprises in financial <br>services, healthcare, telecommunications and government.<br>**Director Experience:** Ms. Morea served as a member of the Board of Directors <br>of SunTrust Banks, Inc. from 2012 until December 2019 and Truist Financial <br>Corp. since December 2019. She also served on the Board of KLDiscovery Inc. <br>from April 2016 until June 2023. Ms. Morea also serves on the boards of Carlyle <br>and other private equity portfolio companies.<br>The Board believes that Ms. Morea's executive management experience and <br>information technology expertise provide valuable leadership experience and <br>market knowledge of a significant segment of our business. |
| **Age:** 71<br>**Director since:** 2013<br>**Independent**<br>**Chair of the Board**<br>**Committees:** <br>Compensation; Nominating | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Served as President of <br>CGI, one of the largest independent information technology firms in North <br>America, from May 2004 until her retirement at the end of 2011. Ms. Morea also <br>served as a Board Director for CGI from February 2012 to May 2013. Ms. Morea <br>currently serves on the Board of Directors of Truist (NYSE:TFC) and is an <br>Operating Executive of The Carlyle Group, where she focuses on technology <br>and business services. Ms. Morea is also a member of the Advisory Board of <br>Blue Delta Capital Partners.<br>**Industry Knowledge and Experience: *Information and Technology*** <br>***Expertise:*** Over 40 years of experience; nationally recognized executive in IT <br>software and professional services; and led CGI's IT and business process <br>services in the U.S., EMEA and Asia Pacific for large enterprises in financial <br>services, healthcare, telecommunications and government.<br>**Director Experience:** Ms. Morea served as a member of the Board of Directors <br>of SunTrust Banks, Inc. from 2012 until December 2019 and Truist Financial <br>Corp. since December 2019. She also served on the Board of KLDiscovery Inc. <br>from April 2016 until June 2023. Ms. Morea also serves on the boards of Carlyle <br>and other private equity portfolio companies.<br>The Board believes that Ms. Morea's executive management experience and <br>information technology expertise provide valuable leadership experience and <br>market knowledge of a significant segment of our business. |

---

16 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

**James C. Reagan** 

---

| | |
|:---|:---|
| ![James_Reagan.jpg](saic-20260422_g33.jpg) | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Mr. Reagan was <br>appointed as the company's Chief Executive Officer beginning February 17, <br>2026. From October 23, 2025 to February 16, 2026, Mr. Reagan served as the <br>company's interim Chief Executive Officer. He also previously served as <br>Executive Vice President & Chief Financial Officer for Leidos Holdings, Inc. <br>("Leidos") from July 2015 until his retirement in June 2021. Prior to joining <br>Leidos, Mr. Reagan served as Chief Financial Officer for several organizations <br>including Vencore, Inc., a defense contractor serving the Intelligence <br>Community and Department of Defense, and at PAE, Inc. Mr. Reagan was also <br>the CFO of Aspect Communications until 2005 and held several senior roles at <br>MCI Telecommunications.<br>**Industry Knowledge and Experience:** Over two decades of experience in the <br>government services industry across a vast set of areas including cybersecurity <br>and intelligence, information technology and healthcare, and national security. <br>Mr. Reagan also possesses expertise in software, telecommunications, and <br>real estate.<br>**Financial Expertise:** Over 40 years of experience as a financial leader across a <br>diverse set of industries with extensive experience in transactional mergers and <br>acquisitions and business process optimization to drive shareholder growth. He <br>has been a licensed CPA in the Commonwealth of Virginia since 1982.<br>The Board believes that Mr. Reagan's financial expertise and his deep <br>knowledge and experience in the government services market gained through <br>decades of serving major companies in our industry provide important <br>contributions to the Board. In addition, our Board believes that the company's <br>Chief Executive Officer should serve on the Board of Directors to help <br>communicate the Board's priorities to management as well as bring <br>management's perspective on matters considered by the Board. |
| **Age:** 67<br>**Director since:** 2023<br>**Chief Executive Officer**<br>**Committee:** Technology | **Select Qualifications and Skills:**<br>**Leadership and Executive Management Experience:** Mr. Reagan was <br>appointed as the company's Chief Executive Officer beginning February 17, <br>2026. From October 23, 2025 to February 16, 2026, Mr. Reagan served as the <br>company's interim Chief Executive Officer. He also previously served as <br>Executive Vice President & Chief Financial Officer for Leidos Holdings, Inc. <br>("Leidos") from July 2015 until his retirement in June 2021. Prior to joining <br>Leidos, Mr. Reagan served as Chief Financial Officer for several organizations <br>including Vencore, Inc., a defense contractor serving the Intelligence <br>Community and Department of Defense, and at PAE, Inc. Mr. Reagan was also <br>the CFO of Aspect Communications until 2005 and held several senior roles at <br>MCI Telecommunications.<br>**Industry Knowledge and Experience:** Over two decades of experience in the <br>government services industry across a vast set of areas including cybersecurity <br>and intelligence, information technology and healthcare, and national security. <br>Mr. Reagan also possesses expertise in software, telecommunications, and <br>real estate.<br>**Financial Expertise:** Over 40 years of experience as a financial leader across a <br>diverse set of industries with extensive experience in transactional mergers and <br>acquisitions and business process optimization to drive shareholder growth. He <br>has been a licensed CPA in the Commonwealth of Virginia since 1982.<br>The Board believes that Mr. Reagan's financial expertise and his deep <br>knowledge and experience in the government services market gained through <br>decades of serving major companies in our industry provide important <br>contributions to the Board. In addition, our Board believes that the company's <br>Chief Executive Officer should serve on the Board of Directors to help <br>communicate the Board's priorities to management as well as bring <br>management's perspective on matters considered by the Board. |

---

**Adm. Michael S. Rogers (USN Ret.)**

---

| | |
|:---|:---|
| ![Adm. Michael Rogers.jpg](saic-20260422_g34.jpg) | **Select Qualifications and Skills:**<br>**Leadership Experience:** Admiral Michael Rogers is a retired four-star officer <br>with 37 years of extensive experience and expertise in military operations, <br>cyber operations, intelligence, advanced technology, national security, and the <br>defense of U.S. military networks. Since 2019, Adm. Rogers has served as <br>Senior Advisor to the Brunswick Group. He retired in 2018 from the U.S. Navy <br>as a four star Admiral after a distinguished career, culminating as Director of <br>the National Security Agency and Commander of U.S. Cyber Command <br>(2014–2018).<br>**Industry Experience: *Military and Government Expertise:*** Prior to Adm. <br>Rogers' retirement, he led the U.S. Fleet Cyber Command and U.S. Tenth <br>Fleet (2011–2014) and served as Director of Intelligence for U.S. Indo Pacific <br>Command and the Joint Staff (2007–2011). A flag officer from 2007 to 2018, <br>he held numerous assignments from 1981 to 2007 in maritime operations, <br>cryptology, intelligence, and joint operations both afloat and ashore around the <br>world. Prior to becoming a flag officer, he served as the Special Assistant to <br>the Chairman of the Joint Chiefs of Staff. <br>Adm. Rogers holds a Bachelor's business degree from Auburn University, a <br>Master's degree in national security from National Defense University <br>graduating with highest distinction and is a graduate (with distinction) of the <br>U.S. Naval War College. He is also a MIT Seminar XXI fellow and a Harvard <br>University Senior Executive in National Security alum. Adm. Rogers' <br>distinguished career as a four-star Navy officer combined with his extensive <br>U.S. and global expertise in technology, intelligence, geopolitics, and defense <br>makes him uniquely qualified to provide invaluable insights and governance on <br>the board of directors.  |
| **Age:** 66<br>**Director since:** 2026<br>**Independent**<br>**Committees:**<br> Audit; Technology | **Select Qualifications and Skills:**<br>**Leadership Experience:** Admiral Michael Rogers is a retired four-star officer <br>with 37 years of extensive experience and expertise in military operations, <br>cyber operations, intelligence, advanced technology, national security, and the <br>defense of U.S. military networks. Since 2019, Adm. Rogers has served as <br>Senior Advisor to the Brunswick Group. He retired in 2018 from the U.S. Navy <br>as a four star Admiral after a distinguished career, culminating as Director of <br>the National Security Agency and Commander of U.S. Cyber Command <br>(2014–2018).<br>**Industry Experience: *Military and Government Expertise:*** Prior to Adm. <br>Rogers' retirement, he led the U.S. Fleet Cyber Command and U.S. Tenth <br>Fleet (2011–2014) and served as Director of Intelligence for U.S. Indo Pacific <br>Command and the Joint Staff (2007–2011). A flag officer from 2007 to 2018, <br>he held numerous assignments from 1981 to 2007 in maritime operations, <br>cryptology, intelligence, and joint operations both afloat and ashore around the <br>world. Prior to becoming a flag officer, he served as the Special Assistant to <br>the Chairman of the Joint Chiefs of Staff. <br>Adm. Rogers holds a Bachelor's business degree from Auburn University, a <br>Master's degree in national security from National Defense University <br>graduating with highest distinction and is a graduate (with distinction) of the <br>U.S. Naval War College. He is also a MIT Seminar XXI fellow and a Harvard <br>University Senior Executive in National Security alum. Adm. Rogers' <br>distinguished career as a four-star Navy officer combined with his extensive <br>U.S. and global expertise in technology, intelligence, geopolitics, and defense <br>makes him uniquely qualified to provide invaluable insights and governance on <br>the board of directors.  |

---

 **saic.com** \| 17<br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

**Steven R. Shane**

---

| | |
|:---|:---|
| ![Steve_Shane.jpg](saic-20260422_g35.jpg) | **Select Qualifications and Skills:**<br>**Leadership:** Served as a Partner of Accenture plc ("Accenture"), a <br>management consulting, technology and outsourcing services firm, until his <br>retirement in 2011 after a 30-year career.<br>**Financial Expertise and Industry Experience: *Consulting and Technology*** <br>***Systems:*** While at Accenture, Mr. Shane was the Managing Partner of the <br>North America Public Service business responsible for Accenture's U.S. <br>federal, state and local and Canadian federal and provincial business. He also <br>held several other senior management positions, including those where he led <br>consulting engagements for many of the largest banking institutions in the <br>United States. Following his retirement from Accenture in 2011, Mr. Shane <br>joined LH&P, LLC ("LH&P"), a boutique consulting company, where he served <br>as an advisor and provides strategic, organizational and business advice to <br>senior executives in some of the largest U.S. financial services and health care <br>companies. <br>**Director Experience:** Mr. Shane previously served on the Board of Directors <br>for ZPower, LLC, a battery technology company, from 2003 until his voluntary <br>retirement in 2019. Mr. Shane has served, since 2013, as an advisor on the <br>Maximus Federal Services Board, an outsourcing company that provides <br>business process services to government health and human services agencies <br>until his voluntary retirement in the fall of 2022. He also served as a Director for <br>Dispersive Networks, LLC, a virtual network solutions provider, from 2014 until <br>his voluntary retirement in January 2020.<br>The Board believes that Mr. Shane's expertise in financial matters and the <br>implementation of significant, mission-critical technology systems for the U.S. <br>government as well as state and local governments offer perspectives that our <br>Board considers valuable to us as a leading provider of technical, engineering <br>and enterprise information technology services to government customers. |
| **Age:** 68<br>**Director since:** 2013<br>**Independent**<br>**Committees:** <br>Compensation (Chair); Technology; Audit | **Select Qualifications and Skills:**<br>**Leadership:** Served as a Partner of Accenture plc ("Accenture"), a <br>management consulting, technology and outsourcing services firm, until his <br>retirement in 2011 after a 30-year career.<br>**Financial Expertise and Industry Experience: *Consulting and Technology*** <br>***Systems:*** While at Accenture, Mr. Shane was the Managing Partner of the <br>North America Public Service business responsible for Accenture's U.S. <br>federal, state and local and Canadian federal and provincial business. He also <br>held several other senior management positions, including those where he led <br>consulting engagements for many of the largest banking institutions in the <br>United States. Following his retirement from Accenture in 2011, Mr. Shane <br>joined LH&P, LLC ("LH&P"), a boutique consulting company, where he served <br>as an advisor and provides strategic, organizational and business advice to <br>senior executives in some of the largest U.S. financial services and health care <br>companies. <br>**Director Experience:** Mr. Shane previously served on the Board of Directors <br>for ZPower, LLC, a battery technology company, from 2003 until his voluntary <br>retirement in 2019. Mr. Shane has served, since 2013, as an advisor on the <br>Maximus Federal Services Board, an outsourcing company that provides <br>business process services to government health and human services agencies <br>until his voluntary retirement in the fall of 2022. He also served as a Director for <br>Dispersive Networks, LLC, a virtual network solutions provider, from 2014 until <br>his voluntary retirement in January 2020.<br>The Board believes that Mr. Shane's expertise in financial matters and the <br>implementation of significant, mission-critical technology systems for the U.S. <br>government as well as state and local governments offer perspectives that our <br>Board considers valuable to us as a leading provider of technical, engineering <br>and enterprise information technology services to government customers. |

---

**John K. Tien, Jr.**

---

| | |
|:---|:---|
| ![John_Tien.jpg](saic-20260422_g36.jpg) | **Select Qualifications and Skills:**<br>**Leadership Experience:** Mr. Tien has extensive leadership experience in the <br>U.S. Federal Government, U.S. military, private sector, and the non-profit <br>sector. His most recent role was as the Senate confirmed Deputy Secretary of <br>the U.S. Department of Homeland Security (DHS) in the Biden Administration <br>from June 2021 to July 2023, the second highest-ranking official in DHS. Prior <br>to then, from 2011 to 2021, Mr. Tien was a senior executive in Citigroup, <br>leading teams in various senior leadership up through managing director: from <br>2020-2021 he served as Head of Business and Process Re-Engineering <br>Transformation for Citigroup's entire U.S. Consumer Bank; from 2016-2020 <br>served Chief Operating Officer (COO) and Chief Technology Officer (CTO) for <br>the Macy's private label and co-brand (American Express) credit card portfolio, <br>and served in a variety of Managing Director-level leadership positions <br>throughout the company from 2011-2016.<br>**Industry Knowledge and Expertise:** Mr. Tien is a graduate of West Point <br>Military Academy and served in the U.S. Army for 24 years as an active-duty <br>officer in a variety of leadership and staff positions in seven different U.S. <br>states, three countries, and three combat tours. He retired at the rank of <br>Colonel. Mr. Tien also served in three other presidential Administrations as an <br>active-duty U.S. Army officer: 1) the Obama Administration National Security <br>Council (NSC) Senior Director for Afghanistan and Pakistan; (2) the Bush <br>Administration NSC Director for Iraq; and (3) the Clinton Administration White <br>House Fellow for the U.S. Trade Representative. During his service both in the <br>Army as well as the U.S. government he gained extensive expertise and <br>knowledge in the federal and military landscape. <br>**Director Experience:** Mr. Tien has served on the Board for Union Pacific <br>(NYSE: UNP) since 2023.<br>Given Mr. Tien's extensive background and expert knowledge spanning the <br>federal, private, and military sectors, coupled with his experience in senior <br>leadership positions, he offers invaluable insights to our Board. |
| **Age:** 62<br>**Director since:** 2024<br>**Independent**<br>**Committees:** <br>Compensation; Nominating | **Select Qualifications and Skills:**<br>**Leadership Experience:** Mr. Tien has extensive leadership experience in the <br>U.S. Federal Government, U.S. military, private sector, and the non-profit <br>sector. His most recent role was as the Senate confirmed Deputy Secretary of <br>the U.S. Department of Homeland Security (DHS) in the Biden Administration <br>from June 2021 to July 2023, the second highest-ranking official in DHS. Prior <br>to then, from 2011 to 2021, Mr. Tien was a senior executive in Citigroup, <br>leading teams in various senior leadership up through managing director: from <br>2020-2021 he served as Head of Business and Process Re-Engineering <br>Transformation for Citigroup's entire U.S. Consumer Bank; from 2016-2020 <br>served Chief Operating Officer (COO) and Chief Technology Officer (CTO) for <br>the Macy's private label and co-brand (American Express) credit card portfolio, <br>and served in a variety of Managing Director-level leadership positions <br>throughout the company from 2011-2016.<br>**Industry Knowledge and Expertise:** Mr. Tien is a graduate of West Point <br>Military Academy and served in the U.S. Army for 24 years as an active-duty <br>officer in a variety of leadership and staff positions in seven different U.S. <br>states, three countries, and three combat tours. He retired at the rank of <br>Colonel. Mr. Tien also served in three other presidential Administrations as an <br>active-duty U.S. Army officer: 1) the Obama Administration National Security <br>Council (NSC) Senior Director for Afghanistan and Pakistan; (2) the Bush <br>Administration NSC Director for Iraq; and (3) the Clinton Administration White <br>House Fellow for the U.S. Trade Representative. During his service both in the <br>Army as well as the U.S. government he gained extensive expertise and <br>knowledge in the federal and military landscape. <br>**Director Experience:** Mr. Tien has served on the Board for Union Pacific <br>(NYSE: UNP) since 2023.<br>Given Mr. Tien's extensive background and expert knowledge spanning the <br>federal, private, and military sectors, coupled with his experience in senior <br>leadership positions, he offers invaluable insights to our Board. |

---

18 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

**David J. Urban**

---

| | |
|:---|:---|
| ![David_Urban.jpg](saic-20260422_g37.jpg) | **Select Qualifications and Skills:** <br>**Leadership and Executive Management Experience:** Mr. Urban possesses <br>over 30 years of senior leadership experience spanning legal, business, <br>military, political, and public service roles, including his current position as <br>Managing Director at BGR Group, a leading bipartisan lobbying and public <br>relations firm since April of 2022. Mr. Urban also serves in an Of Counsel role <br>to Torridon Law PLLC since June 2024. Prior to joining BGR, Mr. Urban <br>served as Executive Vice President, North American Corporate Affairs at <br>ByteDance from July 2020 to January 2022, the parent company of TikTok, a <br>leading social network, and from January 2002 to July 2020, as President of <br>the American Continental Group, a leading bi-partisan government affairs and <br>strategic consulting firm which provided consulting services to diverse <br>organizations including those across the financial services and technology <br>sectors. <br>**Director Experience:** Since January 2019, Mr. Urban has served on the Board <br>of Directors for Virtu Financial Inc. (NYSE: VIRT). Mr. Urban also serves on <br>the Board of Directors of privately held company SubCom, a role he has had <br>since May 2020, and on the Board of Directors of Eos Energy Enterprises, Inc. <br>(NASDAQ: EOSE) since 2024. Mr. Urban also serves as a member or advisor <br>to various private and non-profit organizations, including The Kennedy Institute <br>for the U.S. Senate, the Johnny Mac Soldiers Fund and the International <br>Republican Institute.<br>**Industry Knowledge and Experience:** Mr. Urban is a graduate of West Point <br>Military Academy and served in the United States Army's 101 Airborne <br>Divisions where he was awarded the Bronze Star. Mr. Urban also served as <br>Chief of Staff to the former U.S. Senator Arlen Specter of Pennsylvania for five <br>years, and currently serves as a senior political contributor for CNN. In <br>addition to his bachelor's degree from West Point, Mr. Urban holds a Master's <br>in Public Administration from the University of Pennsylvania and a Juris Doctor <br>degree from Temple University.<br>Mr. Urban's extensive leadership experience across legal, political, military, and <br>business sectors, combined with his proven track record in executive roles <br>demonstrates his ability to navigate complex industries and drive strategic <br>decisions. His deep understanding of government affairs, technology, and <br>financial services make him a valuable asset to the Board. |
| **Age:** 62<br>**Director since:** 2025<br>**Independent**<br>**Committees:** <br>Compensation; Nominating | **Select Qualifications and Skills:** <br>**Leadership and Executive Management Experience:** Mr. Urban possesses <br>over 30 years of senior leadership experience spanning legal, business, <br>military, political, and public service roles, including his current position as <br>Managing Director at BGR Group, a leading bipartisan lobbying and public <br>relations firm since April of 2022. Mr. Urban also serves in an Of Counsel role <br>to Torridon Law PLLC since June 2024. Prior to joining BGR, Mr. Urban <br>served as Executive Vice President, North American Corporate Affairs at <br>ByteDance from July 2020 to January 2022, the parent company of TikTok, a <br>leading social network, and from January 2002 to July 2020, as President of <br>the American Continental Group, a leading bi-partisan government affairs and <br>strategic consulting firm which provided consulting services to diverse <br>organizations including those across the financial services and technology <br>sectors. <br>**Director Experience:** Since January 2019, Mr. Urban has served on the Board <br>of Directors for Virtu Financial Inc. (NYSE: VIRT). Mr. Urban also serves on <br>the Board of Directors of privately held company SubCom, a role he has had <br>since May 2020, and on the Board of Directors of Eos Energy Enterprises, Inc. <br>(NASDAQ: EOSE) since 2024. Mr. Urban also serves as a member or advisor <br>to various private and non-profit organizations, including The Kennedy Institute <br>for the U.S. Senate, the Johnny Mac Soldiers Fund and the International <br>Republican Institute.<br>**Industry Knowledge and Experience:** Mr. Urban is a graduate of West Point <br>Military Academy and served in the United States Army's 101 Airborne <br>Divisions where he was awarded the Bronze Star. Mr. Urban also served as <br>Chief of Staff to the former U.S. Senator Arlen Specter of Pennsylvania for five <br>years, and currently serves as a senior political contributor for CNN. In <br>addition to his bachelor's degree from West Point, Mr. Urban holds a Master's <br>in Public Administration from the University of Pennsylvania and a Juris Doctor <br>degree from Temple University.<br>Mr. Urban's extensive leadership experience across legal, political, military, and <br>business sectors, combined with his proven track record in executive roles <br>demonstrates his ability to navigate complex industries and drive strategic <br>decisions. His deep understanding of government affairs, technology, and <br>financial services make him a valuable asset to the Board. |

---

 **saic.com** \| 19<br>

**PROPOSAL 1 - ELECTION OF DIRECTORS**<br>

Director Skills and Qualifications

The table below summarizes some of the key skills and expertise of our director nominees. This summary is not intended to be

an exhaustive list of each of our director nominee's skills or contributions to the Board. The absence of a mark does not mean

that a particular director does not possess that qualification or skill.

![Director_Skills_Matrix_v14.jpg](saic-20260422_g38.jpg)

20 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

![SectionDividers3.jpg](saic-20260422_g39.jpg)

 **saic.com** \| 21<br>

**CORPORATE GOVERNANCE**

Corporate Governance Guidelines

Our Board recognizes the importance of strong corporate governance as a means of addressing the various needs of our

stockholders, employees, customers and other stakeholders. As a result, our Board has adopted Corporate Governance

Guidelines which, together with our certificate of incorporation, bylaws, committee charters and other key governance practices

and policies, provide the framework for our corporate governance. Our Corporate Governance Guidelines cover a wide range of

subjects, including criteria for determining the independence and qualification of our directors. These guidelines are available on

our Investor Relations website at investors.saic.com by clicking on the link entitled "Corporate Governance." The Board

recognizes that observing good corporate governance practices is an ongoing responsibility. The Nominating and Corporate

Governance Committee regularly reviews corporate governance developments and recommends revisions to these Corporate

Governance Guidelines and other corporate governance documents as necessary to promote our and our stockholders' best

interests and to help ensure that we comply with all applicable laws, regulations and stock exchange requirements relating to

corporate governance.

Proxy Access

Our bylaws include a "proxy access" provision for director nominations under which eligible stockholders may nominate

candidates for election to our Board and inclusion in our Proxy Statement for our annual meeting of stockholders. The "proxy

access" provision provides that:

• an eligible stockholder, or an eligible group of up to 20 stockholders, representing at least 3% of our outstanding shares of

common stock,

• owning those shares continuously for at least three years,

• can nominate and include in our Proxy Statement director nominees constituting up to 25% of the Board or, if that

percentage is not a whole number, the closest whole number below 25%, but not less than two individuals, for election at our

annual meeting of stockholders.

These "proxy access" director nominees are subject to certain eligibility, procedural and disclosure requirements as further set

forth in Section 3.17 of our bylaws.

Code of Conduct

All of our employees, including our executive officers and our directors, are required to comply with our Code of Conduct, which

describes our standards for protecting company and, customer assets fostering a safe and healthy work environment, dealing

fairly with customers and others, conducting international business properly, reporting misconduct and protecting employees

from retaliation. Our Code of Conduct forms the foundation of our corporate policies and procedures designed to promote ethical

behavior in all aspects of our business.

Our Code of Conduct is available on our Investor Relations website at investors.saic.com by clicking on the link entitled

"Corporate Governance."

Director Independence

The Board annually determines the independence of each of our directors and nominees in accordance with our Corporate

Governance Guidelines. These guidelines provide that "independent" directors are those who are independent of management

and free from any relationship that, in the judgment of the Board, would interfere with their exercise of independent judgment. No

director qualifies as independent unless the Board affirmatively determines that the director has no material relationship with us

(either directly or as a partner, stockholder or officer of an organization with which we have a relationship). The Board has

established independence standards set forth in our Corporate Governance Guidelines that include all elements of

independence required by the listing standards of The Nasdaq Stock Market LLC ("Nasdaq").

22 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

All members of the Audit, Human Resources and Compensation, and Nominating and Corporate Governance Committees must

be independent directors as defined under our Corporate Governance Guidelines. Members of the Audit Committee must also

satisfy a separate independence requirement pursuant to applicable Nasdaq listing standards and the Securities Exchange Act

of 1934, as amended (the "Exchange Act"), which requires that they not accept, directly or indirectly, any consulting, advisory or

other compensatory fee from us or any of our subsidiaries other than their directors' compensation or be an affiliated person of

us or any of our subsidiaries.

Each year, our directors complete a questionnaire which requires them to disclose any transactions with us in which the director

or any member of his or her immediate family might have a direct or potential conflict of interest. Based on an analysis of the

responses, the Board determined that all directors, except for Mr. Reagan, because of his role as our Chief Executive Officer, are

independent under our Corporate Governance Guidelines and free from any relationship that would interfere with the exercise of

their independent judgment.

Criteria for Board Membership

To fulfill its responsibility to identify and recommend to the full Board nominees for election as directors, the Nominating and

Corporate Governance Committee reviews the composition of the Board to determine the qualifications and areas of expertise

needed to further enhance the composition of the Board. In evaluating potential nominees, the Nominating and Corporate

Governance Committee and the Board consider each individual in the context of the Board as a whole, with the objective of

recommending to stockholders a slate of individual director nominees that can best continue the success of our business and

advance stockholders' interests. In evaluating the suitability of individual nominees, the Nominating and Corporate Governance

Committee and the Board consider many factors, including:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | expertise and involvement in areas relevant to our business such as defense, intelligence, science, finance, government <br>or commercial and international business; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | commitment to business ethics, professional reputation, independence and understanding of the responsibilities of a <br>director and the governance processes of a public company; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | demonstrated leadership, with the ability to exercise sound judgment informed by diversity of experience and <br>perspectives; and <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | benefits from the continuing service of qualified incumbent directors in promoting stability and continuity, contributing to <br>the Board's ability to work together as a collective body and giving the company the benefit of experience and insight that <br>its directors have accumulated during their tenure.<br>|

---

The Nominating and Corporate Governance Committee reviews the director selection process annually and the Committee and

the Board collectively assess its effectiveness through an annual written evaluation process. In addition, the Nominating and

Corporate Governance Committee has been directed by the Board to observe the following principles contained in our Corporate

Governance Guidelines:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | a majority of directors must meet the independence criteria established by the Board;  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | based upon the range of 7 to 14 directors currently specified in our bylaws, no more than three directors may be an <br>employee of SAIC; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | commitment to business ethics, professional reputation, independence and understanding of the responsibilities of a <br>director and the governance processes of a public company; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | only a full-time employee who serves as either the Chief Executive Officer or one of his or her direct reports will be <br>considered as a candidate for an employee director position; and <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | no director nominee may be a consultant to the company. |

---

The Board expects a high level of commitment from its members and will review a candidate's other commitments and service

on other boards to ensure that the candidate has sufficient time to devote to the company. In addition, non-employee directors

may not serve on the board of directors of more than four other publicly-traded companies. Moreover, directors are expected to

act ethically at all times and adhere to our Code of Conduct.

 **saic.com** \| 23<br>

**CORPORATE GOVERNANCE**<br>

Board Leadership Structure

The Board is currently led by a non-executive Chair, Ms. Morea, who is an independent director. Our Board believes that it is in

the best interests of stockholders for the Board to have the flexibility to determine the most qualified and appropriate individual to

serve as Chair of the Board, whether that person is an independent director or the Chief Executive Officer. The Board selects the

Chair annually and may decide to separate or combine the roles of Chair of the Board and Chief Executive Officer, if appropriate,

at any time in the future. In cases where the Board determines it is in the best interests of our stockholders to combine the

positions of Chair and Chief Executive Officer, the independent directors will, upon nomination and recommendation by the

Nominating and Corporate Governance Committee, elect a lead independent director with the responsibilities described in our

Corporate Governance Guidelines.

The functions of the non-executive Chair of the Board include:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | planning the Board's annual schedule of meetings and agendas, in consultation with the Chief Executive Officer and <br>Corporate Secretary and other directors as appropriate; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | coordinating with the Chief Executive Officer and the Corporate Secretary to ensure that the Board receives the <br>appropriate quantity and quality of information in a timely manner to enable it to make informed decisions;<br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | chairing all meetings of the Board and of the independent directors in executive session and ensure that meetings are <br>conducted efficiently and effectively; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | facilitating full and candid Board discussions, ensuring all directors express their views on key Board matters and assist <br>the Board in achieving a consensus; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | working with committee chairs to ensure that each committee functions effectively and keeps the Board apprised of <br>actions taken; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | building consensus, developing teamwork and a cohesive Board culture and facilitating formal and informal <br>communication with and among directors; and <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | serving as the liaison between the Board and company management.  |

---

The Board's Role in Risk Oversight

As part of its oversight function, the Board and its committees monitor risk as part of their regular deliberations throughout the

year. When granting authority to management, approving strategies, making decisions and receiving management reports, the

Board considers, among other things, the risks facing the company. The Board also oversees risk in particular areas through its

committee structure.

The Board had the following principal standing committees during our fiscal year ended January 30, 2026 ("fiscal 2026"): Audit,

Technology (formerly Risk Oversight), Human Resources and Compensation, and Nominating and Corporate Governance.

On March 26, 2025, the Board determined that it was in the best interests of the Company and its stockholders to reallocate the

responsibilities of the Risk Oversight Committee between the Nominating and Corporate Governance Committee and a newly

established Technology Committee that will specifically oversee the Company's technology-related opportunities and risks. In

making these changes to the Board committee structure, the Board recognized that the Risk Oversight Committee's discussions

over time increasingly related to the Company's strategic opportunities and risks regarding new technologies, including issues

surrounding artificial intelligence, data management, cybersecurity, and privacy. As a result, the Board determined that a

committee of the Board focused specifically on those issues would provide for more in-depth review and oversight of the

Company's technology-related strategic, enterprise and regulatory opportunities and risks. The Board also determined that the

Nominating and Corporate Governance Committee has the capacity and expertise to oversee the other risk, compliance and

governance responsibilities of the Risk Oversight Committee that are not being assumed by the Technology Committee,

including review of the company's ethics, compliance and enterprise risk management programs, oversight of the Company's

classified business, and review and approval of related party transactions. With this reallocation of responsibilities and the

creation of the Technology Committee, the Board determined to dissolve the Risk Oversight Committee effective as of March 26,

2025. The Technology Committee is comprised of the following members: Yvette M. Kanouff (Chair); Paul Eremenko; Garth N.

Graham; Katharina G. McFarland; Adm. Michael S. Rogers (USN Ret,); and Steven R. Shane.

The charters of the Audit Committee, the Human Resources and Compensation Committee, the Technology Committee, and the

Nominating and Corporate Governance Committee are available in print to any stockholder who requests them and are also

available on our Investor Relations website at investors.saic.com by clicking on the link entitled "Corporate Governance."

24 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

---

| | | | |
|:---|:---|:---|:---|
| **BOARD OF DIRECTORS** | **BOARD OF DIRECTORS** | **BOARD OF DIRECTORS** | **BOARD OF DIRECTORS** |
| ![Audit Committee Icon-01.jpg](saic-20260422_g41.jpg)<br>**Audit Committee**<br>The Audit Committee <br>evaluates the company's <br>guidelines and policies <br>regarding risk assessment <br>and risk management, <br>including risks related to <br>internal control over financial <br>reporting, the company's <br>major financial risk <br>exposures and the steps <br>management has taken to <br>monitor and control those <br>exposures.<br>| ![Risk_Oversight_Commitee_Icon_3-01.jpg](saic-20260422_g42.jpg)<br>**Technology Committee**<br>The Technology Committee <br>oversees the company's <br>technology strategy, <br>evaluates new technologies <br>such as artificial <br>intelligence, and monitors <br>cybersecurity measures to <br>align with business goals <br>and enhance competitive <br>edge. The Committee also <br>monitors technological <br>trends that may impact the <br>company's performance.<br>| ![HR_Compensation_Commitee_Icon_4-01.jpg](saic-20260422_g43.jpg)<br>**Human Resources and** <br>**Compensation** <br>**Committee**<br>The Human Resources and <br>Compensation Committee <br>assesses risks potentially <br>arising from the company's <br>human resources and <br>compensation policies and <br>practices.<br>| ![Governance_Commitee_2-01.jpg](saic-20260422_g44.jpg)<br>**Nominating and** <br>**Corporate Governance** <br>**Committee**<br>The Nominating and <br>Corporate Governance <br>Committee identifies and <br>recommends individuals for <br>selection to the Board, <br>develops and recommends <br>corporate governance <br>guidelines to the Board, <br>makes recommendations <br>regarding the size, <br>composition and charters of <br>the Board and oversees the <br>evaluation of the Board and <br>Board committees. The <br>Committee also oversees the <br>company's regulatory, <br>enterprise and strategic risk; <br>ethics, compliance, and <br>corporate responsibilities; <br>and its classified and <br>business operations. <br>|

---

![Orange Arrow_1@300x-100.jpg](saic-20260422_g45.jpg)

![Blue Arrow@300x-100.jpg](saic-20260422_g46.jpg)

The company also utilizes an internal Enterprise Risk Management Committee comprised of senior management that, among

other things, works with the Chief Executive Officer, the Chief Risk Officer, the committees of the Board and the full Board to

establish the overall corporate risk strategy and oversight of policies, systems, processes and training relating to risk matters

within the company. This committee reported quarterly to the Audit, Technology, and Nominating and Corporate Governance

Committees during fiscal 2026 and reports annually to the full Board on its activities and findings, highlighting the key risks we

face and management's actions for managing those risks.

Corporate Responsibility

We center our corporate responsibility efforts on strong governance that ensures ethical behavior, integrity, accountability and

transparency. Integrating SAIC's values of innovation, integrity and inclusion, we work to position SAIC as an industry leader to

better our business, our customers' ventures, our employees' lives and the communities in which we live and operate.

To execute our corporate responsibility and sustainability priorities, the Nominating and Corporate Governance Committee of

SAIC's Board of Directors is responsible for assessing Company's ethics, compliance and corporate responsibility programs, and

has oversight of the company's environmental, social and governance requirements not otherwise delegated to other committees

of the Board.

Employee Engagement and Culture

In fiscal 2026, our commitment to our employees was reflected in our fiscal 2026 culture survey results, where we exceeded the

national benchmark for overall survey results by 4%. Very positively, 9 of 10 employees would recommend SAIC as a good place

to work, and 8 of 10 reported a good understanding of how to apply the company's strategy in their role.

 **saic.com** \| 25<br>

**CORPORATE GOVERNANCE**<br>

We develop our leadership team from within our workforce by providing training, educational resources and leadership development

programs which are available to all. To ensure greater opportunities for all, we offer several programs that incorporate internal

networking components, provide opportunities for mentoring, upskilling and create engagement with leadership.

Third parties acknowledge our ability to foster an innovative workforce that excels in technical expertise. In fiscal 2026, we

received several noteworthy recognitions including Forbes America's Best Employers for Engineers, Glassdoor's Best Places to

Work in Tech & AI, and Newsweek America's Greatest Workplace for Tech. Additionally, we were recognized by Forbes as one of

Americas' Dream Employers and Best Employers for Veterans.

Giving Back to Our Workforce and Communities

As a strong corporate citizen, we build on our tradition of community engagement and philanthropy.

We invest in longer-term philanthropic support, targeting programs that address our three pillars of focus: military heroes,

community wellness, and STEM. Over the years these efforts include building 21 homes for military heroes, providing an

equivalent of 29 million meals to people in need and supporting hundreds of unique STEM engagements to youth organizations

nationwide. Each year, for the past five years, our employees have volunteered more than 21,000 hours annually in support of

the communities where we live and work.

An important component of this is the SAIC Foundation, a public 501(c)(3) organization to address unforeseen financial impacts

on employees and their families, providing emergency funds when financial hardships or natural disasters arise. Since its

inception in 2020, the foundation has awarded grants equivalent to more than $600,000 in direct support to our employees.

Being Good Stewards of the Environment

Our goal is to be a good steward of the environment by mitigating any known adverse impacts on the environment balanced with

business priorities. Through our ongoing risk assessments, we have narrow exposure to environmental risks. When we identify a

material risk, we address it.

Board of Directors Meetings and Committees

The Board held seven meetings of the entire Board during fiscal 2026. During fiscal 2026, the independent directors met seven

times for regular board meetings, and ten times for executive sessions. Ms. Morea presided as the non-executive Chair of the

Board at all Board meetings held during fiscal 2026 and at all executive sessions of our independent directors as provided by our

Corporate Governance Guidelines. During fiscal 2026, the directors attended at least 91% of the Board and committee meetings.

All directors are expected to attend our 2026 annual meeting of stockholders and all of the directors who were both serving at the

time of and standing for re-election at last year's annual meeting of stockholders attended such meeting.

26 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

![Audit Committee Icon-01.jpg](saic-20260422_g41.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **AUDIT COMMITTEE** | **AUDIT COMMITTEE** | **AUDIT COMMITTEE** | **AUDIT COMMITTEE** |
| **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)(8)(9)</sup> | **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)(8)(9)</sup> | **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)(8)(9)</sup> | **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)(8)(9)</sup> |
| ![Milford_McGuirt.jpg](saic-20260422_g31.jpg) | ![Eremenko.jpg](saic-20260422_g28.jpg) | ![Carolyn_Handlon.jpg](saic-20260422_g29.jpg) | ![Yvette_Kanouff.jpg](saic-20260422_g47.jpg) |
| **Milford W. McGuirt** <br>**(Chair)**<br>| Paul Eremenko  | Carolyn B. Handlon | Yvette M. Kanouff |
| ![Tim_Mayopoulos.jpg](saic-20260422_g48.jpg) | ![Adm. Michael Rogers.jpg](saic-20260422_g34.jpg) | ![Steve_Shane.jpg](saic-20260422_g35.jpg) | ![David_Urban.jpg](saic-20260422_g37.jpg) |
| Timothy J. Mayopoulos | Adm. Michael S. <br>Rogers (USN Ret.) <br>| Steven R. Shane | David J. Urban |
| **Roles and Responsibilities**<br>**The specific responsibilities of the Audit Committee are further set forth in its charter** <br>**and include:**<br>•**Internal Controls and Disclosure Controls**—Review and provide feedback on management's <br>assessment of, and the report on, the effectiveness of the company's internal control over financial <br>reporting, and the independent, registered public accounting firm's related report.<br>•**Independent Audit**—Appoint, retain, oversee, evaluate, and if necessary, replace the company's <br>independent registered public accounting firm, including the lead audit partner, for the purpose of <br>preparing or issuing an audit report on our annual consolidated financial statements and performing <br>other audit, review or attest services; pre-approve all audit and non-audit services and related fees; and <br>evaluate the independent registered public accounting firm's qualifications, performance and <br>independence, in light of among other things, non-audit services and fees.<br>•**Internal Audit**—Review the qualifications, structure and performance of the internal audit function; <br>review and approve the company's internal audit plan; and periodically review findings from completed <br>audits, status of major audits in process, and any significant difficulties, disagreements with <br>management or restrictions encountered in the scope of the company's internal audit department's <br>work.<br>•**Financial Reporting**—Review and discuss with management, the independent registered public <br>accounting firm and the internal auditor the company's Annual Report on Form 10-K and Quarterly <br>Reports on Form 10-Q; and discuss with the independent registered public accounting firm the auditor's <br>judgments and recommendations about the accounting principles used to prepare our consolidated <br>financial statements.<br>•**Ethical and Legal Compliance**—Review the effectiveness of our system for monitoring compliance <br>with laws and regulations; establish procedures for the receipt, retention and treatment of complaints <br>regarding accounting, internal accounting controls or auditing matters (including procedures for <br>receiving and handling complaints on a confidential and anonymous basis); and evaluate and handle <br>any complaints submitted to or reported to the Audit Committee.<br>•**Other Responsibilities**—Discuss and evaluate our guidelines and policies regarding risk assessment <br>and risk management; discuss our major financial risk exposures and the steps management has taken <br>to monitor and control those exposures; and review our litigation, government investigation and legal <br>compliance matters that could have a significant impact on our financial statements. | **Roles and Responsibilities**<br>**The specific responsibilities of the Audit Committee are further set forth in its charter** <br>**and include:**<br>•**Internal Controls and Disclosure Controls**—Review and provide feedback on management's <br>assessment of, and the report on, the effectiveness of the company's internal control over financial <br>reporting, and the independent, registered public accounting firm's related report.<br>•**Independent Audit**—Appoint, retain, oversee, evaluate, and if necessary, replace the company's <br>independent registered public accounting firm, including the lead audit partner, for the purpose of <br>preparing or issuing an audit report on our annual consolidated financial statements and performing <br>other audit, review or attest services; pre-approve all audit and non-audit services and related fees; and <br>evaluate the independent registered public accounting firm's qualifications, performance and <br>independence, in light of among other things, non-audit services and fees.<br>•**Internal Audit**—Review the qualifications, structure and performance of the internal audit function; <br>review and approve the company's internal audit plan; and periodically review findings from completed <br>audits, status of major audits in process, and any significant difficulties, disagreements with <br>management or restrictions encountered in the scope of the company's internal audit department's <br>work.<br>•**Financial Reporting**—Review and discuss with management, the independent registered public <br>accounting firm and the internal auditor the company's Annual Report on Form 10-K and Quarterly <br>Reports on Form 10-Q; and discuss with the independent registered public accounting firm the auditor's <br>judgments and recommendations about the accounting principles used to prepare our consolidated <br>financial statements.<br>•**Ethical and Legal Compliance**—Review the effectiveness of our system for monitoring compliance <br>with laws and regulations; establish procedures for the receipt, retention and treatment of complaints <br>regarding accounting, internal accounting controls or auditing matters (including procedures for <br>receiving and handling complaints on a confidential and anonymous basis); and evaluate and handle <br>any complaints submitted to or reported to the Audit Committee.<br>•**Other Responsibilities**—Discuss and evaluate our guidelines and policies regarding risk assessment <br>and risk management; discuss our major financial risk exposures and the steps management has taken <br>to monitor and control those exposures; and review our litigation, government investigation and legal <br>compliance matters that could have a significant impact on our financial statements. | **Roles and Responsibilities**<br>**The specific responsibilities of the Audit Committee are further set forth in its charter** <br>**and include:**<br>•**Internal Controls and Disclosure Controls**—Review and provide feedback on management's <br>assessment of, and the report on, the effectiveness of the company's internal control over financial <br>reporting, and the independent, registered public accounting firm's related report.<br>•**Independent Audit**—Appoint, retain, oversee, evaluate, and if necessary, replace the company's <br>independent registered public accounting firm, including the lead audit partner, for the purpose of <br>preparing or issuing an audit report on our annual consolidated financial statements and performing <br>other audit, review or attest services; pre-approve all audit and non-audit services and related fees; and <br>evaluate the independent registered public accounting firm's qualifications, performance and <br>independence, in light of among other things, non-audit services and fees.<br>•**Internal Audit**—Review the qualifications, structure and performance of the internal audit function; <br>review and approve the company's internal audit plan; and periodically review findings from completed <br>audits, status of major audits in process, and any significant difficulties, disagreements with <br>management or restrictions encountered in the scope of the company's internal audit department's <br>work.<br>•**Financial Reporting**—Review and discuss with management, the independent registered public <br>accounting firm and the internal auditor the company's Annual Report on Form 10-K and Quarterly <br>Reports on Form 10-Q; and discuss with the independent registered public accounting firm the auditor's <br>judgments and recommendations about the accounting principles used to prepare our consolidated <br>financial statements.<br>•**Ethical and Legal Compliance**—Review the effectiveness of our system for monitoring compliance <br>with laws and regulations; establish procedures for the receipt, retention and treatment of complaints <br>regarding accounting, internal accounting controls or auditing matters (including procedures for <br>receiving and handling complaints on a confidential and anonymous basis); and evaluate and handle <br>any complaints submitted to or reported to the Audit Committee.<br>•**Other Responsibilities**—Discuss and evaluate our guidelines and policies regarding risk assessment <br>and risk management; discuss our major financial risk exposures and the steps management has taken <br>to monitor and control those exposures; and review our litigation, government investigation and legal <br>compliance matters that could have a significant impact on our financial statements. | **Roles and Responsibilities**<br>**The specific responsibilities of the Audit Committee are further set forth in its charter** <br>**and include:**<br>•**Internal Controls and Disclosure Controls**—Review and provide feedback on management's <br>assessment of, and the report on, the effectiveness of the company's internal control over financial <br>reporting, and the independent, registered public accounting firm's related report.<br>•**Independent Audit**—Appoint, retain, oversee, evaluate, and if necessary, replace the company's <br>independent registered public accounting firm, including the lead audit partner, for the purpose of <br>preparing or issuing an audit report on our annual consolidated financial statements and performing <br>other audit, review or attest services; pre-approve all audit and non-audit services and related fees; and <br>evaluate the independent registered public accounting firm's qualifications, performance and <br>independence, in light of among other things, non-audit services and fees.<br>•**Internal Audit**—Review the qualifications, structure and performance of the internal audit function; <br>review and approve the company's internal audit plan; and periodically review findings from completed <br>audits, status of major audits in process, and any significant difficulties, disagreements with <br>management or restrictions encountered in the scope of the company's internal audit department's <br>work.<br>•**Financial Reporting**—Review and discuss with management, the independent registered public <br>accounting firm and the internal auditor the company's Annual Report on Form 10-K and Quarterly <br>Reports on Form 10-Q; and discuss with the independent registered public accounting firm the auditor's <br>judgments and recommendations about the accounting principles used to prepare our consolidated <br>financial statements.<br>•**Ethical and Legal Compliance**—Review the effectiveness of our system for monitoring compliance <br>with laws and regulations; establish procedures for the receipt, retention and treatment of complaints <br>regarding accounting, internal accounting controls or auditing matters (including procedures for <br>receiving and handling complaints on a confidential and anonymous basis); and evaluate and handle <br>any complaints submitted to or reported to the Audit Committee.<br>•**Other Responsibilities**—Discuss and evaluate our guidelines and policies regarding risk assessment <br>and risk management; discuss our major financial risk exposures and the steps management has taken <br>to monitor and control those exposures; and review our litigation, government investigation and legal <br>compliance matters that could have a significant impact on our financial statements. |

---

![](saic-20260422_g49.gif)

**4**

Meetings

held in Fiscal

2026

(1)The Board has determined that each member of the Audit Committee is independent for purposes of our Corporate

Governance Guidelines, as well as for purposes of the requirements of the Exchange Act and the applicable Nasdaq

listing standards.

 **saic.com** \| 27<br>

 **CORPORATE GOVERNANCE**<br>

(2)The Board has determined that each member of the Audit Committee qualifies as an Audit Committee "financial

expert" or financially literate as defined by the rules under the Exchange Act. The backgrounds and experience of the

Audit Committee financial experts are set forth above in "Proposal 1—Election of Directors."

(3)Mr. Reagan served on the Audit Committee for fiscal 2026 until he assumed the role of Interim CEO for SAIC on

October 23, 2025. He has been removed from the Audit Committee as a result of a change in his nonindependent

status.

(4)Mr. Urban was appointed to the Audit Committee effective September 15, 2025. Mr. Urban stepped down from the

Audit Committee effective April 8, 2026 to fulfill duties on other Committees.

(5) Mr. Mayopoulos served as a member of the Audit Committee for fiscal 2026. He is not standing for re-election at the

2026 annual meeting of stockholders.

(6) Ms. Kanouff served as a member of the Audit Committee for fiscal 2026. She is not standing for re-election at the

2026 annual meeting of stockholders.

(7)Mr. Eremenko was appointed to the Audit Committee effective April 8, 2026.

(8)Adm. Rogers was appointed to the Audit Committee effective April 8, 2026.

(9)Mr. Shane was appointed to the Audit Committee effective April 8, 2026.

28 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

![Technology_Commitee_Icon_3.jpg](saic-20260422_g50.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **TECHNOLOGY COMMITTEE**<sup>(1)</sup> | **TECHNOLOGY COMMITTEE**<sup>(1)</sup> | **TECHNOLOGY COMMITTEE**<sup>(1)</sup> | **TECHNOLOGY COMMITTEE**<sup>(1)</sup> |
| **MEMBERS**<sup>(2)(3)(4)(5)(6)(7)(8)(9)</sup> | **MEMBERS**<sup>(2)(3)(4)(5)(6)(7)(8)(9)</sup> | **MEMBERS**<sup>(2)(3)(4)(5)(6)(7)(8)(9)</sup> | **MEMBERS**<sup>(2)(3)(4)(5)(6)(7)(8)(9)</sup> |
| ![Katherina_McFarland.jpg](saic-20260422_g30.jpg) | ![Eremenko.jpg](saic-20260422_g28.jpg) | ![Garth_Graham.jpg](saic-20260422_g51.jpg) | ![Yvette_Kanouff.jpg](saic-20260422_g47.jpg) |
| **Katharina G. McFarland** <br>**(Chair)**<br>| Paul Eremenko  | Garth N. Graham | Yvette M. Kanouff |
| ![James_Reagan.jpg](saic-20260422_g33.jpg) | ![Adm. Michael Rogers.jpg](saic-20260422_g34.jpg) | ![Steve_Shane.jpg](saic-20260422_g35.jpg) |  |
| James C. Reagan | Adm. Michael S. <br>Rogers (USN Ret.) <br>| Steven R. Shane |  |
| **Roles and Responsibilities**<br>**During fiscal 2026, the responsibilities of the Technology Committee included:**<br>•**Technology-Related Regulatory, Enterprise, and Strategic Risks**—Oversaw critical technology-<br>related risks and ensuring the company met its compliance obligations with laws, regulations, and <br>industry standards, including data protection laws and technology procurement policies. The committee <br>monitored the effectiveness of risk mitigation strategies addressing potential operational disruptions <br>caused by cyber threats, emerging technologies, and supply chain and third-party vulnerabilities. <br>Additionally, the committee conducted thorough evaluations of technology risks associated with <br>mergers, acquisitions, and divestitures and provided guidance on policies related to data management, <br>cybersecurity, privacy, and artificial intelligence. Through proactive oversight, the committee ensured the <br>company remained vigilant in managing enterprise and strategic risks tied to its technology operations.<br>•**Strategic Opportunities**—Played a key role in advancing the company's strategic direction by <br>reviewing and assessing its overall technology strategy for growth opportunities. The committee <br>evaluated emerging technologies within and outside the company to identify their potential to drive <br>innovation and competitive advantage. It provided strategic oversight on technology-related mergers, <br>acquisitions, and divestitures, ensuring these actions aligned with the company's objectives. <br>Additionally, the committee reviewed the company's approach to fostering partnerships and venture <br>opportunities, positioning the organization to capitalize on collaborative technology initiatives and further <br>promoting the company's strategic vision and technological leadership. | **Roles and Responsibilities**<br>**During fiscal 2026, the responsibilities of the Technology Committee included:**<br>•**Technology-Related Regulatory, Enterprise, and Strategic Risks**—Oversaw critical technology-<br>related risks and ensuring the company met its compliance obligations with laws, regulations, and <br>industry standards, including data protection laws and technology procurement policies. The committee <br>monitored the effectiveness of risk mitigation strategies addressing potential operational disruptions <br>caused by cyber threats, emerging technologies, and supply chain and third-party vulnerabilities. <br>Additionally, the committee conducted thorough evaluations of technology risks associated with <br>mergers, acquisitions, and divestitures and provided guidance on policies related to data management, <br>cybersecurity, privacy, and artificial intelligence. Through proactive oversight, the committee ensured the <br>company remained vigilant in managing enterprise and strategic risks tied to its technology operations.<br>•**Strategic Opportunities**—Played a key role in advancing the company's strategic direction by <br>reviewing and assessing its overall technology strategy for growth opportunities. The committee <br>evaluated emerging technologies within and outside the company to identify their potential to drive <br>innovation and competitive advantage. It provided strategic oversight on technology-related mergers, <br>acquisitions, and divestitures, ensuring these actions aligned with the company's objectives. <br>Additionally, the committee reviewed the company's approach to fostering partnerships and venture <br>opportunities, positioning the organization to capitalize on collaborative technology initiatives and further <br>promoting the company's strategic vision and technological leadership. | **Roles and Responsibilities**<br>**During fiscal 2026, the responsibilities of the Technology Committee included:**<br>•**Technology-Related Regulatory, Enterprise, and Strategic Risks**—Oversaw critical technology-<br>related risks and ensuring the company met its compliance obligations with laws, regulations, and <br>industry standards, including data protection laws and technology procurement policies. The committee <br>monitored the effectiveness of risk mitigation strategies addressing potential operational disruptions <br>caused by cyber threats, emerging technologies, and supply chain and third-party vulnerabilities. <br>Additionally, the committee conducted thorough evaluations of technology risks associated with <br>mergers, acquisitions, and divestitures and provided guidance on policies related to data management, <br>cybersecurity, privacy, and artificial intelligence. Through proactive oversight, the committee ensured the <br>company remained vigilant in managing enterprise and strategic risks tied to its technology operations.<br>•**Strategic Opportunities**—Played a key role in advancing the company's strategic direction by <br>reviewing and assessing its overall technology strategy for growth opportunities. The committee <br>evaluated emerging technologies within and outside the company to identify their potential to drive <br>innovation and competitive advantage. It provided strategic oversight on technology-related mergers, <br>acquisitions, and divestitures, ensuring these actions aligned with the company's objectives. <br>Additionally, the committee reviewed the company's approach to fostering partnerships and venture <br>opportunities, positioning the organization to capitalize on collaborative technology initiatives and further <br>promoting the company's strategic vision and technological leadership. | **Roles and Responsibilities**<br>**During fiscal 2026, the responsibilities of the Technology Committee included:**<br>•**Technology-Related Regulatory, Enterprise, and Strategic Risks**—Oversaw critical technology-<br>related risks and ensuring the company met its compliance obligations with laws, regulations, and <br>industry standards, including data protection laws and technology procurement policies. The committee <br>monitored the effectiveness of risk mitigation strategies addressing potential operational disruptions <br>caused by cyber threats, emerging technologies, and supply chain and third-party vulnerabilities. <br>Additionally, the committee conducted thorough evaluations of technology risks associated with <br>mergers, acquisitions, and divestitures and provided guidance on policies related to data management, <br>cybersecurity, privacy, and artificial intelligence. Through proactive oversight, the committee ensured the <br>company remained vigilant in managing enterprise and strategic risks tied to its technology operations.<br>•**Strategic Opportunities**—Played a key role in advancing the company's strategic direction by <br>reviewing and assessing its overall technology strategy for growth opportunities. The committee <br>evaluated emerging technologies within and outside the company to identify their potential to drive <br>innovation and competitive advantage. It provided strategic oversight on technology-related mergers, <br>acquisitions, and divestitures, ensuring these actions aligned with the company's objectives. <br>Additionally, the committee reviewed the company's approach to fostering partnerships and venture <br>opportunities, positioning the organization to capitalize on collaborative technology initiatives and further <br>promoting the company's strategic vision and technological leadership. |

---

![](saic-20260422_g49.gif)

**4**

Meetings

held in Fiscal

2026

(1)The Risk Oversight Committee dissolved effective as of March 26, 2025 and became the Technology Committee.

(2)Ms. Townes-Whitley served on the Technology Committee for fiscal 2026 until her departure from the Board and the

Committee effective as of October 23, 2025.

(3) For fiscal 2026, the Board determined that each member of the Technology Committee was independent for

purposes of our Corporate Governance Guidelines as well as for purposes of the Exchange Act and the applicable

Nasdaq listing standards except for Ms. Townes-Whitley and Mr. Reagan upon his appointment to the committee.

(4) Ms. Kanouff served as the Chair of the Technology Committee for fiscal 2026. She is not standing for re-election at

the 2026 annual meeting of stockholders. Ms. Kanouff stepped down as Chair of the Technology Committee

effective April 8, 2026.

(5) Dr. Graham served as a member of the Technology Committee for fiscal 2026. He is not standing for re-election at the

2026 annual meeting of stockholders.

(6)Mr. Reagan was appointed to the Technology Committee effective April 8, 2026.

(7)Mr. Eremenko was appointed to the Technology Committee effective April 8, 2026.

(8)Adm.Rogers was appointed to the Technology Committee effective April 8, 2026.

(9)Ms. McFarland was appointed Chair of the Technology Committee effective April 8, 2026.

 **saic.com** \| 29<br>

 **CORPORATE GOVERNANCE**<br>

![HR_Compensation_Commitee_Icon_4-01.jpg](saic-20260422_g43.jpg)

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **HUMAN RESOURCES AND COMPENSATION COMMITTEE** | **HUMAN RESOURCES AND COMPENSATION COMMITTEE** | **HUMAN RESOURCES AND COMPENSATION COMMITTEE** | **HUMAN RESOURCES AND COMPENSATION COMMITTEE** | **HUMAN RESOURCES AND COMPENSATION COMMITTEE** | **HUMAN RESOURCES AND COMPENSATION COMMITTEE** |
| **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)</sup> | **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)</sup> | **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)</sup> | **MEMBERS**<sup>(1)(2)(3)(4)(5)(6)(7)</sup> |  |  |
| ![Steve_Shane.jpg](saic-20260422_g35.jpg) | ![Garth_Graham.jpg](saic-20260422_g51.jpg) | ![Tim_Mayopoulos.jpg](saic-20260422_g48.jpg) | ![Donna_Morea.jpg](saic-20260422_g32.jpg) | ![John_Tien.jpg](saic-20260422_g36.jpg) | ![David_Urban.jpg](saic-20260422_g37.jpg) |
| **Steven R.** <br>**Shane (Chair)** <br>| Garth N. <br>Graham<br>| Timothy J. <br>Mayopoulos<br>| Donna S. Morea  | John K. Tien, Jr. | David J. Urban |
| **Roles and Responsibilities**<br>**The responsibilities of the Human Resources and Compensation Committee are further** <br>**set forth in its charter and include:**<br>•Determining the compensation of our Chief Executive Officer and reviewing and approving the <br>compensation of our other executive officers;<br>•Reviewing and evaluating, with the Chief Executive Officer, the long-range plans for management <br>succession;<br>•Exercising all rights, authority and functions reserved to such committee under all of our equity, <br>retirement and other compensation plans;<br>•Approving and making recommendations to the Board regarding non-employee director compensation;<br>•Preparing an annual report on executive compensation for inclusion in our proxy statement or Annual <br>Report on Form 10-K in accordance with the rules and regulations of the SEC; and<br>•Periodically reviewing our human resources strategy, policies and programs. | **Roles and Responsibilities**<br>**The responsibilities of the Human Resources and Compensation Committee are further** <br>**set forth in its charter and include:**<br>•Determining the compensation of our Chief Executive Officer and reviewing and approving the <br>compensation of our other executive officers;<br>•Reviewing and evaluating, with the Chief Executive Officer, the long-range plans for management <br>succession;<br>•Exercising all rights, authority and functions reserved to such committee under all of our equity, <br>retirement and other compensation plans;<br>•Approving and making recommendations to the Board regarding non-employee director compensation;<br>•Preparing an annual report on executive compensation for inclusion in our proxy statement or Annual <br>Report on Form 10-K in accordance with the rules and regulations of the SEC; and<br>•Periodically reviewing our human resources strategy, policies and programs. | **Roles and Responsibilities**<br>**The responsibilities of the Human Resources and Compensation Committee are further** <br>**set forth in its charter and include:**<br>•Determining the compensation of our Chief Executive Officer and reviewing and approving the <br>compensation of our other executive officers;<br>•Reviewing and evaluating, with the Chief Executive Officer, the long-range plans for management <br>succession;<br>•Exercising all rights, authority and functions reserved to such committee under all of our equity, <br>retirement and other compensation plans;<br>•Approving and making recommendations to the Board regarding non-employee director compensation;<br>•Preparing an annual report on executive compensation for inclusion in our proxy statement or Annual <br>Report on Form 10-K in accordance with the rules and regulations of the SEC; and<br>•Periodically reviewing our human resources strategy, policies and programs. | **Roles and Responsibilities**<br>**The responsibilities of the Human Resources and Compensation Committee are further** <br>**set forth in its charter and include:**<br>•Determining the compensation of our Chief Executive Officer and reviewing and approving the <br>compensation of our other executive officers;<br>•Reviewing and evaluating, with the Chief Executive Officer, the long-range plans for management <br>succession;<br>•Exercising all rights, authority and functions reserved to such committee under all of our equity, <br>retirement and other compensation plans;<br>•Approving and making recommendations to the Board regarding non-employee director compensation;<br>•Preparing an annual report on executive compensation for inclusion in our proxy statement or Annual <br>Report on Form 10-K in accordance with the rules and regulations of the SEC; and<br>•Periodically reviewing our human resources strategy, policies and programs. | **Roles and Responsibilities**<br>**The responsibilities of the Human Resources and Compensation Committee are further** <br>**set forth in its charter and include:**<br>•Determining the compensation of our Chief Executive Officer and reviewing and approving the <br>compensation of our other executive officers;<br>•Reviewing and evaluating, with the Chief Executive Officer, the long-range plans for management <br>succession;<br>•Exercising all rights, authority and functions reserved to such committee under all of our equity, <br>retirement and other compensation plans;<br>•Approving and making recommendations to the Board regarding non-employee director compensation;<br>•Preparing an annual report on executive compensation for inclusion in our proxy statement or Annual <br>Report on Form 10-K in accordance with the rules and regulations of the SEC; and<br>•Periodically reviewing our human resources strategy, policies and programs. | **Roles and Responsibilities**<br>**The responsibilities of the Human Resources and Compensation Committee are further** <br>**set forth in its charter and include:**<br>•Determining the compensation of our Chief Executive Officer and reviewing and approving the <br>compensation of our other executive officers;<br>•Reviewing and evaluating, with the Chief Executive Officer, the long-range plans for management <br>succession;<br>•Exercising all rights, authority and functions reserved to such committee under all of our equity, <br>retirement and other compensation plans;<br>•Approving and making recommendations to the Board regarding non-employee director compensation;<br>•Preparing an annual report on executive compensation for inclusion in our proxy statement or Annual <br>Report on Form 10-K in accordance with the rules and regulations of the SEC; and<br>•Periodically reviewing our human resources strategy, policies and programs. |

---

![](saic-20260422_g49.gif)

**5**

Meetings

held in Fiscal

2026

(1)The Board has determined that each member of the Human Resources and Compensation Committee is

independent for purposes of our Corporate Governance Guidelines as well as for purposes of the Exchange Act and

the applicable Nasdaq listing standards.

(2)The Committee's processes and procedures for the consideration and determination of executive compensation are

discussed in further detail under "Compensation Discussion and Analysis" below.

(3)Mr. Reagan served on the Human Resources and Compensation Committee for fiscal 2026 until he assumed the role

of Interim CEO for SAIC on October 23, 2025. He has been removed from the Human Resources and

Compensation Committee as a result of a change in his nonindependent status.

(4)Mr. Tien was appointed to the Human Resources and Compensation Committee effective September 17, 2025.

(5) Mr. Mayopoulos served as a member of the Human Resources and Compensation Committee for fiscal 2026. He is

not standing for re-election at the 2026 annual meeting of stockholders.

(6) Dr. Graham served as a member of the Human Resources and Compensation Committee for fiscal 2026. He is not

standing for re-election at the 2026 annual meeting of stockholders.

(7)Mr. Urban was appointed to the Human Resources and Compensation Committee effective April 8, 2026.

30 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

Role of Independent Compensation Consultant

The Human Resources and Compensation Committee has retained Frederic W. Cook & Co., Inc. ("FW Cook") as its independent

compensation consultant to assist the Committee in evaluating executive compensation programs and in setting executive officer

compensation. The consultant only serves the Human Resources and Compensation Committee in an advisory role and does

not decide or approve any compensation actions. The consultant reports directly to the Human Resources and Compensation

Committee and does not perform any services for management. The consultant's duties include the following:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | reviewing our total compensation philosophy, peer group and target competitive positioning for reasonableness and <br>appropriateness; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | reviewing our overall executive compensation program and advising the Committee on evolving trends and best <br>practices; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | providing independent analyses and recommendations to the Committee on directors' and executive officers' compensation <br>and new compensation and benefits programs that management submits to the Committee for approval; and <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | reviewing the Compensation Discussion and Analysis section of our Proxy Statement. |

---

The consultant interacts directly with members of management only on matters under the Human Resources and Compensation

Committee's oversight and with the knowledge and permission of the Committee. The Human Resources and Compensation

Committee has assessed the independence of FW Cook pursuant to SEC and Nasdaq rules and concluded that the firm's work

for the Committee does not raise any conflict of interest.

Compensation Committee Interlocks and Insider Participation

None of the members of our Human Resources and Compensation Committee have, at any time, been an officer or employee of

ours. None of our executive officers currently serve, or in the past fiscal year have served, as a member of the board of directors

or compensation committee of any entity that has one or more executive officers serving on our Board or Human Resources and

Compensation Committee.

 **saic.com** \| 31<br>

 **CORPORATE GOVERNANCE**<br>

![Nominating_Corporate_Governance_Commitee_Icon.jpg](saic-20260422_g52.jpg)

---

| | | | |
|:---|:---|:---|:---|
| **NOMINATING AND CORPORATE GOVERNANCE COMMITTEE** | **NOMINATING AND CORPORATE GOVERNANCE COMMITTEE** | **NOMINATING AND CORPORATE GOVERNANCE COMMITTEE** | **NOMINATING AND CORPORATE GOVERNANCE COMMITTEE** |
| **MEMBERS**<sup>(1)(2)(3)</sup> | **MEMBERS**<sup>(1)(2)(3)</sup> | **MEMBERS**<sup>(1)(2)(3)</sup> | **MEMBERS**<sup>(1)(2)(3)</sup> |
| ![Katherina_McFarland.jpg](saic-20260422_g30.jpg) | ![Carolyn_Handlon.jpg](saic-20260422_g29.jpg) | ![Tim_Mayopoulos.jpg](saic-20260422_g48.jpg) | ![Milford_McGuirt.jpg](saic-20260422_g31.jpg) |
| **Katharina G.** <br>**McFarland (Chair)**<br>| Carolyn B. <br>Handlon<br>| Timothy J. Mayopoulos | Milford W. McGuirt  |
| ![Donna_Morea.jpg](saic-20260422_g32.jpg) | ![John_Tien.jpg](saic-20260422_g36.jpg) | ![David_Urban.jpg](saic-20260422_g37.jpg) |  |
| Donna S. Morea | John K. Tien, Jr. | David J. Urban |  |
| **Roles and Responsibilities**<br>**The responsibilities of the Nominating and Corporate Governance Committee are** <br>**further set forth in its charter and include:**<br>•Evaluating, identifying and recommending director nominees, including nominees proposed by <br>stockholders;<br>•Reviewing and making recommendations regarding the composition and procedures of the Board;<br>•Making recommendations regarding the size, composition and charters of the Board's committees;<br>•Developing and recommending to the Board a set of corporate governance principles, including <br>recommending an independent director to serve as non-executive Chair of the Board or as Lead <br>Director (as applicable); Overseeing the company's environmental, social and governance <br>requirements, programs, goals and risks; and<br>•Developing and overseeing an annual self-evaluation process of the Board and its committees.<br>**During Fiscal 2026 the committee performed the following additional duties as assigned** <br>**in their charter:**<br>•Monitoring and Overseeing Regulatory, Enterprise and Strategic Risk Areas, including reviewing the <br>following: operational, compliance and reputation risk management activities; and enterprise legal and <br>strategic risk management activities, material regulatory matters, technology oversight and cyber risk.<br>•Monitoring and Overseeing Policies and Practices Relating to Ethics, Compliance, and Corporate <br>Responsibility, including reviewing the following: our Code of Conduct; third-party risk; safety; <br>environmental, sustainability and governance matters; contributions to charitable and other tax-exempt <br>organizations; and political contributions and government relations.<br>•Overseeing Case Management and Personal Conflict of Interest Review Process for Executive <br>Officers and Independent Directors, including: the receipt, retention and treatment of complaints <br>involving alleged misconduct, unethical behavior, violation of the company's policies or potential <br>conflict of interest involving an executive officer or any other person or matter of concern presented to <br>the Committee by the Board. <br>•Overseeing the Company's Classified Business, including: the general oversight of the company's <br>classified business activities and making recommendations to the Board and management concerning <br>the review of the strategic, operational and financial aspects of the company's classified business; and <br>the review of policies, processes, procedures, training, risk assessment and management activities <br>applicable to the company's classified business activities to the extent that they deviate from those <br>applicable to the company's non-classified business activities. | **Roles and Responsibilities**<br>**The responsibilities of the Nominating and Corporate Governance Committee are** <br>**further set forth in its charter and include:**<br>•Evaluating, identifying and recommending director nominees, including nominees proposed by <br>stockholders;<br>•Reviewing and making recommendations regarding the composition and procedures of the Board;<br>•Making recommendations regarding the size, composition and charters of the Board's committees;<br>•Developing and recommending to the Board a set of corporate governance principles, including <br>recommending an independent director to serve as non-executive Chair of the Board or as Lead <br>Director (as applicable); Overseeing the company's environmental, social and governance <br>requirements, programs, goals and risks; and<br>•Developing and overseeing an annual self-evaluation process of the Board and its committees.<br>**During Fiscal 2026 the committee performed the following additional duties as assigned** <br>**in their charter:**<br>•Monitoring and Overseeing Regulatory, Enterprise and Strategic Risk Areas, including reviewing the <br>following: operational, compliance and reputation risk management activities; and enterprise legal and <br>strategic risk management activities, material regulatory matters, technology oversight and cyber risk.<br>•Monitoring and Overseeing Policies and Practices Relating to Ethics, Compliance, and Corporate <br>Responsibility, including reviewing the following: our Code of Conduct; third-party risk; safety; <br>environmental, sustainability and governance matters; contributions to charitable and other tax-exempt <br>organizations; and political contributions and government relations.<br>•Overseeing Case Management and Personal Conflict of Interest Review Process for Executive <br>Officers and Independent Directors, including: the receipt, retention and treatment of complaints <br>involving alleged misconduct, unethical behavior, violation of the company's policies or potential <br>conflict of interest involving an executive officer or any other person or matter of concern presented to <br>the Committee by the Board. <br>•Overseeing the Company's Classified Business, including: the general oversight of the company's <br>classified business activities and making recommendations to the Board and management concerning <br>the review of the strategic, operational and financial aspects of the company's classified business; and <br>the review of policies, processes, procedures, training, risk assessment and management activities <br>applicable to the company's classified business activities to the extent that they deviate from those <br>applicable to the company's non-classified business activities. | **Roles and Responsibilities**<br>**The responsibilities of the Nominating and Corporate Governance Committee are** <br>**further set forth in its charter and include:**<br>•Evaluating, identifying and recommending director nominees, including nominees proposed by <br>stockholders;<br>•Reviewing and making recommendations regarding the composition and procedures of the Board;<br>•Making recommendations regarding the size, composition and charters of the Board's committees;<br>•Developing and recommending to the Board a set of corporate governance principles, including <br>recommending an independent director to serve as non-executive Chair of the Board or as Lead <br>Director (as applicable); Overseeing the company's environmental, social and governance <br>requirements, programs, goals and risks; and<br>•Developing and overseeing an annual self-evaluation process of the Board and its committees.<br>**During Fiscal 2026 the committee performed the following additional duties as assigned** <br>**in their charter:**<br>•Monitoring and Overseeing Regulatory, Enterprise and Strategic Risk Areas, including reviewing the <br>following: operational, compliance and reputation risk management activities; and enterprise legal and <br>strategic risk management activities, material regulatory matters, technology oversight and cyber risk.<br>•Monitoring and Overseeing Policies and Practices Relating to Ethics, Compliance, and Corporate <br>Responsibility, including reviewing the following: our Code of Conduct; third-party risk; safety; <br>environmental, sustainability and governance matters; contributions to charitable and other tax-exempt <br>organizations; and political contributions and government relations.<br>•Overseeing Case Management and Personal Conflict of Interest Review Process for Executive <br>Officers and Independent Directors, including: the receipt, retention and treatment of complaints <br>involving alleged misconduct, unethical behavior, violation of the company's policies or potential <br>conflict of interest involving an executive officer or any other person or matter of concern presented to <br>the Committee by the Board. <br>•Overseeing the Company's Classified Business, including: the general oversight of the company's <br>classified business activities and making recommendations to the Board and management concerning <br>the review of the strategic, operational and financial aspects of the company's classified business; and <br>the review of policies, processes, procedures, training, risk assessment and management activities <br>applicable to the company's classified business activities to the extent that they deviate from those <br>applicable to the company's non-classified business activities. | **Roles and Responsibilities**<br>**The responsibilities of the Nominating and Corporate Governance Committee are** <br>**further set forth in its charter and include:**<br>•Evaluating, identifying and recommending director nominees, including nominees proposed by <br>stockholders;<br>•Reviewing and making recommendations regarding the composition and procedures of the Board;<br>•Making recommendations regarding the size, composition and charters of the Board's committees;<br>•Developing and recommending to the Board a set of corporate governance principles, including <br>recommending an independent director to serve as non-executive Chair of the Board or as Lead <br>Director (as applicable); Overseeing the company's environmental, social and governance <br>requirements, programs, goals and risks; and<br>•Developing and overseeing an annual self-evaluation process of the Board and its committees.<br>**During Fiscal 2026 the committee performed the following additional duties as assigned** <br>**in their charter:**<br>•Monitoring and Overseeing Regulatory, Enterprise and Strategic Risk Areas, including reviewing the <br>following: operational, compliance and reputation risk management activities; and enterprise legal and <br>strategic risk management activities, material regulatory matters, technology oversight and cyber risk.<br>•Monitoring and Overseeing Policies and Practices Relating to Ethics, Compliance, and Corporate <br>Responsibility, including reviewing the following: our Code of Conduct; third-party risk; safety; <br>environmental, sustainability and governance matters; contributions to charitable and other tax-exempt <br>organizations; and political contributions and government relations.<br>•Overseeing Case Management and Personal Conflict of Interest Review Process for Executive <br>Officers and Independent Directors, including: the receipt, retention and treatment of complaints <br>involving alleged misconduct, unethical behavior, violation of the company's policies or potential <br>conflict of interest involving an executive officer or any other person or matter of concern presented to <br>the Committee by the Board. <br>•Overseeing the Company's Classified Business, including: the general oversight of the company's <br>classified business activities and making recommendations to the Board and management concerning <br>the review of the strategic, operational and financial aspects of the company's classified business; and <br>the review of policies, processes, procedures, training, risk assessment and management activities <br>applicable to the company's classified business activities to the extent that they deviate from those <br>applicable to the company's non-classified business activities. |

---

![](saic-20260422_g49.gif)

**4**

Meetings

held in Fiscal

2026

32 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

(1)The Board has determined that each member of the Nominating and Corporate Governance Committee is

independent for purposes of our Corporate Governance Guidelines as well as for purposes of the Exchange Act and

the applicable Nasdaq listing standards.

(2) Mr. Mayopoulos served as a member of the Nominating and Corporate Governance Committee for fiscal 2026. He is

not standing for re-election at the 2026 annual meeting of stockholders.

(3)Mr. Urban was appointed to the Nominating and Corporate Governance Committee effective April 8, 2026.

Director Nominations Process

The Nominating and Corporate Governance Committee utilizes a variety of methods for identifying and evaluating nominees for

directors. The Committee regularly assesses the Board's current and projected strengths and needs by, among other things,

reviewing the Board's current profile, the criteria for Board membership described on page 22 of this Proxy Statement and our

current and future needs.

To the extent that vacancies on the Board are anticipated or otherwise arise, the Nominating and Corporate Governance

Committee prepares a target candidate profile and develops an initial list of director candidates identified by the current members

of the Board, business contacts, community leaders and members of management. The Committee may also retain a

professional search firm to assist it in developing a list of qualified candidates. The Nominating and Corporate Governance

Committee also considers any stockholder recommendations for director nominees that are properly received.

The Committee then screens and evaluates the resulting slate of director candidates to identify those individuals who best fit the

target candidate profile and Board membership criteria and provides the Board with its recommendations. The Board then

considers the recommendations and votes on whether to nominate the director candidate for election by the stockholders at the

annual meeting or to appoint the director candidate to fill a vacancy on the Board.

Stockholder Nominations

Any stockholder may nominate a person for election as a director by complying with the procedures set forth in our bylaws.

Under Section 3.03 of our bylaws, in order for a stockholder to nominate a person for election as a director, the stockholder must

give timely notice to our Corporate Secretary prior to the meeting at which directors are to be elected. To be timely, notice must

be delivered to the Corporate Secretary not later than the close of business on the 90th day, nor earlier than the close of

business on the 120th day, prior to the first anniversary of the preceding year's annual meeting. If the date of the annual meeting

is more than 30 days before or more than 70 days after such anniversary date, however, notice by the stockholder must be

delivered not earlier than the close of business on the 120th day prior to that annual meeting and not later than the close of

business on the 90th day prior to that annual meeting or the 10th day following the day on which we first publicly announce the

date of that annual meeting, whichever occurs later.

The stockholder's notice must include certain information as further provided in Section 3.03 of our bylaws about the nominee,

the stockholder and the underlying beneficial owner, if any, including his or her respective name, age, address, occupation,

shares, rights to acquire shares, information about derivatives, hedges, short positions, understandings or agreements regarding

the economic and voting interests of the nominee, the stockholder and related persons with respect to our stock, if any, and any

other information as would be required to be disclosed in a Proxy Statement soliciting proxies for the election of the proposed

nominee. In addition, the notice must contain certain information about the stockholder proposing to nominate that person. We

may require any proposed nominee to furnish such other information as may reasonably be required to determine the eligibility of

the proposed nominee to serve as a director. A stockholder's notice must be updated, if necessary, so that the information

submitted is true and correct as of the record date for determining stockholders entitled to receive notice of the meeting.

In addition to the requirements set forth above, stockholders who intend to solicit proxies in support of director nominees other

than the company's nominees must comply with the additional requirements of Rule 14a-19(b) under the Exchange Act.

Mandatory Retirement Policy

The Board has adopted a mandatory retirement age of 75 for all directors. It is the general policy of the Nominating and

Corporate Governance Committee not to nominate candidates for re-election at any annual stockholder meeting to be held after

he or she has attained the applicable retirement age.

 **saic.com** \| 33<br>

 **CORPORATE GOVERNANCE**<br>

Board of Directors Compensation

Our director compensation program is designed to attract and fairly compensate non-employee board members for the work

required to oversee a company of SAIC's size, industry, and complexity and to align their interests with the long-term interests of

our stockholders.

The Human Resources and Compensation Committee periodically reviews the director compensation program with the

assistance of FW Cook, our independent compensation consultant and recommends to the Board the form and amount of

compensation to be provided. The director compensation described below represents the total compensation received by our

non-employee directors for their service.

Our director compensation program consists primarily of a cash component and an equity component with compensation levels

informed by peer comparator group data and in recognition of the significant amount of time required of our directors in fulfilling

their duties, as well as the skill and expertise of our directors.

Cash Compensation

Our directors receive a cash retainer for their service on the Board. For fiscal 2026, the annual retainer was $125,000 and the

annual retainer for the Chair of each committee of the Board was an additional $20,000, except for the Chair of the Nominating

and Corporate Governance Committee, where the annual retainer was an additional $15,000, and the Chair of the Audit

Committee, where the annual retainer was an additional $25,000. The annual retainer for the Independent Chair of the Board

was an additional $200,000. Effective January 1, 2026, the Nominating and Corporate Governance Committee Chair retainer

was increased by $5,000. These retainers are paid quarterly in advance. In addition to the cash retainers, non-employee

directors also receive $2,000 for each meeting of the Board and each committee meeting of the Board that they attend beginning

with the second meeting above the standard number of meetings over the course of a given year. We also reimburse our

directors for expenses incurred while attending meetings or otherwise performing services as a director.

Equity Compensation

Directors are eligible to receive equity awards under our equity incentive plan. For fiscal 2026, each director, other than Mr.

Urban, was granted equity awards consisting of $170,000 in value of restricted stock units ("RSUs"). In connection with his

appointment to the Board, Mr. Urban was granted a prorated equity award of $127,500 in value of RSUs. These RSUs vest on

the earlier of one year from the date of grant or on the date of the next annual meeting of stockholders following the date of

grant. A director's equity awards will become fully vested as a result of a Change in Control, Death or Disability as described in

the plan. If a director retires due to our mandatory retirement policy, the director's equity awards continue to vest as scheduled.

Deferral Plans

Directors are eligible to defer all or any portion of their cash retainers and fees into our SAIC Deferred Compensation Plan

("Deferred Compensation Plan"). This plan is described in further detail in the "Executive Compensation — Nonqualified Deferred

Compensation" section of this Proxy Statement.

Director Compensation Table

The following table sets forth information regarding the compensation earned or paid to our directors for their service in fiscal 2026.

Mr. Reagan served as a non-employee director in fiscal 2026 through October 22, 2025, at which time he was appointed Interim

Chief Executive Officer. Because he was an executive officer of the Company for a portion of fiscal 2026, Mr. Reagan is not

included in this table. See "Compensation Discussion & Analysis — Compensation Tables — Summary Compensation Table" for

information about the compensation earned by Mr. Reagan in fiscal 2026 in his capacity as both a non-employee director and

Interim Chief Executive Officer of the Company.

34 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

---

| | | | |
|:---|:---|:---|:---|
| **Name** | **Fees earned or paid in cash ($)**<sup>(1)</sup> | **Stock awards ($)**<sup>(2)</sup> | **Total ($)** |
| **Garth N. Graham** | 137000 | 170000 | 307000 |
| **Carolyn B. Handlon** | 137000 | 170000 | 307000 |
| **Yvette M. Kanouff** | 147000 | 170000 | 317000 |
| **Timothy J. Mayopoulos** | 127000 | 170000 | 297000 |
| **Katharina G. McFarland** | 142000 | 170000 | 312000 |
| **Milford W. McGuirt** | 152000 | 170000 | 322000 |
| **Donna S. Morea** | 337000 | 170000 | 507000 |
| **Steven R. Shane** | 167000 | 170000 | 337000 |
| **John K. Tien, Jr.** | 125000 | 170000 | 295000 |
| **David J. Urban**<sup>(3)</sup> | 80056 | 127500 | 207556 |

---

(1)Amounts in this column represent the aggregate dollar amount of all fees earned or paid in cash for services as a director, including annual

retainer fees, committee and chair fees and meeting fees. Directors are eligible to defer all or any portion of their cash retainers and fees

into our Deferred Compensation Plan.

(2)Amounts in this column reflect the grant date fair value computed in accordance with stock-based compensation accounting rules (FASB

ASC Topic 718). For fiscal 2026, each director received 1,644 RSUs, other than Mr. Urban who received 1,253 RSUs. For more information

regarding our application of FASB ASC Topic 718, including the assumptions used in the calculations of these amounts, please refer to

Note 8 of Notes to Consolidated Financial Statements contained in our Annual Report on Form 10-K for fiscal 2026 filed with the SEC on

March 16, 2026.

(3) Mr. Urban annual fees and equity were prorated to reflect the portion of the year that he served on the Board since his appointment on

September 15, 2025.

At the end of fiscal 2026, the following non-employee directors held the corresponding number of unvested RSUs:

---

| | |
|:---|:---|
| **Name** | **Unvested stock units** |
| **Garth N. Graham** | 1644 |
| **Carolyn B. Handlon** | 1644 |
| **Yvette M. Kanouff** | 1644 |
| **Timothy J. Mayopoulos** | 1644 |
| **Katharina G. McFarland** | 1644 |
| **Milford W. McGuirt** | 1644 |
| **Donna S. Morea** | 1644 |
| **Steven R. Shane** | 1644 |
| **John K. Tien, Jr.** | 1644 |
| **David J. Urban** | 1253 |

---

At the end of fiscal 2026, our non-employee directors held vested options to purchase the following number of shares of our

common stock:

---

| | |
|:---|:---|
| **Name**<sup>(1)</sup> | **Aggregate shares subject to outstanding options** |
| **Donna S. Morea** | 2876 |
| **Steven R. Shane** | 2876 |

---

(1)The Board discontinued stock option grants for non-employee directors effective as of January 1, 2020; therefore, Ms. Morea and Mr. Shane

are the only non-employee directors who held outstanding options at the end of fiscal 2026.

 **saic.com** \| 35<br>

 **CORPORATE GOVERNANCE**<br>

Stock Ownership Guidelines and Policies

The Board believes that directors should acquire and hold shares of our stock in an amount that is meaningful and appropriate.

To encourage directors to have a material investment in our stock, the Board has adopted stock ownership guidelines that

require directors to hold shares of our stock with a value of at least five times the amount of each director's annual cash retainer.

Board members are required to hold all shares of stock acquired under our equity programs until this target value is achieved.

The sum of all shares owned outright, shares held in a trust for the benefit of the director or his/her immediate family members,

and one-half (50%) of unvested time-based RSUs count toward the required ownership. No other equity holdings count toward

meeting the ownership requirement including any unvested, unexercised stock options. In addition to these ownership

guidelines, our directors are also subject to policies that prohibit certain short-term or speculative transactions in our securities

that we believe carry a greater risk of liability for insider trading violations or may create an appearance of impropriety. Our

guidelines require directors to obtain pre-clearance from our General Counsel for all transactions in our securities. During fiscal

2026, all members of the Board were in compliance with these stock policies and have either met or are making adequate

progress toward the stock ownership guidelines.

Insider Trading Policy

We have adopted an insider trading policy governing the purchase, sale and other dispositions of our securities by directors,

officers, employees and other covered persons that we believe are reasonably designed to promote compliance with insider

trading laws, rules and regulations, and listing standards applicable to SAIC. It is also the policy of the company that we will not

engage in transactions in SAIC securities while in possession of material non-public information relating to the company or SAIC

securities. A copy of our insider trading policy is filed as Exhibit 19 to our Annual Report on Form 10-K for fiscal 2026, filed with

the SEC on March 16, 2026.

Related Party Transactions

The Board has adopted written policies and procedures for the review and approval of transactions between us and certain

"related parties," which are generally considered to be our directors and executive officers, nominees for director, holders of five

percent or more of our outstanding capital stock and members of their immediate families. Prior to March 26, 2025, the Board

delegated to the Risk Oversight Committee the authority to review and approve the material terms of any proposed related party

transaction. Effective as of March 26, 2025, such authority was delegated to the Nominating and Corporate Governance

Committee upon the dissolution of the Risk Oversight Committee. If a proposed related party transaction involves a non-

employee director or nominee for election as a director and may be material to a consideration of that person's independence,

the matter is also considered by the Chair of the Board.

In determining whether to approve or ratify a related party transaction, the Nominating and Corporate Governance Committee

considers, among other factors it deems appropriate, the following factors:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | potential benefits to us;  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | the impact on a director's or nominee's independence or an executive officer's relationship with or service to us; and  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | whether the related party transaction is on terms no less favorable than terms generally available to an unaffiliated third-<br>party under the same or similar circumstances and the extent of the related party's interest in the transaction.<br>|

---

In deciding to approve a transaction, the Nominating and Corporate Governance Committee may, in its sole discretion, impose

any conditions it deems appropriate on us or the related party. Any transactions involving the compensation of executive officers,

however, are to be reviewed and approved by the Human Resources and Compensation Committee. If a related party

transaction will be ongoing, the Nominating and Corporate Governance Committee may establish guidelines to be followed in our

ongoing dealings with the related party. Thereafter, the Nominating and Corporate Governance Committee will review and

assess ongoing relationships with the related party on at least an annual basis to determine whether they are in compliance with

the Committee's guidelines and that the related party transaction remains appropriate.

We engage in transactions and have relationships with many entities, including educational and professional organizations, in

the ordinary course of our business. Some of our directors, executive officers or their immediate family members may be

directors, officers, partners, employees or stockholders of these entities. We carry out transactions with these firms on customary

terms. There were no transactions during fiscal 2026 in which any related party had a direct or indirect material interest.

36 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**CORPORATE GOVERNANCE**<br>

Communication with the Board of Directors

Any interested party may communicate with the Chair of the Board and the Chairs of our Audit, Human Resources and

Compensation, Technology, and Nominating and Corporate Governance Committees on Board and committee related issues by

sending an e-mail to the following (as applicable):

• boardchair@saic.com;

• auditchair@saic.com;

• compensationchair@saic.com;

• techcommchair@saic.com; or

• nomgovchair@saic.com.

You may also write to them or to any other director, the independent directors as a group or the Board generally at the following

address:

SAIC

Attention: Corporate Secretary

12010 Sunset Hills Road

Reston, Virginia 20190

Relevant communications will be forwarded to the recipients noted in the communication. Communications sent to the Board or

the independent directors as a group will be forwarded to the Chair of the Board.

 **saic.com** \| 37<br>

![SectionDividers4.jpg](saic-20260422_g53.jpg)

38 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION**<br>

**PROPOSAL 2 - ADVISORY (NON-BINDING)** 

**VOTE ON EXECUTIVE COMPENSATION**

The Board unanimously

recommends a vote FOR

this Proposal.

![Check in Box-01.jpg](saic-20260422_g26.jpg)

As required by Section 14A of the Exchange Act, we are providing our stockholders with the opportunity to vote to approve, on a

non-binding, advisory basis, the compensation of our named executive officers as disclosed in this Proxy Statement in

accordance with the compensation disclosure rules of the SEC.

We urge stockholders to read the Compensation Discussion and Analysis section ("CD&A") contained in this Proxy Statement,

which describes in detail how we closely align the interests of our named executive officers with the interests of our stockholders.

As described in the CD&A, our compensation programs are designed to:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | pay for performance by tying a majority of an executive officer's compensation to the attainment of financial and other <br>performance measures that, the Board believes, promotes the creation of long-term stockholder value and positions the <br>company for long-term success; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | generally provide the same types of benefits for executive officers as other employees, with no pension or death benefits <br>for executive officers; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | target total direct compensation at the median level among companies with which we compete for executive talent;  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | enable us to recover, or "clawback," incentive compensation if there is any material restatement of our financial results, or <br>if an executive officer is involved in misconduct; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | require our executive officers to own a significant amount of shares of our common stock;  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | avoid incentives that encourage unnecessary or excessive risk-taking; and  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | compete effectively for talented executives who will contribute to our long-term success.  |

---

The Human Resources and Compensation Committee and the Board believe that these programs and policies are effective in

implementing our pay for performance philosophy and achieving its goals. This non-binding, advisory stockholder vote,

commonly known as "Say-on-Pay," gives you, as a stockholder, the opportunity to advise whether or not you approve of our

executive compensation programs and policies by voting on the following resolution:

RESOLVED, that the stockholders approve, on an advisory basis, the compensation of the named executive officers, as

disclosed pursuant to the compensation disclosure rules of the SEC, including the Compensation Discussion and Analysis,

compensation tables and any related material as set forth in this Proxy Statement.

The vote on this resolution is not intended to address any specific element of compensation; rather, the vote relates to the

compensation of our named executive officers, as described in the CD&A and Executive Compensation sections of this Proxy

Statement in accordance with the compensation disclosure rules of the SEC. The vote is advisory, which means that the vote is

not binding on the company, our Board or the Human Resources and Compensation Committee. However, as an expression of

our stockholders' view, the Human Resources and Compensation Committee considers the vote when making future executive

compensation decisions.

Over the past five years, stockholders have consistently approved our Say-on-Pay resolution, at an average of 94% votes cast in

favor. The Human Resources and Compensation Committee, which is composed exclusively of independent directors, views this

historically strong level of support for our executive compensation programs as indicative of broad stockholder agreement with

the pay for performance philosophy on which our executive compensation programs are premised.

At our 2025 annual meeting, our stockholders approved the compensation of our NEOs, with approximately 85% of stockholder

votes cast in favor of our 2025 Say-on-Pay resolution.

 **saic.com** \| 39<br>

**PROPOSAL 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION**<br>

Vote Required

The affirmative vote of a majority of the shares of our common stock present or represented and entitled to vote on Proposal 2

either in person or by proxy is required to approve the proposal. Abstentions have the effect of a vote against the proposal.

Broker non-votes are not entitled to vote on the proposal and will not be counted in evaluating the results of the vote. Shares of

common stock represented by properly executed, timely received and unrevoked proxies will be voted in accordance with the

instructions indicated thereon. In the absence of specific instructions, properly executed, timely received and unrevoked proxies

will be voted "FOR" the proposal. This advisory vote on executive compensation is non-binding.

Recommendation of the Board

The Board unanimously recommends a vote FOR the non-binding, advisory approval of the compensation of our named

executive officers, as disclosed in this Proxy Statement.

40 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**Proposal 3 - Advisory (Non-Binding) Vote on Frequency of Vote on Executive Compensation**<br>

![SectionDividers5.jpg](saic-20260422_g54.jpg)

 **saic.com** \| 41<br>

**Proposal 3 - Advisory (Non-Binding) Vote on Frequency of Vote on Executive Compensation**<br>

**Proposal 3 - Advisory (Non-Binding)** 

**Vote on Frequency of Vote on** 

**Executive Compensation**

The Board unanimously

recommends a vote for a

frequency of **ONE YEAR** 

for **t**his Proposal.

![Check in Box-01.jpg](saic-20260422_g26.jpg)

We are providing our stockholders with the opportunity to vote, on a non-binding, advisory basis, on whether future advisory

votes on executive compensation, or "Say-on-Pay," of the nature reflected in Proposal 2 above should occur every year, every

two years or every three years.

At our 2020 annual meeting of stockholders, the stockholders of the company recommended one year as the frequency of

advisory voting on executive compensation. We have had annual Say-on-Pay votes since our 2020 annual meeting. After careful

consideration of the three alternatives, the Board believes that continuing to hold an advisory vote on executive compensation

every year is the most appropriate policy for the company at this time and recommends that stockholders vote for future advisory

votes on executive compensation to occur every year.

While our executive compensation programs are designed to promote a long-term connection between pay and performance, the

Board recognizes that executive compensation decisions and disclosures are made annually and that an annual advisory vote on

executive compensation would provide us with more direct and immediate feedback. Stockholders should note, however, that

because the advisory vote on executive compensation occurs after the beginning of the compensation year, it may not be

appropriate or even feasible to change the company's current annual or multi-year executive compensation programs in

response to any one year's advisory vote before the following year's annual meeting of stockholders. If we decide that

responsive changes are appropriate, but immediate implementation is not practical, the impact of those changes may not be fully

reflected in the following year's proxy statement. In addition, the different elements of our executive compensation programs are

designed to operate in an integrated manner and to complement one another, which may affect our ability to consider and

implement responsive changes.

Vote Required

This advisory vote on the frequency of future Say-on-Pay votes is non-binding. Stockholders will be able to specify one of four

choices for this Proposal 3 on the proxy and voting instruction card: one year, two years, three years or abstain. The frequency of

future Say-on-Pay votes receiving the highest number of votes (one, two or three years) by stockholders will be considered the

frequency recommended by stockholders. Abstentions, a failure to vote and broker "non-votes" will have no effect on the

outcome of the proposal. Shares of common stock represented by properly executed, timely received and unrevoked proxies will

be voted in accordance with the instructions indicated thereon. In the absence of specific instructions, properly executed, timely

received and unrevoked proxies will be voted for "ONE YEAR" as the frequency of future Say-on-Pay votes.

Stockholders are not voting to approve or disapprove the Board's recommendation. We currently expect to conduct an annual

advisory vote on executive compensation, unless the voting results indicate a stockholder preference for a less frequent vote. In

any case, the Board may vary its practice in future years based on factors such as discussions with stockholders and the

adoption of material changes to compensation programs.

Recommendation of the Board

The Board unanimously recommends stockholders vote "ONE YEAR" as the frequency to conduct future advisory votes on

executive compensation.

42 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

![SectionDividers6.jpg](saic-20260422_g55.jpg)

 **saic.com** \| 43<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

**COMPENSATION DISCUSSION AND ANALYSIS**

This Compensation Discussion and Analysis ("CD&A") provides important information about our executive compensation

philosophy and programs for fiscal 2026. In addition, this CD&A describes compensation decisions made by our Human

Resources and Compensation Committee of the Board (sometimes referred to in this CD&A as the "Committee"), which is

responsible for overseeing the compensation programs for our executive officers (current and former), including the officers

named in the executive compensation tables in this Proxy Statement (collectively, the "named executive officers" or "NEOs").

Our Named Executive Officers for Fiscal 2026

---

| | | | | |
|:---|:---|:---|:---|:---|
| ![James_Reagan.jpg](saic-20260422_g33.jpg) | ![Prabu Natarajan.jpg](saic-20260422_g56.jpg) | ![Srini Attili.jpg](saic-20260422_g57.jpg) | ![Hillary Hageman.jpg](saic-20260422_g58.jpg) | ![Kathleen McCarthy.jpg](saic-20260422_g59.jpg) |
| **James C. Reagan** <br>Chief <br>Executive Officer<br>| **Prabu Natarajan**<br>Executive Vice President, <br>Chief Financial Officer<br>| **Srinivas Attili** <br>Executive Vice President, <br>Civilian Business Group<br>| **Hilary L. Hageman**<br>Executive Vice President, <br>General Counsel and <br>Corporate Secretary<br>| **Kathleen T. McCarthy**<br>Executive Vice President, <br>Chief Human Resources <br>Officer<br>|

---

Former Executive Officers who were Named Executive Officers for Fiscal 2026:

• Toni Townes-Whitley - Former Chief Executive Officer

• James J. Jackson - Former Executive Vice President, Army Business Group

• David C. Ray - Former Executive Vice President, Space and Intelligence Business Group

Executive Transition

Ms. Townes-Whitley served as Chief Executive Officer and a member of the Board until her separation from service on October

23, 2025. Ms. Townes-Whitley received the standard benefits as described in the section "Executive Compensation—Potential

Payments upon Termination or a Change in Control" pursuant to the Severance Policy.

Mr. Reagan, who was already a member of the Board, was appointed as interim Chief Executive Officer, effective as of October

23, 2025, and transitioned to permanent CEO on February 17, 2026. Previously, he served as an independent director and

member of the audit and compensation committees. His selection as permanent CEO followed an extensive search process and

was unanimously approved by the Board. As interim CEO, Mr. Reagan received annual compensation outlined in the "Executive

Compensation" section. As permanent CEO, he receives annual compensation comparable to compensation paid to prior CEOs

and aligned with competitive pay levels observed among the Company's market peers. As an employee director, he does not

serve on any Board committees or receive additional compensation for his Board service.

As a result of the business group consolidation and reorganization, Mr. Jackson, who served as EVP, Army Business Group, and

Mr. Ray, who served as EVP, Space and Intelligence Business Group, until November 13, 2025 served as non-executive

employees of the company until their separation from service effective January 30, 2026. They received the standard benefits as

described in the section "Executive Compensation—Potential Payments upon Termination or a Change in Control" pursuant to

the Severance Policy.

44 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

CD&A **Table of Contents**

---

| | | | |
|:---|:---|:---|:---|
| **Executive Summary** | <u>[44](#i73c85df74d034e4782df5be37f0f1467_34948)</u> | **Other Policies and Considerations** | <u>[55](#i73c85df74d034e4782df5be37f0f1467_34962)</u> |
| Fiscal 2026 Business Highlights | <u>[44](#i73c85df74d034e4782df5be37f0f1467_34942)</u> | Assessment of Risks in our Compensation Programs | <u>[55](#i73c85df74d034e4782df5be37f0f1467_34953)</u> |
| Compensation Philosophy and Pay Mix | <u>[45](#i73c85df74d034e4782df5be37f0f1467_34943)</u> | Equity Award Grant Practices | <u>[55](#i73c85df74d034e4782df5be37f0f1467_34963)</u> |
| Program Design Overview | <u>[46](#i73c85df74d034e4782df5be37f0f1467_34945)</u> | Stock Ownership Guidelines and Stock Holding <br>Requirements | <u>[55](#i73c85df74d034e4782df5be37f0f1467_34961)</u> |
| Governance of Our Compensation Programs | <u>[47](#i73c85df74d034e4782df5be37f0f1467_34951)</u> | Prohibition on Hedging or Pledging Company Stock <br>or Purchasing "On Margin" | <u>[56](#i73c85df74d034e4782df5be37f0f1467_34957)</u> |
| Results of 2025 Stockholder Advisory Vote | <u>[47](#i73c85df74d034e4782df5be37f0f1467_34949)</u> | "Clawback" or Compensation Recoupment Policies | <u>[56](#i73c85df74d034e4782df5be37f0f1467_34956)</u> |
| **Principal Elements and Objectives of Our** <br>**Compensation Program** | <u>[48](#i73c85df74d034e4782df5be37f0f1467_34952)</u> | Post-Employment Benefits | <u>[56](#i73c85df74d034e4782df5be37f0f1467_34964)</u> |
| **Committee Process for Determining Compensation** | <u>[49](#i73c85df74d034e4782df5be37f0f1467_34944)</u> | Executive Severance and Change in Control Policy | <u>[57](#i73c85df74d034e4782df5be37f0f1467_34958)</u> |
| Components of Fiscal 2026 Compensation Programs | <u>[50](#i73c85df74d034e4782df5be37f0f1467_34946)</u> |  |  |
| **Other Benefits Provided in Fiscal 2026** | <u>[54](#i73c85df74d034e4782df5be37f0f1467_34947)</u> |  |  |

---

Executive Summary

Fiscal 2026 Business Highlights

In fiscal year 2026, we delivered solid financial performance in a challenging market environment. While revenue declined due to

softer demand and several recompete losses, profitability and cash generation remained strong, supported by disciplined

execution and the unwavering dedication of our workforce, who continued to advance higher-value mission and engineering work

for our customers.

Throughout the year, we advanced our strategic priorities, strengthened operational discipline, and made progress aligning our

portfolio with areas where we have the greatest right to win. We secured several noteworthy program awards while navigating

pressure in our large enterprise IT portfolio. Our book-to-bill trending back above 1.0x and a positive budget environment support

our expectation of returning to growth. Meanwhile, robust free cash flow reflected strong program execution and demonstrated

the resilience of our business.

![Business Highlights 12.jpg](saic-20260422_g60.jpg)

(1)Non-GAAP financial measure; see the Appendix to Proxy Statement for a reconciliation of such measure against the most directly

comparable GAAP financial measure.

 **saic.com** \| 45<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

Full-year adjusted EBITDA<sup>(1)</sup> increased to 9.7% of revenues, up from 9.5% in the prior year, reflecting cost efficiencies and solid

program performance. Operating cash flow and free cash flow<sup>(1)</sup> were again strong at $609 million and $577 million, respectively,

enabling continued shareholder returns while supporting strategic investments, such as our SilverEdge acquisition. Our

enterprise transformation and business development initiatives position us well as we enter fiscal year 2027 with a focus on

improving growth, enhancing margins, and supporting our customers' most critical missions.

We attribute our stock's relative underperformance to recent revenue declines driven by poor recompete results in certain

portions of our portfolio. Going forward, we will tighten our bidding criteria in these parts of the market. At the same time, we are

increasing investment in areas of the business that are performing at or above industry standards. We expect this refined

allocation of resources and renewed focus to support long-term value creation. Our compensation programs, particularly the use

of a relative TSR metric in our long-term incentive awards, reinforces management accountability and ensures continued

alignment with shareholders over multi-year performance periods.

Total Shareholder Return ("TSR")

as of January 30, 2026

![Total_Share_Holder_Return_2026_v3.jpg](saic-20260422_g61.jpg)

Compensation Philosophy and Pay Mix

The Company maintains a strong "pay-for-performance" compensation philosophy focused on attracting and retaining high

quality executive talent and rewarding our executive officers primarily through variable compensation. Fixed compensation (i.e.,

base salary) is set at appropriate levels to avoid competitive disadvantage and comprises the smallest portion of overall

compensation. We believe that this philosophy serves to both encourage and recognize performance excellence and helps drive

stockholder value while facilitating a sustainable fixed-cost structure.

The charts below depict approximate percentages for each element of target total direct compensation during fiscal 2026 and

demonstrate how compensation is significantly weighted towards variable at-risk compensation (short-term cash incentives,

performance stock units ("PSUs"), and restricted stock units ("RSUs")). For the CEO pay mix chart, the following percentages

represent the compensation of our former CEO, Ms. Townes-Whitley, during her employment until her separation from service

effective October 23, 2025, and our current CEO, Mr. Reagan, during his service as Interim Chief Executive Officer beginning

October 23, 2025. For the Other NEOs pay mix chart, the following percentages represent compensation for the former and

current NEOs. The details of CEO and Other NEOs compensation are provided in the "Executive Compensation" section of this

Proxy Statement.

46 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

---

| | |
|:---|:---|
| ![CEO Compensation 12-01.jpg](saic-20260422_g62.jpg) | ![CEO Compensation 11-02.jpg](saic-20260422_g63.jpg) |

---

Total target direct compensation for NEOs is benchmarked against median levels of compensation of comparable positions in

publicly traded companies of our size and in our industry. Consistent with our pay-for-performance philosophy, actual earned

compensation varies above or below the median level based on the degree to which specific performance goals are achieved,

changes in our stock value over time and the individual performance of each NEO.

As indicated above, base salary represents a significantly smaller portion of overall compensation than variable compensation

while a more meaningful portion is allocated to annual cash incentive awards that focus executives on near-term objectives

supporting our long-term strategy. The largest portion of overall compensation for our executive officers is allocated to long-term

incentives, supporting long-term value creation and aligning the interests of our executive officers with those of our stockholders.

Program Design Overview

For fiscal 2026, we maintained the short-term performance metrics used over the past several fiscal years. The short-term

incentive plan combines revenue, adjusted EBITDA dollars, and adjusted operating cash flow performance with an individual

leadership score multiplier. For the long-term PSU metrics for fiscal 2026, we replaced cumulative adjusted operating cash flow

with cumulative free cash flow to better align with our long-term business strategy and shareholder focus. The PSUs granted in

fiscal 2026 continued to include cumulative adjusted EBITDA and relative total shareholder return as the other two performance

metrics. The PSUs are performance-based RSUs that vest and are settled at the end of a three-year performance period. The

combination of PSUs and time-based RSUs (vesting over 3 years) provide an appropriate balance of medium-term and long-

term incentives. See the Appendix to this Proxy Statement for a reconciliation as to how each non-GAAP performance measure

is calculated as compared to the most closely comparable GAAP measure.

By aligning significant portions of NEOs' compensation with profitable growth and cash flow, a substantial portion of total

compensation for our NEOs is directly linked to key metrics that we believe drive long-term sustained stockholder returns.

Based on Company performance in fiscal 2026, the calculated payout of the short-term cash portion of annual incentives was

66.7% of target, as discussed in greater detail beginning on page 52. The Committee applied an individual leadership score

multiplier up to 1.2x to the calculated annual incentive awards for each NEO, based upon an assessment of each executive's

relative performance during the year. PSUs granted for the fiscal 2024 through 2026 performance period were earned at 113.1%

of target, as discussed in greater detail on page 55.

 **saic.com** \| 47<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

Governance of Our Compensation Programs

Our compensation programs incorporate best practices regarding corporate governance, risk mitigation and alignment of

executive officers' interests with stockholders' interests. The following are key features of our compensation practices:

---

| | |
|:---|:---|
| **AT SAIC, WE ...** | **AT SAIC, WE DO NOT ...** |
| Believe in pay for performance—simply put, we reward <br>our NEOs when the company performs. <br>Conduct an annual review by the Committee to <br>establish a group of comparable companies to be used <br>in compensation decisions. <br>Review and consider feedback provided by our <br>stockholders related to executive compensation <br>matters. <br>Mitigate against imprudent risk-taking through <br>balancing features in the design of our compensation <br>programs. <br>Subject cash and equity-based incentive compensation <br>to "clawback" policies if there is a restatement of our <br>financial results for any reason or if the employee was <br>involved in misconduct. <br>Require significant stock ownership of our executive <br>officers. <br>Use an independent compensation consultant who <br>reports directly to the Committee. <br>Provide "double-trigger" provisions for certain change in <br>control benefits. <br>| Permit cash buyout or re-pricing of underwater stock <br>options. <br>Guarantee any bonus payouts to executive officers. <br>Provide employment agreements for executive officers. <br>Provide golden parachute excise tax gross-ups on <br>change in control benefits. <br>Permit hedging or pledging of Company stock or <br>purchasing Company stock on margin by our executive <br>officers. <br>Offer defined benefit pension benefits to our executive <br>officers or other employees. <br>Provide excessive perquisites for executive officers.<br>|

---

![Check@300x-100.jpg](saic-20260422_g40.jpg)

![X@300x-100.jpg](saic-20260422_g64.jpg)

![X@300x-100.jpg](saic-20260422_g64.jpg)

![Check@300x-100.jpg](saic-20260422_g40.jpg)

![X@300x-100.jpg](saic-20260422_g64.jpg)

![Check@300x-100.jpg](saic-20260422_g40.jpg)

![X@300x-100.jpg](saic-20260422_g64.jpg)

![X@300x-100.jpg](saic-20260422_g64.jpg)

![Check@300x-100.jpg](saic-20260422_g40.jpg)

![X@300x-100.jpg](saic-20260422_g64.jpg)

![Check@300x-100.jpg](saic-20260422_g40.jpg)

![X@300x-100.jpg](saic-20260422_g64.jpg)

![Check@300x-100.jpg](saic-20260422_g40.jpg)

![Check@300x-100.jpg](saic-20260422_g40.jpg)

![Check@300x-100.jpg](saic-20260422_g40.jpg)

Results of 2025 Stockholder Advisory Vote

Over the past five years, as shown in the graphic below, our stockholders have consistently approved our executive advisory

vote, commonly referred to as a "Say-on-Pay" vote, at an average of 94%.The Committee, which is composed exclusively of

independent directors, views this historically strong level of support for our executive compensation programs as indicative of

broad stockholder agreement with the pay for performance philosophy on which our executive compensation programs are

premised.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **2021** | **2022** | **2023** | **2024** | **2025** |
| 97% | 97% | 94% | 97% | 85% |

---

At our 2025 annual meeting, our stockholders approved the compensation of our NEOs, with approximately 85% of stockholder

votes cast in favor of our 2025 Say-on-Pay resolution. As support for the resolution was not as robust as SAIC has historically

experienced, the company initiated targeted shareholder outreach to understand the underlying reasons.

We welcome feedback from stockholders regarding our executive compensation programs, which are described in more detail

below. Stockholders desiring to communicate with the Board or the Human Resources and Compensation Committee may do so

as described under "Communication with the Board of Directors" in this Proxy Statement. The Committee will continue to take

into account stockholder votes on Say-on-Pay resolutions when evaluating our compensation philosophy and making changes to

our compensation programs and practices. See "Proposal 2—Advisory (Non-Binding) Vote on Executive Compensation" in this

Proxy Statement for additional information on our 2026 Say-on-Pay resolution.

48 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

Principal Elements and Objectives of Our Compensation Program

The following chart summarizes the components, relevant performance measures and time frames of our compensation program

for fiscal 2026. Consistent with our philosophy of tying pay to performance, base salary represents a significantly smaller portion

of overall compensation than variable compensation. We use a combination of cash and equity incentive awards to foster and

reward performance in key areas over near-term and long-term timeframes. We discuss each component beginning on page 51.

![variable_incentive_compensation_2026_v4.jpg](saic-20260422_g65.jpg)

 **saic.com** \| 49<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

Committee Process for Determining Compensation

At the beginning of each fiscal year, the Committee reviews and approves the following elements of compensation to be provided

to each of our NEOs:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | base salary;  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | payout range for the annual cash incentive awards that may be earned for the upcoming year and the performance goals <br>and criteria upon which the amount of the awards will be determined; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | mix and amount of equity incentive awards to be granted to our executive officers; and  |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | payout range for PSUs that may be earned for the performance period beginning in that fiscal year and the length of the <br>performance period, goals and criteria upon which the amount of the awards for the relevant performance period will be <br>determined.<br>|

---

In determining the amounts of compensation to be awarded to our NEOs, the Committee considers the Company's overall

performance and competitive market data for our compensation peer group.

**Company performance is the primary factor in determining variable compensation.** The amount of any cash or

performance-based equity incentive awards to be paid upon completion of the applicable performance period is determined

based upon our achievement of short- and long-term financial goals set at the beginning of the fiscal year or performance period,

as the case may be. However, the final cash incentive award payout also reflects an individual leadership multiplier score. The

Committee retains the ability to use negative discretion to reduce payouts when appropriate.

**Individual performance is a factor in setting base salaries.** In determining base salaries for our NEOs, the Committee

reviews a performance assessment for each of our executive officers, as well as compensation recommendations for the NEOs

other than the Chief Executive Officer made by the Chief Executive Officer. The Committee also considers market data, analysis

and recommendations regarding executive officer compensation provided by FW Cook, its independent compensation

consultant. The NEOs do not propose their own compensation.

**The Committee assesses our Chief Executive Officer's performance.** In determining compensation for our Chief

Executive Officer, the Committee meets in executive session and evaluates his or her performance based on his or her

achievement of performance objectives that are established at the beginning of the fiscal year. Formal input is received from the

independent directors and the executive leadership team. The Committee also considers the Chief Executive Officer's leadership

contributions towards the Company's performance, including financial results, development and achievement of strategic

objectives, progress in building capability among the executive leadership team, development of a succession plan for executive

leadership and corporate governance leadership, as well as market data and analysis and recommendations provided by the

Committee's independent compensation consultant. The Committee determines the Chief Executive Officer's compensation and

then reviews his or her evaluation and compensation with the Board's independent directors. The Chief Executive Officer does

not propose his or her own compensation and is not present for discussions of his or her performance and compensation. The

Independent Chair of the Board and the Chair of the Committee then present the Committee's evaluation and compensation

determination to the Chief Executive Officer.

**The Committee closely monitors laws, regulations and guidance regarding executive compensation,** 

including that which is applicable to companies doing business with the U.S. Government. We are committed to ensuring

compliance with all such laws, regulations and guidance. Among other things, our strong "pay-for-performance" compensation

philosophy incentivizes meeting or exceeding strategic performance objectives while driving strong operational success on our

contracts that support our U.S. Government customers' mission priorities.

**The Committee reviews our compensation peer group annually.** The Committee uses peer group information as a

reference point for assessing compensation levels and practices. The Committee, with the assistance of FW Cook, annually

reviews and approves the list of companies to ensure its appropriateness. In evaluating and selecting companies for inclusion in

the peer group, the Committee targets comparably sized publicly traded information technology, consulting, defense, and

engineering companies, as well as companies with whom we compete for executive talent with similar roles and responsibilities,

which we refer to as our "compensation peer group."

For fiscal 2026, the compensation peer group used to determine target compensation was reviewed and approved by the

Committee in the fall 2024 Committee meeting and remained unchanged from the previous year.

50 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

---

| | |
|:---|:---|
| Booz Allen Hamilton Holding Corporation (BAH) | KBR, Inc. (KBR) |
| CACI International Inc (CACI) | Leidos Holdings, Inc. (LDOS) |
| CGI Inc. (GIB) | Maximus, Inc. (MMS) |
| DXC Technology Company (DXC) | Parsons Corporation (PSN) |
| Huntington Ingalls Industries, Inc. (HII) | Tetra Tech, Inc. (TTEK) |
| ICF International (ICFI) | Textron Inc. (TXT) |
| Jacobs Solutions Inc. (J) | |

---

The compensation peer group generally reflects companies with annual revenues between one-third to three times our estimated

revenues for the fiscal year in which the peer group is reviewed. Compensation data from two nationally-recognized, broad-

based third-party surveys provides the Committee with additional perspective regarding the competitive landscape for executive

talent. To be competitive in the market for our executive-level talent, we benchmark overall compensation for our NEOs against

the market median. Actual cash incentive awards paid and PSUs earned vary, consistent with our pay-for-performance

philosophy, based on pre-established performance metrics and may therefore generate realized compensation that is higher or

lower than the market median.

Components of Fiscal 2026 Compensation Programs

**Base Salary** 

In reviewing and approving the fiscal 2026 base salaries for our NEOs, the Committee considered its independent compensation

consultant's analysis of pay levels which indicated that base salaries were generally competitive to market. Individual base

salaries also reflect the Committee's judgment with respect to each NEO's roles and responsibilities, leadership skills,

performance and work experience. The Committee reviews NEOs' base salaries annually or at the time of a promotion or a

substantial change in responsibilities based on the above-described criteria.

In fiscal 2026, base salaries for certain NEOs were increased to better align their compensation with the market for comparable

positions and are summarized below.

---

| | | |
|:---|:---|:---|
| **Name** | **Fiscal 2026 Base Salary**  | **Percentage Increase from Fiscal 2025 Base Salary** |
| **James C. Reagan**<sup>(1)</sup> | $1200000 | __ |
| **Prabu Natarajan** | $720000 | 0.0% |
| **Kathleen T. McCarthy**<sup>(2)</sup> | $575000 | __ |
| **Srinivas Attili** | $550000 | 0.0% |
| **Hilary L. Hageman**<sup>(3)</sup> | $600000 | 4.3% |
| **Toni Townes-Whitley** | $1200000 | 0.0% |
| **James J. Jackson**<sup>(3)</sup> | $425000 | 6.3% |
| **David C. Ray** | $425000 | 0.0% |

---

(1)Mr. Reagan was appointed Interim Chief Executive Officer in fiscal 2026 and earned a prorated percentage of his annual base salary for the

period from October 23, 2025 through the fiscal year end. His fiscal 2026 annual base salary was set at the same level as that of our former

Chief Executive Officer.

(2)Ms. McCarthy joined the Company in fiscal 2026 and earned a prorated percentage of her annual base salary for the period from May 12,

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2025 through the fiscal year end.

(3)Ms. Hageman and Mr. Jackson received base salary increases to be more competitive with peer group and/or survey market median

compensation.

 **saic.com** \| 51<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

**Short-Term Incentive Awards** 

Our short-term incentive ("STI") plan is the primary compensation element used to reward NEO accomplishments against

established business goals approved by our Committee within a given year. Our annual cash incentive awards are based upon

performance against predetermined goals for the fiscal year to encourage and reward contributions to our annual financial,

operating and strategic objectives.

**Performance goals for short-term incentive awards.** At the beginning of each fiscal year, the Committee sets and

approves threshold, target and maximum performance goals for the upcoming year based on objective financial goals. Further,

the Committee reviews and approves the corresponding target cash incentive awards based upon the achievement of those

goals. No amount is payable for below-threshold performance. When threshold performance is met, payouts are determined on a

straight-line basis between threshold and target performance and between target and maximum performance up to a maximum

payout of 200%.

The diagram below illustrates how we determined fiscal 2026 cash incentive awards to our NEOs under our STI plan, which is

followed by a more detailed description of the performance for fiscal 2026.

![Company Program 1.jpg](saic-20260422_g66.jpg)

(1)EBITDA is a non-GAAP financial measure and should be read in conjunction with net income, a GAAP financial measure; see the

Management's Discussion and Analysis of Financial Conditions and Results of Operations section in Part II, Item 7 of our Annual Report on

Form 10-K for the year ended January 30, 2026, for further information.

**Performance measures for fiscal 2026.** The financial performance measures for fiscal 2026 were closely aligned with the

Company's strategy for sustained profitable growth and long-term value creation.

For fiscal 2026, we maintained the core financial measures that we used in fiscal 2024 and 2025: revenue, adjusted EBITDA,

and adjusted operating cash flow with equal weightings of 33.3%. These metrics focus on profitable growth and strong cash

generation. The financial performance measures, their relative weightings, the threshold, target and maximum achievement

levels and actual performance for our short-term incentive program for fiscal 2026, as approved by the Committee, are reflected

in the table below.

**Fiscal 2026 Short-Term Incentive Awards**

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Financial Measures**<sup>(1)</sup> | **Weight** | **Threshold** | **Target** | **Maximum** | **Actual**<sup>(1)</sup> | **% of Target** <br>**Achieved**<br>| **Weighted** <br>**Avg Payout %**<br>|
| Adjusted Revenue | 33.3% | $7.574B  | $7.808B  | $8.042B  | $7.288B | 93.3% | 0.0% |
| Adjusted EBITDA | 33.3% | $728M  | $750M  | $787M  | $711M | 94.8% | 0.0% |
| Adjusted Operating Cash Flow | 33.3% | $552M  | $569M  | $597M  | $618M | 108.6% | 66.7% |
| **STI Financial Score %** | **STI Financial Score %** | **STI Financial Score %** | **STI Financial Score %** | **STI Financial Score %** | **STI Financial Score %** | **STI Financial Score %** | 66.7% |

---

(1)See the Appendix to this Proxy Statement for a reconciliation as to how each adjusted non-GAAP performance measure is calculated as

compared to the most closely comparable GAAP measure.

52 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

**Determination of leadership score.** The score reflects performance during the fiscal year and is focused on both what and

how results were achieved based on a mix of quantitative and qualitative performance and leadership expectations with a focus

on enabling our strategic culture shifts and upholding our core values. The leadership score range for the NEOs is up to 1.2x

(meaning that a multiplier up to +20% may apply) to allow for greater differentiation in executive payouts to account for outsized

negative or positive performance and drive greater ability to reflect leader accountability. The final score is based upon an

assessment of each executive's relative performance and is determined by the Committee for the Chief Executive Officer and

with input from the Chief Executive Officer for the other NEOs.

**Determination of short-term incentive amounts.** For fiscal 2026, the Committee set the STI target amount at 150% of

base salary for the Chief Executive Officer and between 80% and 100% of base salary for the other NEOs based on applicable

market data. Using the STI target award amount, the Committee applied the financial and leadership score based upon an

assessment of each executive's relative performance during the year. The STI amount paid is subject to a maximum payout of

200% of target. For our NEOs, the STI target award amounts as a percentage of base salary and STI amount paid for fiscal 2026

were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name** | **Base Salary** | **STI Target as % of** <br>**Base Salary**<br>| **STI Financial Score** | **STI Amount Paid** |
| **James C. Reagan**<sup>(1)</sup> | $1200000 | 150% | 66.7% | $400200 |
| **Prabu Natarajan** | $720000 | 100% | 66.7% | $576288 |
| **Kathleen T. McCarthy** | $575000 | 90% | 66.7% | $414207 |
| **Srinivas Attili** | $550000 | 80% | 66.7% | $234784 |
| **Hilary L. Hageman** | $600000 | 100% | 66.7% | $480240 |
| **Toni Townes-Whitley**<sup>(2)</sup> | $1200000 | 150% | 66.7% | $360180 |
| **James J. Jackson** | $425000 | 80% | 66.7% | $181424 |
| **David C. Ray** | $425000 | 80% | 66.7% | $158746 |

---

(1)Mr. Reagan was appointed Interim Chief Executive Officer in fiscal 2026 and his short-term incentive was prorated based on number of

months worked from October 23, 2025 through the fiscal year end.

(2) Ms. Townes-Whitley served as Chief Executive Officer until her separation from service in fiscal 2026 and her short-term incentive was

prorated based on number of months worked from the start of the fiscal year to her separation from service effective October 23, 2025.

**Long-Term Incentive Awards** 

We provide equity incentive awards to our NEOs to motivate them to stay with us and build long-term shareholder value through

their future performance. We benchmark our NEOs' long-term incentive award opportunities at the median of the competitive

market. The following forms of long-term incentive compensation were provided to our NEOs in fiscal year 2026:

 **saic.com** \| 53<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

---

| | |
|:---|:---|
| ![Incentive Awards 5.jpg](saic-20260422_g67.jpg) | **Performance Stock Units (60%)**<br>Incentivize our NEOs to achieve specific measurable financial goals <br>over a three-year performance cycle. Earned shares vest and are <br>issued at the end of the performance cycle and range from 0% for <br>below threshold performance to 200% for maximum performance. <br>PSUs are granted annually in overlapping performance cycles and <br>serve as a tool to align pay and Company performance and to retain our <br>NEOs. Dividend equivalents are accumulated in cash and are paid at <br>the end of the three-year performance cycle to the extent that the <br>underlying PSUs are earned. <br>|
| ![Incentive Awards 5.jpg](saic-20260422_g67.jpg) | **Restricted Stock Unit (40%)**<br>Align pay and Company performance as reflected in our stock price, <br>encourage retention of our NEOs' services and promote continued <br>investment by our executives in Company stock. RSUs awarded in <br>fiscal 2026 vest over a three-year period in 33% installments at each <br>anniversary of the grant date. Dividend equivalents on unvested RSUs <br>accumulate in cash and are paid when and if the underlying RSUs vest.<br>|

---

**Fiscal 2026-2028 Performance Stock Units**

For fiscal 2026, 60% of the long-term incentives awarded to our NEOs were provided in the form of PSUs (valued at target

payout). The performance measures and corresponding weightings for the fiscal 2026 PSUs are as follows:

---

| | | |
|:---|:---|:---|
| **Performance Measures**  | **Weight** | **Description** |
| Cumulative Adjusted EBITDA | 33.3% | Three-year cumulative goal set at the beginning of the performance period |
| Cumulative Adjusted Free Cash <br>Flow<br>| 33.3% | Three-year cumulative goal set at the beginning of the performance period |
| Relative Total Shareholder Return <br>(rTSR) <br>| 33.3% | Three-year TSR performance compared to our compensation peer group. <br>TSR is calculated based on a 30 trading day average at the beginning and <br>end of the performance period, with dividends assumed to be reinvested as <br>of ex-dividend date. <br>|

---

At the beginning of each three-year performance period, the Committee establishes the performance measures to be used for

that performance period, their weightings and the levels of performance on those measures for the entire three-year performance

period that will generate threshold, target, and maximum payouts. The number of PSUs delivered at the end of the three-year

performance cycle may range from 0% for below threshold performance to 50% for threshold performance and up to 200% for

maximum performance. When the performance threshold is met, payouts are determined on a straight line interpolation basis for

performance levels between threshold and target and between target and maximum. The final PSU payout is delivered at the

end of the three-year performance cycle.

The financial targets are closely aligned with the Company's long-term financial strategy, and not publicly disclosed at the time of

the award issuance due to the proprietary and competitive nature of this information. For rTSR, we measure our ranking as

compared to our compensation peer group. Threshold is set at the 25th percentile, target at the 50th percentile and maximum at

the 75th percentile. For rTSR, the range for payout is 0% for threshold performance to 200% for maximum performance with

payouts determined on a straight line interpolation. Final achievement and payouts for each of the above goals will be

determined and disclosed by the Committee following the conclusion of fiscal 2028.

In addition to the annual long-term incentive awards, Ms. McCarthy received a one-time sign-on grant on June 6, 2025 with a

grant date fair value of $400,067 that vests 33% on the first, second and third year anniversaries of the grant date. Mr. Reagan

received a one-time sign-on RSU award on December 5, 2025 in connection with his appointment as Interim Chief Executive

Officer with a grant date fair value of $2,000,072 and that vests the earlier of the one year anniversary of the grant date or the

appointment of a permanent CEO, which occurred on February 17, 2026 when Mr. Reagan was appointed permanent CEO.

Prior to his Interim CEO status, Mr. Reagan also received the annual grant of RSUs as a non-employee director in June 2025

with a grant date fair value of $170,039. Each of the sign-on awards are aimed at recruiting and retaining critical executives of

the Company.

54 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

**Certification of Fiscal 2024-2026 Performance Stock Units.** The Compensation Committee reviewed and approved

performance against pre-established targets for the fiscal 2024-2026 PSUs. Payout amounts for fiscal 2024-2026 performance

stock units were as follows:

**Fiscal 2024-2026 Performance Stock Units Payout**

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Performance Measures**  | **Performance** <br>**Period**<br>| **Weight** | **Threshold** <br>**50%**<br>| **Target 100%** | **Maximum** <br>**200%**<br>| **Actual**<sup>(1)</sup> | **% of Target** <br>**Achieved**<br>| **Weighted** <br>**Avg** <br>**Payout %**<br>|
| Cumulative Adjusted EBITDA | FY24-26 | 33% | $1.991B | $2.075B | $2.159B | $2.101B | 101.6% | 139.3% |
| Cumulative Adjusted Operating <br>Cash Flow<br>| FY24-26 | 33% | $1.454B | $1.514B | $1.590B | $1.694B | 111.9% | 200.0% |
| **Performance Measures** | **Performance** <br>**Period**<br>| **Weight** | **Threshold** <br>**0%**<br>| **Target 100%** | **Maximum** <br>**200%**<br>| **Actual**<sup>(1)</sup> |  | **Weighted** <br>**Avg** <br>**Payout %**<br>|
| Relative Total Shareholder Return | FY24-26 | 33% | 25.0% | 50.0% | 75.0% | 25.0% |  | 0.0% |
| **PSU Payout Percentage** | **PSU Payout Percentage** | **PSU Payout Percentage** | **PSU Payout Percentage** | **PSU Payout Percentage** | **PSU Payout Percentage** | **PSU Payout Percentage** | **PSU Payout Percentage** | **113.1%** |

---

(1)See the Appendix to this Proxy Statement for a reconciliation as to how each adjusted non-GAAP performance measure is calculated as

compared to the most closely comparable GAAP measure.

Other Benefits Provided in Fiscal 2026

In addition to the elements of direct compensation described above, we also provide our NEOs with the following benefits:

**Health and welfare benefits.** Our NEOs are entitled to participate in the health and welfare plans that we generally offer to

all of our eligible employees, which provide medical, dental, health, group term life insurance and disability benefits. We believe

that these health and welfare benefits are reasonable in scope and amount and are of the kind typically offered by other

companies against which we compete for executive talent. Additionally, our NEOs are eligible to participate in a physical health

program. The program provides the NEOs with a comprehensive medical assessment and personalized preventive strategies to

maintain and improve personal health.

**Retirement benefits.** Our NEOs are entitled to participate in the same defined contribution retirement plan that is generally

available to all of our eligible employees. Currently, we provide matching contributions to eligible participants' retirement plan

accounts based on a percentage of their eligible compensation under applicable rules. The amount of contributions we made to

the retirement plan accounts of each of our participating NEOs in fiscal 2026 was $14,000 per person with the exception of Mr.

Ray, Mr. Reagan and Ms. McCarthy. The matching contribution amount for Ms. McCarthy was $9,952. Mr. Ray and Mr. Reagan

did not contribute to the SAIC Retirement Plan. The Committee believes that contributions to this retirement program permit our

NEOs to save for their retirement in a tax-effective manner, are reasonable in scope and amount and are of the kind typically

offered by other companies against which we compete for executive talent.

**Deferred compensation plan.** To provide other tax-deferred means to save for retirement, we maintain the Deferred

Compensation Plan that allows our NEOs and other eligible participants to elect to defer a portion of any cash incentive awards

granted to them under our incentive plans and a portion of their eligible salary. Though the Company may make discretionary

contributions to participating NEOs, we made no contributions to NEOs' Deferred Compensation Plan accounts for fiscal 2026.

Vested deferred balances under the Deferred Compensation Plan will generally be paid upon retirement or termination. We also have

an additional frozen deferred compensation plan. These plans are described in more detail under "Executive Compensation,

Nonqualified Deferred Compensation" below in this Proxy Statement.

**Perquisites and personal benefits.** We do not provide excessive perquisites or personal benefits to our NEOs. Given the

nature of our business, we believe security is necessary and generally provided to other executives within our industry. As the

safety and security of our NEOs is of utmost importance, certain security measures are provided, including physical security,

residential security, network security and dark web monitoring in response to escalating cybersecurity threats.

 **saic.com** \| 55<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

Other Policies and Considerations

Assessment of Risks in our Compensation Programs

In the design and oversight of our compensation programs for NEOs and all employees, each year the Committee, with

assistance from FW Cook, the Committee's independent compensation consultant, and management, assesses risks related to

our pay practices and incentive programs. The risk assessment is focused on identifying risks associated with our compensation

programs and the mix of each type of compensation element we provide to our NEOs and all employees, as well as the

measures that the Company may employ to mitigate those risks. The Committee believes that the following features of our

compensation programs effectively mitigate excessive risk-taking that could harm our value or reward poor judgment by our

NEOs or other employees:

---

| | |
|:---|:---|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | short-term incentive measures are balanced among different financial measures, with goals that are intended to be <br>achievable upon realistic levels of performance; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | significant weighting towards long-term incentive compensation promotes long-term decision making and discourages <br>short-term risk-taking; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | goals are based on Company performance measures, which mitigates excessive risk-taking within any particular <br>business operation; <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | maximum payouts are capped at levels that do not reward excessive risk-taking; |
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | our compensation recoupment policies allow us to recover compensation based on financial results that are <br>subsequently restated or if fraud or intentional misconduct is involved; and <br>|
| ![Check@300x-100.jpg](saic-20260422_g40.jpg) | our stock ownership guidelines encourage a long-term perspective. |

---

For fiscal 2026, the Human Resources and Compensation Committee discussed and analyzed risks associated with the

Company's compensation policies and practices for executive officers and all employees generally. The Committee did not

identify any risks arising from the Company's compensation programs or practices that are reasonably likely to have a material

adverse effect on the Company.

Equity Award Grant Practices

The Committee is responsible for the administration of our equity incentive plans. Generally, in advance of each fiscal year, the

Committee will select predetermined dates on which equity awards will be granted to our employees, including our NEOs, during

the following fiscal year. These grant dates are selected to occur after the dates we anticipate releasing our annual or quarterly

financial results. We generally grant equity incentive awards to our directors, executive officers and all other eligible employees

on an annual basis shortly after we announce our financial results for the recently completed fiscal year. In addition to these

annual grants, the Committee predetermines four quarterly dates on which any additional equity incentive awards may be made

to eligible NEOs or other employees in connection with an offer of employment, for retention purposes or to recognize

performance. The company does not schedule its equity grants in anticipation of the release of material non-public information

("MNPI") nor does the company time the release of MNPI based on equity grant dates. The Committee approves all equity

awards made to our NEOs.

Employee Stock Ownership Guidelines and Stock Holding Requirements

We encourage our employees to own our stock so that they are motivated to maximize our long-term performance and drive

sustained stock value creation. We have adopted stock ownership guidelines for our executive officers that require them to

accumulate and maintain stock holdings calculated as a multiple of their base salary, depending on their role. The sum of all

shares owned outright, shares held in a trust for the benefit of the employee or his/her immediate family members, vested stock

held in the KESDP and MSCP compensation plans, stock held in a retirement plan and one-half (50%) of unvested time-based

RSUs count toward the required ownership. No other equity holdings count toward meeting the ownership requirement including

any unvested PSUs or unvested, unexercised stock options.

56 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

---

| | |
|:---|:---|
| **POSITION** | **TARGET OWNERSHIP (Multiple of Base Salary)**  |
| Chief Executive Officer | 5x |
| Other Named Executive Officers | 3x |

---

In addition to stock ownership guidelines, we also maintain a stock holding requirements policy, which mandates that executive

officers must hold 100% of the net shares acquired under our equity incentive programs until the applicable multiple of base

salary is achieved.

Prohibition on Hedging or Pledging Company Stock or Purchasing "On Margin"

We have established policies that prohibit all executive officers, directors and employees from engaging in any short selling and

hedging transactions in our securities that may carry a greater risk of liability for insider trading violations and also create an

appearance of impropriety. For example, with respect to our securities, our executive officers, directors and employees are not

permitted to engage in any short sales or any trading in puts, calls or other derivatives on an exchange or other organized

market. In addition, we prohibit our executive officers, directors and employees from pledging company stock as collateral for a

loan or purchasing company stock "on margin." Further, our executive officers, directors and senior managers are required to

obtain pre-clearance from our General Counsel for all transactions in our securities.

"Clawback" or Compensation Recoupment Policies

We maintain a mandatory compensation recovery policy for our current and former Section 16 officers and other officers as

designated by the Human Resources and Compensation Committee to require recovery of certain incentive-based compensation

pursuant to Rule 10D-1 of the Exchange Act and the applicable stock exchange rules. This mandatory compensation recovery

policy was filed as an exhibit to our annual report on Form 10-K for the fiscal year ended February 2, 2024.

In addition (and not in lieu of the mandatory compensation recovery policy), we have a discretionary compensation recovery

policy pursuant to which we may require executive officers and other employees who receive incentive compensation to return

cash and equity incentives if there is a required accounting restatement to correct an error in previously issued financial

statements (upon which the incentive compensation was based). If we determine that recovery is appropriate, we will seek

repayment of the difference between the incentive compensation paid and the incentive compensation that would have been

paid, if any, based on the restated financial results. This policy also gives us discretion to recover cash and equity incentive

compensation from any employee involved in fraud or intentional misconduct whether or not such conduct results in a

restatement of our financial results. In cases of fraud or misconduct, we may seek recovery of short-term cash incentives and/or

any equity compensation paid (and/or any subsequent gains realized from the sale of any underlying SAIC shares). We may

seek to recover the applicable amount of compensation from incentive compensation paid or awarded, as a reduction from future

payments of incentive compensation, or by cancellation of outstanding equity awards.

Post-Employment Benefits

We do not maintain a defined benefit or other supplemental retirement plan that would entitle our executive officers to receive

company-funded payments if they leave the Company.

Upon certain terminations of employment, including death, disability, retirement or a change in control, our employees, including

our NEOs, may be eligible for continued vesting of equity awards on the normal schedule or accelerated vesting in full or on a

pro rata basis, depending on the nature of the event and the type of award. The purpose of these provisions is to protect

previously earned or granted awards by making them available following the specified event. Because these termination

provisions are contained in our standard award agreements for all recipients and relate to previously granted or earned awards,

we do not consider these potential termination benefits as a separate item in compensation decisions for our NEOs. Our long-

term incentive plans do not provide for additional benefits or tax gross-ups. For more information about potential post-employment

benefits, see "Executive Compensation—Potential Payments upon Termination or a Change in Control" in this Proxy Statement.

 **saic.com** \| 57<br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

Executive Severance and Change in Control Policy

None of the NEOs have employment agreements with the Company. We maintain an Executive Severance, Change in Control

and Retirement Policy which specifies the compensation and benefits payable in connection with certain termination events for

our executive officers in change in control, non-change in control, and retirement events as further described in this Proxy

Statement under "Executive Compensation—Potential Payments upon Termination or a Change in Control." We believe that this

policy provides an important benefit to us by helping alleviate any concern the executive officers might have during a potential

change in control of our Company and permitting them to focus their attention on our business. In addition, we believe that this

policy is an important recruiting and retention tool, as many of the companies with which we compete for talent have similar

arrangements in place for their senior management.

There are no excise tax gross-up provisions authorized by the policy. This policy renews for successive one-year terms each

year, unless the Company provides notice to the eligible executive officers of either amendments to the policy or termination of

the policy or has provided notice to an individual eligible executive officer that he or she is no longer eligible for the policy no later

than November 1 of the term year. This annual term permits the Committee to review regularly the amount of benefits that would

be provided to our executive officers in connection with certain termination events and to consider whether to continue providing

those benefits.

For the upcoming fiscal year, the Committee intends to review the Executive Severance, Change in Control and Retirement

Policy to ensure it remains market-aligned and competitive with industry peers.

58 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**COMPENSATION DISCUSSION AND ANALYSIS**<br>

Human Resources and Compensation Committee Report

The Human Resources and Compensation Committee has reviewed and discussed with our management the Compensation

Discussion and Analysis included in this Proxy Statement. Based upon this review and discussion, the Committee recommended

to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.

Steven R. Shane (Chair)

Garth N. Graham

Timothy J. Mayopoulos

Donna S. Morea

John K. Tien Jr.

David J. Urban

 **saic.com** \| 59<br>

**EXECUTIVE COMPENSATION**<br>

![SectionDividers7.jpg](saic-20260422_g68.jpg)

60 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

**EXECUTIVE COMPENSATION**

Summary Compensation Table

The following table sets forth information regarding compensation earned by our NEOs. The compensation set forth below was

earned for service to SAIC during fiscal 2026, and, if applicable, during fiscal 2025 and fiscal 2024. All compensation is

disclosed, whether or not such amounts were paid in such year.

Beginning October 23, 2025, Mr. Reagan served as the Interim CEO and transitioned to the permanent role of CEO on February 17,

2026. He continues to serve as a director of the Company and, prior to October 23, 2025, was an independent director and served

on the audit and compensation committee.

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Name and**<br>**principal position**<br>| **Fiscal** <br>**Year**<sup>(1)</sup><br>| **Salary**<br>**($)**<sup>(2)</sup><br>| **Bonus** <br>**($)**<sup>(3)</sup><br>| **Stock**<br>**awards** <br>**($)**<sup>(4)</sup><br>| **Non-equity** <br>**incentive plan** <br>**compensation** <br>**($)**<sup>(5)</sup><br>| **All other**<br>**compensation** <br>**($)**<sup>(6)</sup><br>| **Total ($)** |
| **James C. Reagan** <br>Interim Chief Executive Officer<br>| 2026 | 381904 |  | 2170111 | 400200 | 1268 | 2953483 |
| **Prabu Natarajan**<br>Chief Financial Officer | 2026 | 720000 |  | 1908866 | 576288 | 25803 | 3230957 |
| **Prabu Natarajan**<br>Chief Financial Officer | 2025 | 716923 |  | 1695945 | 1143072 | 15131 | 3571071 |
| **Prabu Natarajan**<br>Chief Financial Officer | 2024 | 696154 |  | 1784097 | 1400000 | 27538 | 3907789 |
| **Kathleen T. McCarthy**<br>Executive Vice President, Chief <br>Human Resources Officer<br>| 2026 | 398077 | 300000 | 1564113 | 414207 | 222266 | 2898663 |
| **Hilary L. Hageman**<br>Executive Vice President, General <br>Counsel and Corporate Secretary | 2026 | 596154 |  | 1459828 | 480240 | 14000 | 2550222 |
| **Hilary L. Hageman**<br>Executive Vice President, General <br>Counsel and Corporate Secretary | 2025 | 571154 |  | 1296884 | 836798 | 15131 | 2719967 |
| **Srinivas Attili**<br>Executive Vice President, Civilian <br>Business Group | 2026 | 550000 |  | 909534 | 234784 | 34035 | 1728353 |
| **Srinivas Attili**<br>Executive Vice President, Civilian <br>Business Group | 2025 | 391346 | 1000000 | 1704111 | 480249 | 20517 | 3596223 |
| **Toni Townes-Whitley** <br>Former Chief Executive Officer | 2026 | 923077 |  | 8420562 | 360180 | 8378227 | 18082046 |
| **Toni Townes-Whitley** <br>Former Chief Executive Officer | 2025 | 1200000 |  | 6384074 | 2619540 | 38129 | 10241743 |
| **Toni Townes-Whitley** <br>Former Chief Executive Officer | 2024 | 578077 |  | 7175963 | 3232320 | 3958 | 10990318 |
| **James J. Jackson**<br>Former Executive Vice President, <br>Army Business Group<br>| 2026 | 421154 |  | 842184 | 181424 | 1191122 | 2635884 |
| **David C. Ray**<br>Former Executive Vice President, <br>Space and Intelligence Business <br>Group | 2026 | 425000 |  | 561541 | 158746 | 1290478 | 2435765 |
| **David C. Ray**<br>Former Executive Vice President, <br>Space and Intelligence Business <br>Group | 2025 | 424878 |  | 1498931 | 359856 | 1331 | 2284996 |

---

 **saic.com** \| 61<br>

**EXECUTIVE COMPENSATION**<br>

(1)Compensation is provided only for fiscal years for which each individual qualified as a NEO.

(2) For Mr. Reagan, the amount shown in this column represents $95,750 in the cash retainer for his service as a non-employee director in

fiscal 2026 through October 22, 2025, and $286,154 in base salary earned during fiscal 2026 for his service as Interim Chief Executive

Officer beginning October 23, 2025. For Ms. Townes-Whitley, the amount shown in this column for fiscal 2026 represents her salary during

employment until her separation from service effective October 23, 2025. For Mr. Jackson and Mr. Ray, the amount shown in this column for

fiscal 2026 represents their salary during employment until separation from service effective January 30, 2026.

(3)In connection with her appointment as Executive Vice President, Chief Human Resources Officer, Ms. McCarthy received a sign-on bonus

of $300,000.

(4)Amounts shown in this column reflect the grant date fair value computed in accordance with stock-based compensation accounting rules

(FASB ASC Topic 718). The amounts shown include the aggregate grant date fair value of RSUs and PSUs. Values for the PSUs are

computed based on the target number of shares. If the maximum level of the performance conditions was achieved, the value of the fiscal

2026 PSUs included in the "Stock Awards" column would be as follows: Mr. Natarajan, $2,457,581; Ms. McCarthy, $1,448,046; Ms.

Hageman, $1,879,433; Mr. Attili, $1,170,984; Ms. Townes-Whitley, $10,841,102; Mr. Jackson, $1,084,275; and Mr. Ray, $722,944. Amounts

shown in this column also include for Ms. McCarthy, the RSU sign-on award that she received with a grant date fair value of $400,067, and

for Mr. Reagan, the RSU sign-on award he received in connection with his appointment as Interim Chief Executive Officer that had a grant

date fair value of $2,000,072 and the annual grant of RSUs that he received as a non-employee director with a grant date fair value of

$170,039.

&nbsp;&nbsp;&nbsp;&nbsp;For more information regarding our application of FASB ASC Topic 718, including the assumptions used in the calculations of these

amounts, please refer to Note 8 of Notes to Consolidated Financial Statements contained in our Annual Report on Form 10-K for fiscal 2026

filed with the SEC on March 16, 2026.

(5)Amounts shown in this column represent the actual amounts paid to the NEOs under our cash incentive award program for performance in

fiscal 2026. The threshold, target and maximum payouts are shown in the "Grants of Plan-Based Awards" table under the column headed

"Estimated future payouts under non-equity incentive plan awards."

(6)Amounts shown in this column for fiscal 2026 include matching contributions of $14,000 made by the Company under the SAIC Retirement

Plan on behalf of all of our NEOs with the exception of Ms. McCarthy whose amount was $9,952 and Mr. Reagan and Mr. Ray, who did not

contribute to the SAIC Retirement Plan. Amounts shown also include expenses related to the physical health program benefits during fiscal

2026 on behalf of our NEOs as follows: Mr. Natarajan, $5,550; Ms. McCarthy, $5,550; Mr. Attili, $5,550; and Ms. Townes-Whitley, $2,100.

Additionally, amounts shown reflect expenses related to security costs which include residential security, network security and dark web

monitoring on behalf of our NEOs as follows: Mr. Natarajan, $6,253; Ms. McCarthy, $4,000; Mr. Attili, $14,485; and Ms. Townes-Whitley,

$44,972. Amounts shown for Ms. McCarthy also include taxable relocation expenses of $202,764. Amounts shown for Mr. Reagan and Ms.

Townes-Whitley also include taxable transportation expenses of $1,268, and $252 respectively. Amounts shown for Ms. Townes-Whitley

includes total cash severance benefits per the terms of her separation from service on October 23, 2025 and the benefits provided under

the Company's Executive Severance, Change in Control and Retirement Policy in the amount of $8,316,903. Amounts shown for Mr.

Jackson and Mr. Ray include total cash severance benefits per the terms of their separation from service on January 30, 2026 and the

benefits provided under the Company's Executive Severance, Change in Control and Retirement Policy in the amount as follows: Mr.

Jackson, $1,177,122; and Mr. Ray, $1,290,478. Ms. Townes-Whitley, Mr. Jackson and Mr. Ray incurred FICA tax obligations in the amount

of $111,164, $17,589, and $33,249 respectively, in connection with the vesting of outstanding RSUs. The Company paid the tax obligation

on their behalf and the former executives repaid the Company in full via payroll deduction. This repayment approach through payroll

deduction is the Company's standard approach for any employee that has RSUs vest after the employee becomes Special Retirement Plan

eligible.

62 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

Grants of Plan-Based Awards

The annual cash incentive plan for fiscal 2026 is described in the CD&A. For services during fiscal 2026, the NEOs received two

types of equity incentive plan awards: (1) restricted stock units, and (2) performance stock units. Annual RSU grants vest over

three years. PSU grants vest subject to performance goals related to the three-year cumulative adjusted EBITDA, cumulative

adjusted free cash flow, and relative TSR. Dividend equivalents on unvested RSUs and PSUs accumulate in cash and are paid

when and if the underlying awards vest. The following table sets forth information regarding the cash and equity incentive awards

made to our NEOs in fiscal 2026 pursuant to our STI Plan and our 2023 Equity Incentive Plan.

---

| | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | | | | **Estimated future payouts** <br>**under non equity** <br>**incentive plan awards**<sup>(1)</sup>  | **Estimated future payouts** <br>**under non equity** <br>**incentive plan awards**<sup>(1)</sup>  | **Estimated future payouts** <br>**under non equity** <br>**incentive plan awards**<sup>(1)</sup>  | **Estimated future payouts** <br>**under equity incentive plan awards**<sup>(2)</sup>  | **Estimated future payouts** <br>**under equity incentive plan awards**<sup>(2)</sup>  | **Estimated future payouts** <br>**under equity incentive plan awards**<sup>(2)</sup>  | **All other**<br>**stock**<br>**awards;**<br>**number of** <br>**shares of** <br>**stock or** <br>**units (#)**<sup>(3)</sup> | **Grant date**<br>**fair value** <br>**of** <br>**stock and**<br>**option** <br>**awards ($)**<sup>(4)</sup> |
| **Name** | **Award**<br>**type**<br>| **Grant**<br>**date**<br>| **Approval**<br>**date**<br>| **Threshold** <br>**($)**<br>| **Target**<br>**($)**<br>| **Maximum** <br>**($)**<br>| **Threshold** <br>**(#)**<br>| **Target** <br>**(#)**<br>| **Maximum** <br>**(#)**<br>| **All other**<br>**stock**<br>**awards;**<br>**number of** <br>**shares of** <br>**stock or** <br>**units (#)**<sup>(3)</sup> | **Grant date**<br>**fair value** <br>**of** <br>**stock and**<br>**option** <br>**awards ($)**<sup>(4)</sup> |
| **Mr. Reagan** | Cash |  |  | 900000 | 1800000 | 3600000 |  |  |  |  |  |
|  | RSU<sup>(5)</sup> | 06/04/2025 | 06/03/2025 |  |  |  |  |  |  | 1644 | 170039 |
|  | RSU<sup>(6)</sup> | 12/05/2025 | 10/23/2025 |  |  |  |  |  |  | 19649 | 2000072 |
| **Mr. Natarajan** | Cash |  |  | 360000 | 720000 | 1440000 |  |  |  |  |  |
|  | PSU | 04/04/2025 | 03/25/2025 |  |  |  | 4464 | 8928 | 17856 |  | 1228790 |
|  | RSU | 04/04/2025 | 03/25/2025 |  |  |  |  |  |  | 5952 | 680076 |
| **Ms. McCarthy** | Cash |  |  | 258750 | 517500 | 1035000 |  |  |  |  |  |
|  | PSU | 06/06/2025 | 04/04/2025 |  |  |  | 3222 | 6443 | 12886 |  | 724023 |
|  | RSU | 06/06/2025 | 04/04/2025 |  |  |  |  |  |  | 4295 | 440023 |
|  | RSU | 06/06/2025 | 04/04/2025 |  |  |  |  |  |  | 3905 | 400067 |
| **Ms. Hageman** | Cash |  |  | 300000 | 600000 | 1200000 |  |  |  |  |  |
|  | PSU | 04/04/2025 | 03/25/2025 |  |  |  | 3414 | 6827 | 13654 |  | 939716 |
|  | RSU | 04/04/2025 | 03/25/2025 |  |  |  |  |  |  | 4552 | 520112 |
| **Mr. Attili** | Cash |  |  | 220000 | 440000 | 880000 |  |  |  |  |  |
|  | PSU | 04/04/2025 | 03/25/2025 |  |  |  | 2127 | 4254 | 8508 |  | 585492 |
|  | RSU | 04/04/2025 | 03/25/2025 |  |  |  |  |  |  | 2836 | 324041 |
| **Ms. Townes-Whitley** | Cash |  |  | 900000 | 1800000 | 3600000 |  |  |  |  |  |
|  | PSU | 04/04/2025 | 03/25/2025 |  |  |  | 19692 | 39384 | 78768 |  | 5420551 |
|  | RSU | 04/04/2025 | 03/25/2025 |  |  |  |  |  |  | 26256 | 3000011 |
| **Mr. Jackson** | Cash |  |  | 170000 | 340000 | 680000 |  |  |  |  |  |
|  | PSU | 04/04/2025 | 03/25/2025 |  |  |  | 1970 | 3939 | 7878 |  | 542138 |
|  | RSU | 04/04/2025 | 03/25/2025 |  |  |  |  |  |  | 2626 | 300047 |
| **Mr. Ray** | Cash |  |  | 170000 | 340000 | 680000 |  |  |  |  |  |
|  | PSU | 04/04/2025 | 03/25/2025 |  |  |  | 1313 | 2626 | 5252 |  | 361472 |
|  | RSU | 04/04/2025 | 03/25/2025 |  |  |  |  |  |  | 1751 | 200069 |

---

 **saic.com** \| 63<br>

**EXECUTIVE COMPENSATION**<br>

(1)Amounts in these columns represent the threshold, target and maximum payout amounts of cash incentive awards with actual payouts

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;based upon the achievement of pre-established levels of performance during fiscal 2026, as discussed in our CD&A in this Proxy Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The actual amounts that were paid to our NEOs with respect to fiscal 2026 are set forth in the table entitled "Summary Compensation Table"

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;under the column headed "Non-equity incentive plan compensation."

(2)Amounts in these columns represent PSUs which are subject to performance goals related to the three-year cumulative adjusted EBITDA,

three-year cumulative adjusted free cash flow, and relative total shareholder return. Shares are issuable at the end of the three-year

performance cycle depending on the level that the predetermined goals have been satisfied, subject to the Human Resources and

Compensation Committee's discretion to decrease the number of shares that are ultimately issued at the end of the performance cycle.

(3)Amounts in this column, other than the amounts for Mr. Reagan, represent April 4, 2025 and June 6, 2025 grants of RSUs, which vest 33%

on the first, second, and third year anniversaries of the date of grant.

(4)Amounts represent the grant date fair value determined in accordance with FASB ASC Topic 718. These amounts do not reflect the value

that may be actually realized by the recipient and do not reflect changes in our stock price after the date of grant. The values included for

the PSUs are based on the target number of shares.

(5)Amount reflects the annual grant of RSUs that Mr. Reagan received as a non-employee director, which vests in full on the earlier of one

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;year from the date of grant or on the date of the next annual meeting of stockholders following the date of grant.

(6)Amount reflects the RSU sign-on award that Mr. Reagan received in connection with his appointment as Interim Chief Executive Officer,

which vested on February 17, 2026, the date Mr. Reagan was appointed permanent Chief Executive Officer.

64 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

Outstanding Equity Awards at Fiscal Year End

The following table sets forth information regarding outstanding equity awards that were held by our NEOs at the end of fiscal 2026.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | **Stock awards** | **Stock awards** | **Stock awards** | **Stock awards** |
| <br>**Name**  | <br>**Grant Date** | **Number of shares of** <br>**stock or units that have** <br>**not vested (#)**<sup>(1)</sup><br>| **Market value of shares** <br>**of stock or units that** <br>**have not vested ($)**<sup>(2)</sup><br>| **Equity Incentive Plan** <br>**awards; number of**<br>**unearned shares, units** <br>**or other rights that** <br>**have not vested (#)**<sup>(3)</sup><br>| **Equity Incentive Plan** <br>**awards; market or** <br>**payout value of** <br>**unearned shares, units** <br>**or other rights that** <br>**have not vested ($)**<sup>(2)</sup><br>|
| **Mr. Reagan** | 12/05/2025 | 19649 | 1999482 |  |  |
|  | 06/04/2025 | 1644 | 167293 |  |  |
| **Mr. Natarajan** | 04/04/2025 | 5952 | 605676 |  |  |
|  | 04/04/2025 |  |  | 17856 | 1817027 |
|  | 04/05/2024 | 3503 | 356465 |  |  |
|  | 04/05/2024 |  |  | 15758 | 1603534 |
|  | 04/07/2023 | 1855 | 188765 |  |  |
| **Ms. McCarthy** | 06/06/2025 | 8200 | 834432 |  |  |
|  | 06/06/2025 |  |  | 12886 | 1311279 |
| **Ms. Hageman** | 04/04/2025 | 4552 | 463212 |  |  |
|  | 04/04/2025 |  |  | 13654 | 1389431 |
|  | 04/05/2024 | 2679 | 272615 |  |  |
|  | 04/05/2024 |  |  | 12050 | 1226208 |
|  | 04/07/2023 | 1484 | 151012 |  |  |
| **Mr. Attili** | 04/04/2025 | 2836 | 288591 |  |  |
|  | 04/04/2025 |  |  | 8508 | 865774 |
|  | 06/07/2024 | 7559 | 769204 |  |  |
|  | 06/07/2024 |  |  | 8322 | 846847 |
| **Ms. Townes-Whitley** | 04/04/2025 | 26256 | 2671811 |  |  |
|  | 04/04/2025 |  |  | 78768 | 8015432 |
|  | 04/05/2024 | 13183 | 1341502 |  |  |
|  | 04/05/2024 |  |  | 59320 | 6036403 |
|  | 06/12/2023 | 8008 | 814894 |  |  |
| **Mr. Jackson** | 04/04/2025 | 2626 | 267222 |  |  |
|  | 04/04/2025 |  |  | 7878 | 801665 |
|  | 04/05/2024 | 1031 | 104915 |  |  |
|  | 04/05/2024 |  |  | 4636 | 471759 |
|  | 04/07/2023 | 464 | 47217 |  |  |
| **Mr. Ray** | 04/04/2025 | 1751 | 178182 |  |  |
|  | 04/04/2025 |  |  | 5252 | 534444 |
|  | 09/13/2024 | 7411 | 754143 |  |  |
|  | 04/05/2024 | 1031 | 104915 |  |  |
|  | 04/05/2024 |  |  | 4636 | 471759 |
|  | 04/07/2023 | 526 | 53526 |  |  |

---

(1)Information in this column relates to RSUs held by our NEOs at the end of fiscal 2026. All RSUs except the RSUs granted on September 13,

2024, June 4, 2025 and December 5, 2025 vest annually over a three-year period at each anniversary of the grant date. The September 13,

2024 award will vest in full on January 29, 2027. The June 4, 2025 award pertains to the annual grant that Mr. Reagan received as a non-

employee director that will vest in full on June 3, 2026. The December 5, 2025 award vested on February 17, 2026 with the appointment of

Mr. Reagan as permanent CEO.

(2)Based on $101.76 per share, the closing sales price of our common stock on Nasdaq on January 30, 2026.

(3)The number of PSUs reflected in this column represent the PSUs awarded for the fiscal 2025-2027 and fiscal 2026-2028 performance

cycles. The number of PSUs that can be earned has been disclosed in this column at a maximum payout based on performance through

January 30, 2026. The PSUs are not settled until after the performance period when performance results are certified by the Human

Resources and Compensation Committee.

 **saic.com** \| 65<br>

**EXECUTIVE COMPENSATION**<br>

Option Exercises and Stock Vested

The following table sets forth information regarding shares of common stock acquired by our NEOs during fiscal 2026 upon the

vesting of RSUs and the vesting of fiscal 2024-2026 PSUs.

---

| | | |
|:---|:---|:---|
| | **Stock awards** | **Stock awards** |
| <br>**Name** | **Number of shares acquired on vesting (#)**<sup>(1)</sup> | **Value realized on vesting ($)**<sup>(2)</sup> |
| **Mr. Reagan** | 1451 | 148394 |
| **Mr. Natarajan** | 15202 | 1598412 |
| **Ms. McCarthy** |  |  |
| **Ms. Hageman** | 13943 | 1444364 |
| **Mr. Attili** | 3777 | 390995 |
| **Ms. Townes-Whitley** | 55306 | 5701399 |
| **Mr. Jackson**<sup>(3)</sup> | 3337 | 352172 |
| **Mr. Ray**<sup>(3)</sup> | 3769 | 397949 |

---

(1) Includes PSUs earned in connection with the PSU for the fiscal 2024-2026 performance period and a portion of time-based RSUs granted

during previous fiscal years.

(2) Value realized on vesting disclosed above is based on the closing price per share of our common stock on Nasdaq on the applicable vest

date. For the earned fiscal 2024-2026 PSUs, the value is based on the closing price per share of our common stock on Nasdaq on the

vesting date of January 30, 2026 of $101.76.

(3) The FY24-26 PSU grant for Mr. Jackson and Mr. Ray was subject to different performance conditions under a non-NEO plan (Cumulative

EBITDA and Cumulative Operating Cash Flow each weighted 50%; Relative TSR performance applied as a modifier) with a final PSU

payout percentage of 135.7% of target.

66 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

Nonqualified Deferred Compensation

The Deferred Compensation Plan became effective January 1, 2015 and is a pre-tax savings plan that allows eligible

participants, which includes our NEOs, to defer up to 80% of their salary and cash bonus compensation as well as director cash

retainer and meeting fees. Deferrals into the Deferred Compensation Plan are not included as eligible compensation for the

calculation of the company match in the SAIC Retirement Plan. If there is a loss of company match in the SAIC Retirement Plan

because of a deferral into the Deferred Compensation Plan, the Company may, at its sole discretion, make up the difference in

company matching contribution to the Deferred Compensation Plan. Participants elect to have deferred balances paid on a

specific date while they are still employed or upon retirement or separation of service in the form of a lump sum payment or in

annual installments over five, 10, or 15 years.

The SAIC 401(k) Excess Deferral Plan ("Excess Plan") was closed on December 31, 2014 and no further deferrals are allowed.

The investment options in the Excess Plan are similar to those in the SAIC Retirement Plan (our 401(k) plan), but do not include

the SAIC Stock Fund. Vested deferred balances under this plan will generally be paid following retirement or separation from

service in the form of a lump sum payment or annual installments paid over a period of up to 10 years.

The SAIC Key Executive Stock Deferral Plan was closed on December 31, 2014 and no further deferrals are allowed. Participant

balances generally correspond to stock units of our common stock which may be held by a rabbi trust to fund benefits for

participants. We make no contributions to participants' accounts under the Key Executive Stock Deferral Plan. Distributions

under the Key Executive Stock Deferral Plan are then made to participants in shares of common stock corresponding to the

number of vested stock units held for the participant. Vested deferred balances under this plan will generally be paid upon

retirement or separation from service.

The following table sets forth information regarding deferrals under and aggregate earnings and withdrawals in fiscal 2026

through our nonqualified deferred compensation plans in which the NEOs participated. There were no company matching

contributions made to the NEOs' accounts under any of the plans in fiscal 2026.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name**<sup>(1)</sup> | **Plan** | **Executive** <br>**contributions**<br>**in fiscal 2026**<br>**($)**<sup>(2)</sup><br>| **Aggregate** <br>**earnings in**<br>**fiscal 2026** <br>**($)**<sup>(3)</sup><br>| **Aggregate** <br>**withdrawals/** <br>**distributions** <br>**in fiscal 2026**<br>| **Aggregate** <br>**balance at fiscal** <br>**year-end ($)**<sup>(4)</sup><br>|
| **Mr. Reagan** | &nbsp;&nbsp;&nbsp;&nbsp;Deferred Compensation Plan  | 163260 | 26267 |  | 372461 |
| **Mr. Natarajan** | &nbsp;&nbsp;&nbsp;&nbsp;Deferred Compensation Plan  | 372614 | 153149 |  | 1391744 |
| **Mr. Jackson** | &nbsp;&nbsp;&nbsp;&nbsp;Deferred Compensation Plan  |  | 52960 |  | 663010 |
|  | Excess Plan |  | 5365 |  | 30382 |
|  | Key Executive Stock Deferral Plan |  | (32618) |  | 660525 |
| **Mr. Ray** | Deferred Compensation Plan | 186418 | 161348 |  | 1081885 |

---

(1) Ms. McCarthy, Ms. Hageman, Mr. Attili and Ms. Townes-Whitley are not included in this table because they have not participated in any

nonqualified deferred compensation plans.

(2)Amounts in this column include salary deferrals in fiscal 2026 and annual incentive bonus paid in fiscal 2026 for fiscal 2025 performance.

For Mr. Reagan, $115,385; Mr. Natarajan, $144,000; and Mr. Ray, $78,462 of this amount is reported as fiscal 2026 compensation in the

Summary Compensation Table.

(3)With respect to the Deferred Compensation Plan, amounts in this column represent aggregate returns on the investments elected by

participants from the diverse investment options available to participants under the plans. Participants may change their investment

elections at any time. The returns on the investment options available to eligible participants during fiscal 2026 ranged from -0.14% to

41.03%. The amounts in this column are not included in the Summary Compensation Table.

(4)Amounts in this column represent the value of the holders' accounts at the end of fiscal 2026, which includes the following amounts reported

in the Summary Compensation Table for the amounts contributed by the plan holder for the prior year: Mr. Reagan, $47,875 Director

Retainer and Meeting fees; Mr. Natarajan, $228,614; and Mr. Ray, $107,957.

 **saic.com** \| 67<br>

**EXECUTIVE COMPENSATION**<br>

Potential Payments upon Termination or a Change in Control

We have an Executive Severance, Change in Control and Retirement Policy ("Severance Policy") that applies to designated

eligible officers, including all of our active NEOs, which became effective as of September 5, 2023, and which provides certain

benefits to the active NEOs upon their termination of employment under the circumstances described below, including in

connection with a change in control or retirement. In addition, our Amended and Restated 2013 Equity Incentive Plan ("2013

Plan") and the award agreements thereunder, as well as the 2023 Equity Incentive Plan ("2023 Plan") provide for accelerated

vesting and exercisability of equity awards under the circumstances described below, including in connection with a change in

control (or in the case of the 2023 Plan, upon certain terminations in connection with a change in control).

Severance Policy

Severance benefits under the Severance Policy are conditioned on the NEO signing and not revoking a general waiver and

release and signing and complying with a two-year non-compete agreement.

Under the Severance Policy, if within 90 days preceding or 21 months following a change in control an active NEO is involuntarily

terminated by the Company for any reason other than for cause, death, or disability or resigns for good reason, he or she will be

entitled to receive a lump sum cash payment equal to two times (or three times in the case of our chief executive officer) the sum

of (i) the executive officer's then current annual base salary and (ii) the target annual incentive bonus for the fiscal year in which

the termination occurs. If the executive officer's annual base salary was higher during the 90-day period prior to the change in

control, that higher amount will be used to determine the amount of the lump sum cash payment to which the executive officer is

entitled. The executive officer is also entitled to receive a lump sum cash payment in an amount equal to 24 months (or 36

months in the case of our chief executive officer) of the monthly COBRA premium for continued group medical coverage for the

executive officer and his or her eligible dependents, outplacement services for a period of 12 months and up to a maximum of

$25,000, and a lump sum cash payment equal to a pro-rata portion of the executive's target annual bonus opportunity for the

bonus cycle in which the termination occurs. For a change of control related termination, the NEO's outstanding equity awards

will be governed by the terms of the 2013 Plan or 2023 Plan, as applicable.

Under the terms of the Severance Policy, if, other than during the period before or after a change in control as described above,

an active NEO is involuntarily terminated by the Company for any reason other than for cause, death or disability, he or she will

be entitled to receive a lump sum cash payment equal to 1.5 times (or two times in the case of our chief executive officer) the

sum of (i) the executive officer's then current annual base salary and (ii) the average of the most recent three actual annual cash

bonuses paid (or the average of all of the actual annual cash bonuses paid for such shorter time if the executive officer has not

been employed by us for at least three annual bonus cycles). The executive will continue to vest in all previously granted equity

awards under the 2013 Plan or 2023 Plan per the original terms of the award, but without any minimum holding period

requirements and without any proration of the award. The executive officer is also entitled to receive a lump sum cash payment

in an amount equal to 18 months (or 24 months in the case of our chief executive officer) of the monthly COBRA premium for

continued group medical coverage for the executive officer and his or her eligible dependents, outplacement services for a period

of 12 months and up to a maximum of $25,000, and a lump sum cash payment equal to a pro-rata portion of the executive's

annual bonus opportunity for the bonus cycle in which the executive's termination occurs to be paid per the Company's usual

payment schedule at the percentage payable per the Company's fiscal year annual financial performance goal attainment. After

the COBRA eligibility period has expired, the executive may elect to remain on or join the SAIC health care plan in a retiree rate

pool until Medicare eligible at the executive's expense.

Under the terms of the Severance Policy, if an active NEO intends to retire and provides the Company with at least six months

advanced written notice of their termination and agrees to sign a two-year non-compete agreement, he or she will be entitled to

receive a lump sum cash payment in an amount equal to 18 months (or 24 months in the case of our chief executive officer) of

the monthly COBRA premium for continued group medical coverage for the executive officer and his or her eligible dependents

and a lump sum payment equal to a pro-rata portion of the executive's annual bonus opportunity for the bonus cycle in which the

executive's retirement occurs to be paid per the Company's usual payment schedule at the percentage payable per the

Company's fiscal year annual financial performance goal attainment. After the COBRA eligibility period has expired, the executive

may elect to remain on or join the SAIC health care plan in a retiree rate pool until Medicare eligible at the executive's expense.

The executive will continue to vest in all previously granted equity wards under the 2013 Plan or 2023 Plan per the original terms

of the award, but without any minimum holding period requirements and without any proration of the award.

The Severance Policy generally defines a termination for "cause" if the termination is on account of the officer's (i) conviction, or

entering a plea of no contest, committing an act of fraud, embezzlement, theft or other felony, (ii) willful engagement in illegal

conduct or gross misconduct that is significantly injurious to the Company, or (iii) failure to perform employment duties in a

reasonably satisfactory manner after notice from the Company and, if the failure is capable of being cured, a 30-day opportunity

to cure the failure. A resignation is generally defined to be for "good reason" if it is due to (i) a material adverse change in

authority, duties or responsibilities (including if following a change of control the executive officer is no longer an executive), (ii) a

material reduction in base salary or target bonus or any failure to pay the NEO any compensation to which the NEO is entitled

within 15 days after the date when due, or (iii) a relocation of the individual's principal place of employment of more than 50

68 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

miles, and the Company has failed to remedy the event or condition after receiving notice of the same. The Severance Policy

defines a "change in control" in the same manner as the term is defined in our 2023 Plan, as described below.

The Severance Policy provides that in the event that Internal Revenue Code Section 280G excise taxes may be payable by an

executive, the executive will either receive payment in full, or have their payments cut-back to the largest amount which will avoid

excise taxes, depending on which option results in receipt of the greatest amount of severance benefits by the executive on an

after-tax basis.

The Severance Policy automatically renews on December 31 of the applicable year for the following year, unless, prior to a

"change in control" and not later than November 1 of such year, the Severance Policy is amended or terminated, and participants

are provided notice.

Equity Awards Under the 2013 Plan

Under our 2013 Plan, the vesting of stock option and RSU awards will accelerate in full if the successor entity in a change in

control does not assume or replace outstanding awards or, if such awards are assumed or replaced, and the award recipient's

employment ends within 18 months after the change in control due to termination without cause or resignation for good reason.

The award agreements for PSUs issued under our 2013 Plan provide that if a change in control occurs before the end of a

performance period, the performance period will be terminated and an award recipient will be entitled to receive, immediately

prior to the change in control, a number of shares equal to the number determined by the committee to have been earned for

each fiscal year in the performance period completed before the change in control, plus a pro rata portion of the shares

determined by the committee to have been earned during the year in which the change in control occurred.

The 2013 Plan generally defines a "change in control" as (i) a merger or consolidation in which the Company is not the surviving

corporation, (ii) a merger in which the Company is the surviving corporation but after which the Company's pre-merger

shareholders no longer own their Company shares, (iii) a sale of substantially all of the Company's assets, or (iv) the acquisition,

sale or transfer of more than 50% of the Company's outstanding shares by tender offer or similar transaction. "Cause" for

termination is generally defined in the 2013 Plan as employment-related dishonesty, fraud or misconduct likely to cause significant

injury to the Company or its personnel, and "good reason" is defined in a manner similar to that under the Severance Policy.

Other than in the context of a change in control, RSU awards and option awards will vest in full immediately if employment ends

due to death or disability, and, under those circumstances, options will remain exercisable for a period of time, which under the

2013 Plan is until the expiration date of the option award. Our PSU agreements provide that if employment ends due to death, an

award recipient's estate will be entitled to promptly receive a number of shares determined in the same manner as if a change in

control had occurred on the date of death. If employment ends due to disability, after the completion of the first fiscal year of the

performance period, a pro rata portion (based on the portion of the performance period completed prior to the employment

termination) of the performance stock units determined to have been earned at the end of the three-year performance period will

be paid out after the end of the performance period.

Under our Special Retirement eligibility provisions as described in the award agreement(s), employees who retire, including our

NEOs, may continue vesting in their stock option awards if they have held those options for at least 12 months prior to retirement

and they retire (i) after age 59 1/2 with at least ten years of service or (ii) after age 59 1/2 when age at termination plus years of

service equals at least 70. Our executive officers who retire after reaching the applicable mandatory retirement age, however, will

be allowed to continue to vest in their option awards without regard to the 12 month holding requirement. Under the same

conditions, executive officers may continue vesting in their RSU awards, and may receive the same pro rata payout of PSUs as

applies in the event of a termination due to disability. We have the right to terminate continued vesting if a retiree violates

confidentiality, non-solicitation or similar obligations to us.

In any other termination scenario involving an equity award recipient, including a NEO, the 2013 Plan provides that all unvested

RSUs, options and PSUs are forfeited. Under these circumstances, vested options remain exercisable for 90 days or until the

option expiration date, if earlier. However, as noted above, the Severance policy allows designated eligible officers, including all

of our active NEOs, to continue vesting in their equity awards if the executive officer is involuntarily terminated without cause or

as a result of their retirement.

Equity Awards Under the 2023 Plan

Under our 2023 Plan, upon the occurrence of an award recipient's termination of employment by the Company for any reason

(other than cause, death, or disability) or upon the recipient's resignation for good reason, in each case, within 18 months of a

change in control, any outstanding awards that are subject to a time-based vesting condition will accelerate and vest in full. The

2023 Plan provides that if a change in control occurs before the end of a performance period, the performance period will be

terminated and an award recipient will be entitled to receive, immediately prior to the change in control, a number of shares equal

to the number determined by the committee to have been earned for each fiscal year in the performance period completed

 **saic.com** \| 69<br>

**EXECUTIVE COMPENSATION**<br>

before the change in control, plus a pro rata portion of the shares determined by the committee to have been earned during the

fiscal year in which the change in control occurred.

The 2023 Plan generally defines a "change in control" as (i) a merger or consolidation in which the Company is not the surviving

corporation, (ii) a merger in which the Company is the surviving corporation but after which the Company's pre-merger

shareholders no longer own their Company shares, (iii) a sale of substantially all of the Company's assets, or (iv) the acquisition,

sale or transfer of more than 50% of the Company's outstanding shares by tender offer or similar transaction. "Cause" for

termination is generally defined in the 2023 Plan as employment-related dishonesty, fraud, misconduct or disclosure or misuse of

confidential information that is likely to cause significant injury to the Company or its personnel, and "good reason" is defined in a

manner similar to that under the Severance Policy.

Other than in the context of a change in control, RSU awards will vest in full immediately if employment ends due to death or

disability. Our PSU agreements provide that if employment ends due to death, an award recipient's estate will be entitled to

promptly receive a number of shares determined in the same manner as if a change in control had occurred on the date of death.

If employment ends due to disability, a pro rata portion (based on the portion of the performance period completed prior to the

employment termination) of the performance stock units determined to have been earned at the end of the three-year

performance period will be paid out after the end of the performance period.

Under our Special Retirement eligibility provisions as described in the award agreement(s), employees who retire, including our

NEOs, may continue vesting in their RSU awards if they have held those RSUs for at least 12 months prior to retirement and

they retire (i) after age 59 1/2 with at least ten years of service or (ii) after age 59 1/2 when age at termination plus years of

service equals at least 70. Under the same conditions, executive officers may receive the same pro rata payout of PSUs as

applies in the event of a termination due to disability. We have the right to terminate continued vesting if a retiree violates

confidentiality, non-solicitation or similar obligations to us. In addition, as noted above, the Severance Policy allows designated

eligible officers, including all of our active NEOs, to continue vesting in their equity awards if the executive officer is involuntarily

terminated without cause or as a result of their retirement.

In any other termination scenario involving an equity award recipient, including a NEO, the 2023 Plan provides that all unvested

RSUs and PSUs are forfeited.

Other Separation Agreements

In connection with the separation of Ms. Townes-Whitley from the Company, Ms. Townes-Whitley and the Company entered into

a separation agreement that entitles Ms. Townes-Whitley to receive: (i) a cash payment of $8,251,860, which is equal to 2.0

multiplied by the sum of Ms. Townes-Whitley base salary and three-year average bonus payments, which was paid on the 60th

day following the termination date; (ii) a cash payment of $40,043, which is equal to 24 months of the monthly COBRA premium

for continued group medical coverage for Ms. Townes-Whitley; (iii) continued vesting in all previously granted awards under the

2023 Plan per the original terms of the award, but without any minimum holding period requirements and without any proration of

the award; (iv) a cash payment equal to Ms.Townes-Whitley's annual bonus opportunity for the bonus cycle in which the

termination occurred, to be paid per the Company's usual payment schedule and at the percentage payable per the Company's

fiscal year annual bonus financial performance scores; and (v) reimbursement for outplacement services suitable for a period of

12 months and up to a maximum of $25,000.

In connection with the separation of Mr. Jackson from the Company, Mr. Jackson and the Company entered into a separation

agreement that entitles Mr. Jackson to receive: (i) a cash payment of $1,106,394, which is equal to 1.5 multiplied by the sum of

Mr. Jackson base salary and three-year average bonus payments, which was paid on the 60th day following the termination

date; (ii) a cash payment of $45,728, which is equal to 18 months of the monthly COBRA premium for continued group medical

coverage for Mr. Jackson; (iii) continued vesting in all previously granted awards under the 2023 Plan per the original terms of

the award, but without any minimum holding period requirements and without any proration of the award; (iv) a cash payment

equal to Mr. Jackson's annual bonus opportunity for the bonus cycle in which the termination occurred, to be paid per the

Company's usual payment schedule and at the percentage payable per the Company's fiscal year annual bonus financial

performance scores and (v) reimbursement for outplacement services suitable for a period of 12 months and up to a maximum of

$25,000.

In connection with the separation of Mr. Ray from the Company, Mr. Ray and the Company entered into a separation agreement

that entitles Mr. Ray to receive: (i) a cash payment of $1,208,848, which is equal to 1.5 multiplied by the sum of Mr. Ray's base

salary and three-year average bonus payments, payable on the 60th day following the termination date; (ii) a cash payment of

$56,630, which is equal to 18 months of the monthly COBRA premium for continued group medical coverage for Mr. Ray; (iii)

continued vesting in all previously granted awards under the 2023 Plan per the original terms of the award, but without any

minimum holding period requirements and without any proration of the award; and (iv) a cash payment equal to Mr. Ray's annual

bonus opportunity for the bonus cycle in which the termination occurred, to be paid per the Company's usual payment schedule

and at the percentage payable per the Company's fiscal year annual bonus financial performance scores; and (v) reimbursement

for outplacement services suitable for a period of 12 months and up to a maximum of $25,000.

70 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

Estimated Termination and Change in Control Payments and Benefits

The following table sets forth our estimates of the payments and benefits to be made to our NEOs under various termination and

change in control scenarios. In calculating the amounts set forth in the table, we have assumed that (i) the date of termination

was January 30, 2026, the last business day of fiscal 2026, (ii) the date of any related change in control was the same date, and

(iii) the price of our common stock was $101.76 per share, the closing market price of our common stock on the Nasdaq on

January 30, 2026. The table does not reflect payments and benefits that are provided on a non-discriminatory basis to salaried

employees generally upon termination, nor does it reflect amounts attributable to equity-based awards that were already vested,

or distributions of plan balances under our nonqualified deferred compensation plan.

 **saic.com** \| 71<br>

**EXECUTIVE COMPENSATION**<br>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Name** | **Without Cause** <br>**Termination (not in** <br>**connection with a** <br>**Change in Control)** <br>**($)**<br>| **Without Cause or** <br>**With Good Reason** <br>**Termination**<br>**(in connection with** <br>**a Change in** <br>**Control)**<sup>(1)</sup> **($)**<br>| **Retirement ($)** | **Death ($)** | **Disability ($)** |
| **Mr. Reagan** |  |  |  |  |  |
| Bonus<sup>(2)</sup> | 1800000 | 1800000 | 1800000 |  |  |
| Severance<sup>(3)</sup> | 6000000 | 9000000 |  |  |  |
| Medical coverage continuation<sup>(4)</sup> | 51150 | 76725 | 51150 |  |  |
| Outplacement services<sup>(5)</sup> | 25000 | 25000 |  |  |  |
| Restricted stock units<sup>(6)</sup> | 2167992 | 2167992 | 2167992 | 2167992 | 2167992 |
| Performance stock units<sup>(7)</sup> |  |  |  |  |  |
| Applicable cut back<sup>(8)</sup> |  |  |  |  |  |
| Total | 10044142 | 13069717 | 4019142 | 2167992 | 2167992 |
| **Mr. Natarajan** |  |  |  |  |  |
| Bonus<sup>(2)</sup> | 720000 | 720000 | 720000 |  |  |
| Severance<sup>(3)</sup> | 2690386 | 2880000 |  |  |  |
| Medical coverage continuation<sup>(4)</sup> | 56630 | 75506 | 56630 |  |  |
| Outplacement services<sup>(5)</sup> | 25000 | 25000 |  |  |  |
| Restricted stock units<sup>(6)</sup> | 1174135 | 1174135 | 1174135 | 1174135 | 1174135 |
| Performance stock units<sup>(7)</sup> | 1740597 | 854257 | 1740597 | 854257 | 854257 |
| Applicable cut back<sup>(8)</sup> |  |  |  |  |  |
| Total | 6406748 | 5728898 | 3691362 | 2028392 | 2028392 |
| **Ms. McCarthy** |  |  |  |  |  |
| Bonus<sup>(2)</sup> | 517500 | 517500 | 517500 |  |  |
| Severance<sup>(3)</sup> | 1638750 | 2185000 |  |  |  |
| Medical coverage continuation<sup>(4)</sup> | 31819 | 42425 | 31819 |  |  |
| Outplacement services<sup>(5)</sup> | 25000 | 25000 |  |  |  |
| Restricted stock units<sup>(6)</sup> | 840500 | 840500 | 840500 | 840500 | 840500 |
| Performance stock units<sup>(7)</sup> | 660408 | 220136 | 660408 | 220136 | 220136 |
| Applicable cut back<sup>(8)</sup> |  |  |  |  |  |
| Total | 3713977 | 3830561 | 2050227 | 1060636 | 1060636 |
| **Ms. Hageman** |  |  |  |  |  |
| Bonus<sup>(2)</sup> | 600000 | 600000 | 600000 |  |  |
| Severance<sup>(3)</sup> | 2001237 | 2400000 |  |  |  |
| Medical coverage continuation<sup>(4)</sup> | 38363 | 51150 | 38363 |  |  |
| Outplacement services<sup>(5)</sup> | 25000 | 25000 |  |  |  |
| Restricted stock units<sup>(6)</sup> | 904870 | 904870 | 904870 | 904870 | 904870 |
| Performance stock units<sup>(7)</sup> | 1331002 | 653237 | 1331002 | 653237 | 653237 |
| Applicable cut back<sup>(8)</sup> |  |  |  |  |  |
| Total | 4900472 | 4634257 | 2874235 | 1558107 | 1558107 |
| **Mr. Attili** |  |  |  |  |  |
| Bonus<sup>(2)</sup> | 440000 | 440000 | 440000 |  |  |
| Severance<sup>(3)</sup> | 1545374 | 1980000 |  |  |  |
| Medical coverage continuation<sup>(4)</sup> | 39161 | 52215 | 39161 |  |  |
| Outplacement services<sup>(5)</sup> | 25000 | 25000 |  |  |  |
| Restricted stock units<sup>(6)</sup> | 1077724 | 1077724 | 1077724 | 1077724 | 1077724 |
| Performance stock units<sup>(7)</sup> | 870270 | 434310 | 870270 | 434310 | 434310 |
| Applicable cut back<sup>(8)</sup> |  |  |  |  |  |
| Total | 3997529 | 4009249 | 2427155 | 1512034 | 1512034 |

---

72 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

(1)The change in control consequences for PSUs are the same whether or not a qualifying termination (involuntary termination without cause

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;or resignation for good reason) occurs in connection with the change in control. With respect to RSU awards, the 2013 Plan also

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;provides for accelerated vesting of the awards if the successor corporation does not assume or replace the awards in connection with the

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;change in control and the 2023 Plan provides for accelerated vesting upon a qualifying termination in connection with a change in control.

(2)In the case of termination involuntarily without cause, in connection with a change in control, the NEOs receive a pro rata portion of their

target bonus. In case of retirement the NEOs receive a pro rata portion of the actual bonus. However, because the assumed termination

date of January 30, 2026 is the last day of the fiscal year, this column reflects the target bonus amounts of the date of termination.

(3) In the case of a qualifying termination not in connection with a change in control, severance amounts represent a single lump sum payment

equal to two times for Mr. Reagan and 1.5 times for all other NEOs the sum of (a) the NEO's fiscal 2026 base salary and (b) the average of

the annual bonuses paid for fiscal 2025, 2024 and 2023 (or such shorter period, where applicable). In the case of a qualifying termination in

connection with a change in control, severance amounts represent a single lump sum payment equal to three times for Mr. Reagan and two

times for all other NEOs of the sum of (a) the NEO's fiscal 2026 base salary and (b) his or her target annual bonus for fiscal 2026.

(4)In the case of a qualifying termination not in connection with a change in control, these amounts represent a lump sum cash payment

of COBRA benefits for 24 months for Mr. Reagan and 18 months for all other NEOs. In the case of a qualifying termination in connection

with a change in control, these amounts represent a lump sum cash payment of COBRA benefits for 36 months for Mr. Reagan and 24

months for all other NEOs. This payment is made without regard to whether the NEO is participating in the Company's medical coverage

post termination.

(5)These amounts represent the maximum value to the NEO of outplacement counseling services to be provided for 12 months following a

qualifying termination.

(6)These amounts represent the value of RSUs issued under the 2013 Plan or 2023 Plan, as applicable, that were held by the NEO at the end

of fiscal 2026 and whose vesting and payment was accelerated in connection with a change in control, death, or disability or whose vesting

continues without an employment requirement as a result of involuntary termination without cause, retirement, or termination due to death or

disability. The value was calculated by multiplying the number of RSUs whose vesting or payment was accelerated or continued by the

closing market price per share of our common stock on the Nasdaq on January 30, 2026, and includes accrued dividend equivalents as of

January 30, 2026. For more information regarding the number of unvested or unpaid RSUs held by each of the NEOs, see the table under

the caption "Outstanding Equity Awards at Fiscal Year-End."

(7)These amounts represent the value of shares underlying outstanding PSUs issued under the 2013 Plan or 2023 Plan that were held by the

NEO at the end of fiscal 2026 and whose vesting was accelerated or continued in connection with a change in control, involuntary

termination without cause, retirement, termination due to disability, or termination due to death. For PSUs in this table, the value was

calculated by multiplying the number of performance stock units whose vesting was accelerated or continued by the closing market price

per share of our common stock on the Nasdaq on January 30, 2026, and includes accrued dividend equivalents as of January 30, 2026. For

an involuntary termination without cause or retirement under the Severance Policy, the performance stock units earned are determined at

the end of the three-year performance period and are paid at the end of that performance period. For a termination following a change of

control or death, the PSU performance period will be terminated and an award recipient will be entitled to receive, immediately prior to the

change in control, a number of shares equal to the number determined by the committee to have been earned for each fiscal year in the

performance period completed before the change in control, plus a pro rata portion of the shares determined by the committee to have been

earned during the fiscal year in which the change in control occurred. For a termination due to disability, a pro rata portion (based on the

portion of the performance period completed prior to the employment termination) of the performance stock units determined to have been

earned at the end of the three-year performance period will be paid out after the end of the performance period. In this table PSUs are

assumed earned and calculated at 100.0% of target for all fiscal years within a performance period. Note that PSUs from fiscal 2024 are not

included in this table since they are deemed to be earned as of January 30, 2026.

(8)Under the Severance Policy, executives either receive (a) payment in full, or (b) have their payments cutback to avoid excise taxes payable

pursuant to Sections 280G and 4999 of the Internal Revenue Code, depending on which option results in receipt of the greatest amount of

severance benefits by the executive on an after-tax basis. The amount reported under this item is the amount by which NEO's payment

would be reduced if necessary to avoid paying excise taxes because such reduction results in a larger payment than if the excise tax was

triggered.

 **saic.com** \| 73<br>

**EXECUTIVE COMPENSATION**<br>

CEO Pay Ratio

We are providing the following information about the relationship of the median annual total compensation of our employees and

the annual total compensation of James C. Reagan, who was appointed Interim CEO beginning October 23, 2025.

We identified the median employee employed as of December 31, 2025 as follows:

• We collected data for all employees (excluding the CEO), including part-time and full-time, permanent, temporary and

seasonal employees, and excluding independent contractors.

• We used base pay as our consistently applied compensation measure.

• We identified employees within a narrow range of the estimated median and then employed statistical sampling to select the

median employee from within that range.

We then determined our median employee's total compensation, including any perquisites and other benefits, in the same

manner that we determine the total compensation of our NEOs for purposes of the Summary Compensation Table disclosed

above.

Based on the above calculations, for fiscal 2026, our last completed fiscal year:

• the annual total compensation of the median employee was $117,981

• the total compensation of our CEO was $4,509,892 for purposes of this calculation

Since Mr. Reagan assumed the role of interim CEO on October 23, 2025, we have annualized his base salary, short-term

incentive compensation, and other compensation components in accordance with SEC requirements, and also included the

Summary Compensation Table reported amounts for his equity awards.

The Summary Compensation Table provides details of the actual compensation Mr. Reagan received during the fiscal year 2026.

Therefore, we reasonably estimate that the ratio of our CEO's annualized total compensation to the annual total compensation

of our median employee was 38:1. Our pay ratio estimate has been calculated in a manner consistent with item 401(u) of

Regulation S-K.

74 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

Pay Versus Performance

The following table and supporting graphics below set out information about the relationship between executive compensation

actually paid and the Company's financial performance for the five fiscal years in satisfaction of Item 402(v) of Regulation S-K.

The below table presents compensation actually paid ("CAP") to our principal executive officer ("PEO") and (on average) to our

other NEOs ("non-PEOs") during the specified fiscal years alongside summary compensation table ("SCT") totals, total

shareholder return (for the Company and a peer group), net income and the Company selected measure of revenue. The

Company selected this measure as the most important measure used in the last fiscal year to link CAP to our executives and our

performance. This measure is a key metric in the short-term incentive plan for our executives, representing 33% of the target

opportunity as found on page 54.

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **Fiscal** <br>**Year**<sup>(1)</sup><br>| **Summary** <br>**Compensation** <br>**Table Total for** <br>**First PEO** <br>**(Keene) ($)**<br>| **Compensation** <br>**Actually Paid** <br>**to First PEO** <br>**(Keene)**<sup>(2)(3)(4)</sup> <br>**($)**<br>| **Summary** <br>**Compensation** <br>**Table Total for** <br>**Second PEO** <br>**(Townes-**<br>**Whitley) ($)**<br>| **Compensation** <br>**Actually Paid to** <br>**Second PEO** <br>**(Townes-**<br>**Whitley)**<sup>(2)(3)(4)</sup> <br>**($)**<br>| **Summary** <br>**Compensation** <br>**Table Total for** <br>**Third PEO** <br>**(Reagan) ($)**<br>| **Compensation** <br>**Actually Paid to** <br>**Third PEO** <br>**(Reagan)**<sup>(2)(3)(4)</sup> <br>**($)**<br>| **Average** <br>**Summary** <br>**Compensation** <br>**Table Total for** <br>**Non-PEO NEOs** <br>**($)**<br>| **Average** <br>**Compensation** <br>**Actually Paid to** <br>**Non-PEO** <br>**NEOs**<sup>(2)(3)(4)</sup> **($)**<br>| **Total** <br>**Shareholder** <br>**Return**<sup>(5)</sup><br>| **Peer Group** <br>**Total** <br>**Shareholder** <br>**Return**<sup>(5)</sup><br>| **Net Income**<br>**($ in** <br>**millions)**<sup>(6)</sup><br>| **Revenue**<br>**($ in** <br>**millions)**<sup>(7)</sup><br>|
| 2026 |  |  | 18082046 | 15042938 | 2953482 | 2943716 | 2579974 | 2185450 | 113.75 | 195.65 | 358 | 7262 |
| 2025 |  |  | 10241743 | 8432362 |  |  | 3043064 | 2628442 | 119.39 | 183.31 | 362 | 7479 |
| 2024 | 12895917 | 18951966 | 10990318 | 13473423 |  |  | 4541334 | 6387422 | 140.57 | 143.81 | 477 | 7444 |
| 2023 | 8664380 | 13290774 |  |  |  |  | 4681658 | 5523501 | 111.94 | 111.99 | 303 | 7704 |
| 2022 | 8343156 | 6384092 |  |  |  |  | 2563133 | 2239947 | 86.13 | 114.15 | 279 | 7394 |

---

(1) Our PEO and Non-PEO NEOs included in the above compensation columns reflect the following:

---

| | | |
|:---|:---|:---|
| **Fiscal** <br>**Year**<br>| **PEOs** | **Non-PEO NEOs** |
| 2026 | Toni Townes-Whitley; <br>James Reagan<br>| Prabu Natarajan, Srinivas Attili, Hilary L. Hageman, David C. Ray, <br>James J. Jackson, Kathleen T. McCarthy<br>|
| 2025 | Toni Townes-Whitley | Prabu Natarajan, Srinivas Attili, Hilary L. Hageman, David C. Ray |
| 2024 | Nazzic S. Keene; <br>Toni Townes-Whitley<br>| Prabu Natarajan, Robert S. Genter, Michael W. LaRouche, Michelle O'Hara |
| 2023 | Nazzic S. Keene | Prabu Natarajan, Robert S. Genter, Michael W. LaRouche, Michelle O'Hara, Steven G. Mahon |
| 2022 | Nazzic S. Keene | Prabu Natarajan, Robert S. Genter, Michael W. LaRouche, Steven G. Mahon |

---

(2)In accordance with Item 402(v) requirements, the fair value of unvested and outstanding equity awards included in the CAP columns were

remeasured as of the end of each fiscal year, and as of each vesting date, during the fiscal years displayed in the table above. Fair values

as of each measurement date were determined using valuation assumptions and methodologies that are consistent with those used to

estimate fair value in accordance with ASC Topic 718. The fair value of options was determined by using a lattice model, the fair value of the

TSR-modifier and relative TSR-based PSUs was determined by using a Monte Carlo simulated pricing model, non-market based PSUs

reflect the probable outcome of the performance vesting conditions as of each measurement date, and RSUs fair value equals the stock

price on the appropriate measurement date.

(3)For the portion of CAP that is based on the Company's fiscal year-end stock prices, the following prices were used for 2026: $101.76, 2025:

$108.28, for 2024: $129.01, for 2023: $104.08, and for 2022: $81.32.

(4)The dollar amounts reported represent the amount of CAP as computed in accordance with Item 402(v) of SEC Regulation S-K. A

reconciliation of Total Compensation from the SCT to CAP to the PEO and our Non-PEO NEOs (as an average) is shown below:

 **saic.com** \| 75<br>

**EXECUTIVE COMPENSATION**<br>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **First PEO (Keene)** | **First PEO (Keene)** | **First PEO (Keene)** |
| <br>**Adjustments** | **2026** | **2025** | **2024** | **2023** | **2022** |
| Total Compensation from SCT |  |  | $12895917 | $8664380 | $8343156 |
| **Adjustments for stock and option awards:** |  |  |  |  |  |
| (Subtraction): SCT Amounts |  |  | (7254762) | (5840076) | (5333701) |
| Addition: Fair value at year-end of awards granted during <br>the covered fiscal year that are outstanding and <br>unvested at year-end<br>|  |  | 6128313 | 7124332 | 5194332 |
| Addition (Subtraction): Year-over-year change in fair <br>value of awards granted in any prior fiscal year that are <br>outstanding and unvested at year end<br>|  |  | 1734628 | 1852379 | (1238005) |
| Addition: Vesting date fair value of awards granted and <br>vesting during such year<br>|  |  | 2918464 |  |  |
| Addition (Subtraction): Change as of the vesting date <br>(from the end of the prior fiscal year) in fair value of <br>awards granted in any prior fiscal year for which vesting <br>conditions were satisfied during such year<br>|  |  | 2283842 | 1286527 | (762622) |
| Addition: Dividends or other earnings paid on stock or <br>option awards in the covered year prior to vesting if not <br>otherwise included in the total compensation for the <br>covered year<br>|  |  | 245564 | 203232 | 180932 |
| **Compensation Actually Paid (as calculated)** | $— | $— | $18951966 | $13290774 | $6384092 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Second PEO (Townes-Whitley)** | **Second PEO (Townes-Whitley)** | **Second PEO (Townes-Whitley)** |
| <br>**Adjustments** | **2026** | **2025** | **2024** | **2023** | **2022** |
| Total Compensation from SCT | $18082046 | $10241743 | $10990318 | $— | $— |
| **Adjustments for stock and option awards:** |  |  |  |  |  |
| (Subtraction): SCT Amounts | (8420562) | (6384074) | (7175963) |  |  |
| Addition: Fair value at year-end of awards granted <br>during the covered fiscal year that are outstanding and <br>unvested at year-end<br>| 5771943 | 5966499 | 9606473 |  |  |
| Addition (Subtraction): Year-over-year change in fair <br>value of awards granted in any prior fiscal year that are <br>outstanding and unvested at year end<br>| (558076) | (1468134) |  |  |  |
| Addition: Vesting date fair value of awards granted and <br>vesting during such year<br>|  |  |  |  |  |
| Addition (Subtraction): Change as of the vesting date <br>(from the end of the prior fiscal year) in fair value of <br>awards granted in any prior fiscal year for which vesting <br>conditions were satisfied during such year<br>| (66622) | (98246) |  |  |  |
| Addition: Dividends or other earnings paid on stock or <br>option awards in the covered year prior to vesting if not <br>otherwise included in the total compensation for the <br>covered year<br>| 234209 | 174574 | 52595 |  |  |
| **Compensation Actually Paid (as calculated)** | $15042938 | $8432362 | $13473423 | $— | $— |

---

76 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Third PEO (Reagan)** | **Third PEO (Reagan)** | **Third PEO (Reagan)** |
| <br>**Adjustments** | **2026** | **2025** | **2024** | **2023** | **2022** |
| Total Compensation from SCT | $2953482 | $— | $— | $— | $— |
| **Adjustments for stock and option awards:** |  |  |  |  |  |
| (Subtraction): SCT Amounts | (2170111) |  |  |  |  |
| Addition: Fair value at year-end of awards granted <br>during the covered fiscal year that are outstanding and <br>unvested at year-end<br>| 2166776 |  |  |  |  |
| Addition (Subtraction): Year-over-year change in fair <br>value of awards granted in any prior fiscal year that are <br>outstanding and unvested at year end<br>|  |  |  |  |  |
| Addition: Vesting date fair value of awards granted and <br>vesting during such year<br>|  |  |  |  |  |
| Addition (Subtraction): Change as of the vesting date <br>(from the end of the prior fiscal year) in fair value of <br>awards granted in any prior fiscal year for which vesting <br>conditions were satisfied during such year<br>| (8721) |  |  |  |  |
| Addition: Dividends or other earnings paid on stock or <br>option awards in the covered year prior to vesting if not <br>otherwise included in the total compensation for the <br>covered year<br>| 2290 |  |  |  |  |
| **Compensation Actually Paid (as calculated)** | $2943716 | $— | $— | $— | $— |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| | | | **Average of Other NEOs** | **Average of Other NEOs** | **Average of Other NEOs** |
| <br>**Adjustments** | **2026** | **2025** | **2024** | **2023** | **2022** |
| Total Compensation from SCT | $2579974 | $3043064 | $4541334 | $4681658 | $2563133 |
| **Adjustments for stock and option awards:** |  |  |  |  |  |
| (Subtraction): SCT Amounts | (1207678) | (1548968) | (1575993) | (3040104) | (1160628) |
| Addition: Fair value at year-end of awards granted <br>during the covered fiscal year that are outstanding and <br>unvested at year-end<br>| 872700 | 1457430 | 1654263 | 3223412 | 1130294 |
| Addition (Subtraction): Year-over-year change in fair <br>value of awards granted in any prior fiscal year that are <br>outstanding and unvested at year end<br>| (83512) | (200391) | 620349 | 379538 | (211064) |
| Addition: Vesting date fair value of awards granted and <br>vesting during such year<br>|  |  | 311011 |  |  |
| Addition (Subtraction): Change as of the vesting date <br>(from the end of the prior fiscal year) in fair value of <br>awards granted in any prior fiscal year for which vesting <br>conditions were satisfied during such year<br>| (6325) | (168756) | 752594 | 237325 | (117602) |
| Addition: Dividends or other earnings paid on stock or <br>option awards in the covered year prior to vesting if not <br>otherwise included in the total compensation for the <br>covered year<br>| 30291 | 46063 | 83864 | 41672 | 35814 |
| **Compensation Actually Paid (as calculated)** | $2185450 | $2628442 | $6387422 | $5523501 | $2239947 |

---

(5)Peer Group TSR reflects the Dow Jones US Computer Services Index, which is the industry index utilized in the stock performance graph,

as reflected in our Annual Report on the Form 10-K for the fiscal year ended January 30, 2026 pursuant to Item 201(e) of Regulation S-K.

The Company and peer group TSR for each year reflects what the cumulative value of $100 would be, including the reinvestment of

dividends, if such amount were invested on January 29, 2021 (the last day of fiscal 2021) through and including the end of the fiscal year for

each year reported in the table.

(6)Net income is as listed on our Annual Report on Form 10-K in accordance with U.S. GAAP.

 **saic.com** \| 77<br>

**EXECUTIVE COMPENSATION**<br>

(7)Revenue is the financial measure from the tabular list of fiscal 2026 Most Important Measures shown below which, in the Company's

assessment, represents the most important performance measure used to link CAP to our PEO and Non-PEO NEOs to the Company's

performance for fiscal 2026. Revenue is as listed on our Annual Report on the Form 10-K in accordance with U.S. GAAP.

Tabular List of Important Financial Performance Measures

The following table lists the most important financial performance measures we used to link CAP to our executives to Company

performance for the most recently completed fiscal year. These measures are utilized in our short-term and long-term incentive

plans, and are aligned with our pay for performance philosophy. For further information regarding these performance metrics in

our incentive programs, please see the "Compensation Discussion and Analysis" beginning on page 44.

---

| |
|:---|
| **Most Important Measures (Unranked)** |
| Revenue |
| Adjusted EBITDA<sup>(1)</sup> |
| Adjusted Operating Cash Flow<sup>(1)</sup> |

---

(1)Adjusted EBITDA and adjusted operating cash flow are non-GAAP measures. See the Appendix to this Proxy Statement for a reconciliation

as to how each adjusted non-GAAP performance measure for the performance stock units is calculated as compared to the most closely

comparable GAAP measure.

78 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**EXECUTIVE COMPENSATION**<br>

Relationship between Pay and Performance

The following charts present a graphical comparison of CAP and performance figures that are included in the pay versus

performance tabular disclosure above. In addition, the first graph below presents the relationship between the Company's TSR

and that of the selected peer group, the Dow Jones US Computer Services Index. As noted above, CAP for purposes of the

tabular disclosures and the following charts were calculated in accordance with SEC rules and do not fully represent the actual

final amount of compensation earned by or actually paid to our PEO and NEOs during the applicable fiscal years.

**Compensation Actually Paid and Company/Peer Group Total Shareholder Return**

![CAP vs. TSR 2026_v3.jpg](saic-20260422_g69.jpg)

**Compensation Actually Paid and Net Income**

![CAP vs. Net Income_2026_v3.jpg](saic-20260422_g70.jpg)

**Compensation Actually Paid and Revenue**

![CAP vs. Revenue_2026_v3.jpg](saic-20260422_g71.jpg)

 **saic.com** \| 79<br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

![SectionDividers8.jpg](saic-20260422_g72.jpg)

80 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT** 

**TO THE 2023 EQUITY INCENTIVE PLAN TO** 

**INCREASE THE TOTAL NUMBER OF** 

**AUTHORIZED SHARES**

The Board unanimously

recommends a vote **FOR** 

**t**his Proposal.

![Check in Box-01.jpg](saic-20260422_g26.jpg)

We are asking our stockholders to approve an amendment of our 2023 Equity Incentive Plan (referred to in this Proxy Statement

as the "2023 Plan" or the "Plan") to increase the number of shares available for awards under the Plan by 1,088,000 shares.

Our continuing ability to offer equity awards under our long-term equity incentive plan is critical to our ability to attract, motivate

and retain qualified personnel, particularly in light of the highly competitive market for employee talent in which we operate.

Plan History

The 2023 Plan became effective on June 7, 2023, upon approval by our stockholders at our 2023 annual meeting and authorized

2,240,000 shares for issuance pursuant to awards under the Plan.

The 2023 Plan replaced the company's 2013 Equity Incentive Plan (referred to in this Proxy Statement as the "2013 Plan" or the

"Prior Plan"). Awards outstanding under our 2013 Plan as of the date the 2023 Plan became effective continue to be subject to

the terms of the 2013 Plan, but if those awards subsequently expired or were terminated or canceled or forfeited on or after the

effective date of the 2023 Plan, the shares subject to those awards become available for awards under the 2023 Plan.

The 2023 Plan was amended through an Amendment No. 1 effective March 5, 2024, to reflect the change in the Company's

listing from the New York Stock Exchange to The Nasdaq Stock Market LLC.

On March 25, 2026, our Board, at the recommendation of our Human Resources and Compensation Committee (sometimes

referred to in this Proposal 4 as the "Committee"), approved an Amendment No. 2 to the Plan (the "Amendment") to increase the

number of shares available for awards under the Plan subject to approval by our stockholders at the annual meeting.

As of April 8, 2026, the Plan had approximately 1,013,620 shares available for issuance and approximately 45,400,000 basic

weighted average common shares outstanding. These figures reflect shares granted as part of awards made on on April 3, 2026,

as part of the annual grant cycle and any vestings occurring through April 7, 2026. The closing market price for a share of our

common stock as of April 8, 2026 was $97.98 per share.

The Board and the Committee believe that the share increase is necessary to provide for a sufficient number of shares to grant

for equity awards that will attract, motivate and retain employees in future years. If the Amendment is not approved by our

stockholders, the Plan will continue in effect under its current terms and will remain subject to its existing share reserve.

Background of Share Request

Each year, the Committee reviews our overall compensation strategy and determines allocations of cash and equity

compensation in light of our pay-for-performance philosophy. We believe that equity compensation is critical in motivating key

employees and that it effectively aligns employee compensation with stockholder interests. We are also committed to effectively

managing our share reserves for equity compensation while minimizing stockholder dilution.

Our three-year average burn rate was 1.22% for fiscal years 2024 through 2026. We define burn rate as the total number of

shares subject to awards granted to participants in a single year expressed as a percent of our basic weighted average common

shares outstanding for that year. We believe our historical burn rate is reasonable for a company of our size in our industry and

consistent with our peer group.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
| **Grant Issuance and Burn-Rate History** | **FY24** | **FY25** | **FY26** | **FY27 YTD**<sup>C</sup> | **Three-Year Average**<br>**(FY24-26)**<br>|
| Restricted Stock Units Granted | 443481 | 383481 | 517121 | 403906 | 448028 |
| Performance Stock Units Granted<sup>a</sup> | 171858 | 134270 | 168770 | 175465 | 158299 |
| Options Granted<sup>b</sup> | 0 | 0 | 0 | 0 | 0 |
| **Total Shares Granted** | 615339 | 517751 | 685891 | 579371 | 606327 |
| **Weighted Average Common** <br>**Shares Outstanding - Basic**<br>| 53100000 | 50100000 | 46300000 | 45400000 | 49800000 |
| **Burn-Rate** | 1.16% | 1.03% | 1.48% | 1.28% | 1.22% |

---

 **saic.com** \| 81<br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

(a) Reflects the target number of PSUs granted in the applicable year.

(b)The Company has not granted stock options since April 2020.

(c)Fiscal 2027 YTD reflects the April 3, 2026 annual grant and any vestings occurring through April 7, 2026.

---

| | |
|:---|:---|
| **Outstanding Equity Awards** | **As of April 8, 2026** |
| Outstanding Restricted Stock Units | 902651 |
| Outstanding Performance Stock Units<sup>a</sup> | 466815 |
| Outstanding Options<sup>b</sup> | 29074 |
| **Total Outstanding Equity Awards** | 1398540 |

---

(a)Assumes the target performance for outstanding performance-based awards are achieved.

(b)For outstanding options, the weighted average exercise price is approximately $76 and weighted average remaining term is 0.9 years.

In setting the number of additional shares to be available for issuance under the proposal, we considered our estimated

competitive usage needs going forward, which are dependent on a variety of factors, including the price of our shares, and hiring

activity during the next few years, and forfeitures of outstanding awards. While our Committee believes that the assumptions

utilized are reasonable, future share usage will differ from current expectations to the extent that actual events differ from the

assumptions utilized.

In its determination to approve the Amendment, the Board was primarily motivated by a desire to ensure the Company has an

available pool of shares from which to grant long-term equity-based incentive awards, which the Board believes is a primary

incentive and retention mechanism for our employees and directors.

In light of the factors described above, the Board believes that the increase in the number shares available proposed by the

Amendment is reasonable and appropriate at this time.

Key Features of the Plan

The Plan includes a number of features that we believe are consistent with the interests of our stockholders and sound corporate

governance practices, including the following:

• The Plan has a fixed share pool and does not have an "evergreen" share replenishment feature.

• The Plan includes a minimum vesting or performance period of one year for awards, subject only to limited exceptions.

• The Plan contains an annual limit on the aggregate value of all awards granted during a calendar year to any non-employee

director during the calendar year of $500,000.

• The Plan prohibits repricing or cash buyouts of stock options or stock appreciation rights ("SARs").

• The Plan prohibits dividend equivalents on unexercised stock options and SARs, and requires that any dividends and

dividend equivalents payable or credited on unvested full value awards must be subject to the same restrictions and risk of

forfeiture as the underlying shares.

• The Plan does not contain a liberal definition of "change in control."

• The Plan includes a recoupment or "clawback" provision.

• The Plan generally prohibits the transferability of stock options and stock awards prior to the date that unrestricted shares

have been issued.

82 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

Plan Summary

The summary of the key provisions of the Plan, including a number of important compensation and governance best practices to

help ensure the Plan furthers our compensation plan objectives and supports long-term stockholder interests, is set forth below.

The summary is qualified in its entirety by reference to the full text of the Plan as proposed to be amended by the Amendment,

with the revisions marked, which is attached to this Proxy Statement as Appendix B.

Administration

The Plan may be administered by our Board, a committee of our Board or a delegated officer or employee in certain

circumstances. The Board has delegated authority to the Committee to administer the Plan.

Eligibility

Non-statutory stock options, SARs, stock awards and cash awards may be granted under the Plan to employees, directors and

consultants of the company or its affiliates. Incentive stock options may be granted only to our employees or those of our

affiliates. The aggregate grant date fair value of all awards made under the Plan to any non-employee director in a fiscal year is

limited to $500,000. The administrator, in its discretion, selects the individuals to whom stock options, SARs, stock awards and

cash awards may be granted, the time or times at which awards are granted and the terms of awards to be granted under the

Plan.

Minimum Vesting Requirement

Except with respect to a maximum of five percent of the shares that are authorized to be issued under the Plan, the death or

disability of the Recipient, or a change in control, no Award will provide for vesting that is any more rapid than vesting on the one

year anniversary of the date of grant.

Transferability of Awards

In general, no right or interest in any award under the Plan may be assigned, transferred, exchanged or encumbered by a

participant, voluntarily or involuntarily, except by will or the laws of descent and distribution. However, the Committee may

provide that an award (other than an incentive stock option) may be transferable by gift to a participant's family member. In

addition, an incentive stock option may be transferred pursuant to a domestic relations order. Any permitted transferee of such an

award will remain subject to all the terms and conditions of the award applicable to the participant.

Termination of Awards

Generally, unless otherwise provided in the award agreement, if an awardee's service as an employee, consultant or director

terminates other than for death or disability or for cause, vested stock options will remain exercisable for a period of 90 days

following the awardee's termination, or if earlier, until the expiration of the term of the stock options. Unvested restricted stock

awards and restricted stock units are forfeited as of the date of the termination of employment. If an awardee's service as an

employee, consultant or director terminates for cause, all of the awardee's awards will immediately terminate as of the date of

termination unless otherwise provided for in the award agreement. Unless otherwise provided for in the award agreement, if an

awardee becomes disabled or dies while an employee, consultant or director of the company, the vesting of all of the awardee's

unvested awards will accelerate, and all of the awardee's awards will be exercisable until the expiration of the term of the award.

The administrator has the authority to extend the period of time for which an award is to remain exercisable following an

awardee's termination, but not beyond the expiration of the term of the award.

Prohibition on Repricing

Stock options and SARs may not be repriced or cancelled and replaced with lower-priced stock options, SARs, other awards or

cash payments with the effect of lowering the exercise price of previously granted stock options and SARs are prohibited without

the approval of our stockholders.

 **saic.com** \| 83<br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

Dividend Equivalents

Stock awards may include a right to dividends or dividend equivalents, which may be settled in the form of cash, shares or a

combination of both. The Plan requires that any dividends and dividend equivalents payable or credited on unvested full value

awards must be subject to the same restrictions and risk of forfeiture as the underlying shares or share equivalents. However,

dividend equivalents are not permitted on stock options and SARs.

Adjustments on Changes in Capitalization

In the event of any stock dividend, stock split, reverse stock split, recapitalization, combination or reclassification, spin-off,

extraordinary cash dividend or similar change to our capital structure (not including a fundamental transaction or change of

control), our Board or the Committee will make appropriate proportionate adjustments to:

• the number and type of shares available for issuance under the Plan and subject to outstanding awards; and

• the exercise, purchase or repurchase price per share applicable to outstanding awards

The specific form of any such adjustments shall be determined by the Board or the Committee.

Change in Control

If a change in control of the company occurs, then the consequences will be as described below unless the Committee provides

otherwise in an applicable award or other agreement with the participant. For outstanding time-based awards if within 18 months

after the corporate transaction a participant's employment or other service is involuntarily terminated without cause (but not for

death or disability) or the participant resigns with good reason, (i) each of the participant's outstanding options and SARs will

become exercisable in full, and (ii) each of the participant's unvested full value awards will fully vest.

For performance-based awards, in the event of a change in control prior to the end of a performance period, the performance

period will be terminated, and the award will vest based on actual achievement of performance goals for completed fiscal years,

or if the change in control is prior to the end of any fiscal year of the performance period, the award will be pro-rated to reflect the

portion of the year that elapsed prior to the change in control.

In the event of a change of control, the vesting of all awards held by our non-employee directors will accelerate.

For purposes of the Plan, a "change in control" generally refers to a merger, consolidation, the sale of more than 50% of the

shares of our stock via tender offer, or a sale of all or substantially all of the assets of the company.

Term of the Plan

The Plan became effective on June 7, 2023, upon approval by our stockholders at our 2023 annual meeting. The Plan will

terminate on the tenth anniversary of the Plan's effective date, unless the Board terminates the Plan at any earlier time. Awards

outstanding under the Plan at the time it is terminated will continue in accordance with their terms and the terms of the Plan

unless otherwise provided in the applicable agreements.

Amendment and Termination

The Board may amend, suspend or terminate the Plan at any time. However, stockholder approval is required for any

amendment to the Plan to the extent required to comply with applicable laws and listing requirements and if any such

amendment increases the maximum number of shares which may be issued under the Plan, extends the term of the Plan or

awards granted under the Plan, changes the eligibility criteria to receive awards under the Plan, reduces the exercise price of a

stock option or SAR or amends the repricing prohibitions in the Plan. Generally, no amendment of the Plan or an award may

materially alter or impair any outstanding award under the Plan without the consent of the holder of such award.

84 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

Types of Awards

Equity-based awards granted in recent periods consist of time-based restricted stock units and performance-based restricted

stock units. The Company has not granted stock options since April 2020. The Company did not have material stock-based

compensation expense for stock options for fiscal 2026 or fiscal 2025.

Stock Options

Options are exercisable for our common stock and may be in the form of "incentive stock options" within the meaning of Section

422 of the Internal Revenue Code of 1986, as amended (the "Code"), or options to purchase common stock that do not qualify as

incentive stock options, referred to as "nonqualified stock options." The per share exercise price to be paid by a participant at the

time an option is exercised may not be less than 100% of the fair market value of one share of our common stock on the date of

grant, unless the option is granted as a substitute award as described earlier. "Fair market value" as of any date means the

closing sales price as quoted for a share on The Nasdaq Stock Market LLC for the prior trading day, as reported in *The Wall* 

*Street Journal*.

The Committee determines when options vest and become exercisable and in its discretion may accelerate the vesting of any

outstanding option. The means of payment for shares issued upon exercise of an option are specified in each option agreement.

The Plan permits payment to be made by cash, check, wire transfer, cancellation of indebtedness, other shares of our stock (with

some restrictions), broker assisted same-day sales, in certain circumstances a "net exercise" (delivery of cash or stock for any

net appreciation in the shares at the time of exercise over the exercise price) and any other means of consideration permitted by

applicable law and the administrator.

The maximum contractual term for stock options is ten years, but historically the Company granted stock options with a seven-

year contractual term. No option may be exercised after the expiration of its term.

Stock Appreciation Rights

SARs are rights to receive cash and/or shares of our stock based on the amount by which the exercise date fair market value of

a specific number of shares exceeds the grant date fair market value of the exercised portion of the right. The specific terms and

conditions applicable to a SAR will be provided in an individual award agreement. To date, we have not granted any SARs under

the Plan.

Restricted Stock Units and Performance Stock Units

Time-based and performance-based restricted stock units represent a promise to deliver shares of our stock or an amount of

cash or property equal to the value of the underlying shares at a future date.

Performance stock units are rights to receive amounts, denominated in cash or shares of our stock, based upon our or a

participant's performance during a pre-established performance period. A performance stock unit may also contain other terms,

conditions or restrictions, such as the following: (i) the target and maximum amount of shares payable to the participant, (ii) the

level of achievement versus the criteria that will determine the number of shares vested, (iii) forfeiture provisions and (iv) further

terms and conditions, in each case not inconsistent with the Plan, as may be determined from time to time by the administrator.

Other Stock Awards

The Plan permits us to grant a variety of stock awards (including awards having no exercise or purchase price or having an

exercise or purchase price that is less than the fair market value of our stock as of the date of grant of the award, such as

phantom stock rights). Restricted stock grants are awards of a specific number of shares of our stock. Deferred stock is a grant

where shares of our stock are distributed in the future upon or following vesting. Performance stock grants are rights to receive

amounts, denominated in cash or shares of our stock, based upon our or a participant's performance during the period between

the date of grant and a pre-established future date.

Cash Awards

Cash awards may be granted either alone, in addition to or in tandem with other awards granted under the Plan. Cash awards

may be subject to time-based and/or performance conditions.

 **saic.com** \| 85<br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

U.S. Federal Income Tax Consequences of Awards

The following is a general summary of the typical U.S. federal income tax consequences of the issuance and exercise of options

or other awards under the Plan. It does not describe state or other tax consequences of the issuance and exercise of options or

other awards.

The summary is not a detailed or complete description of all U.S. federal tax laws or regulations that may apply, however, and

does not address any local, state or other country laws. Therefore, no one should rely on this summary for individual tax

compliance, planning or decisions. Participants in the Plan are encouraged to consult with their own professional tax advisors

concerning tax aspects of rights under the Plan and should be aware that tax laws may change at any time.

Non-qualified Stock Options

If a participant is granted a non-qualified stock option under the Plan, the participant will not recognize taxable income upon the

grant of the option. Generally, the participant will recognize ordinary income at the time of exercise in an amount equal to the

difference between the fair market value of the shares acquired at the time of exercise and the exercise price paid. The

participant's basis in the common stock for purposes of determining gain or loss on a subsequent sale or disposition of such

shares generally will be the fair market value of our common stock on the date the option was exercised. Any subsequent gain or

loss will be taxable as a capital gain or loss. The company will generally be entitled to a federal income tax deduction at the time

and for the same amount as the participant recognizes as ordinary income.

Incentive Stock Options

If a participant is granted an incentive stock option under the Plan, the participant will not recognize taxable income upon grant of

the option. Additionally, if applicable holding period requirements (a minimum of two years from the date of grant and one year

from the date of exercise) are met, the participant will not recognize taxable income at the time of exercise. However, the excess

of the fair market value of the shares acquired at the time of exercise over the aggregate exercise price is an item of tax

preference income potentially subject to the alternative minimum tax. If shares acquired upon exercise of an incentive stock

option are held for the holding period described above, the gain or loss (in an amount equal to the difference between the fair

market value on the date of sale and the exercise price) upon disposition of the shares will be treated as a long-term capital gain

or loss, and the company will not be entitled to any deduction. Except in the event of death, if the holding period requirements

are not met, the incentive stock option will be treated as one that does not meet the requirements of the Code for incentive stock

options and the tax consequences described for nonqualified stock options will generally apply. An optionee who is granted an

incentive stock option does not recognize taxable income at the time the option is granted or upon its exercise, although the

excess (if any) of the fair market value of the stock at exercise over the exercise price is treated as an item of income for

alternative minimum tax purposes and may subject the optionee to the alternative minimum tax. Alternative minimum tax is an

alternative method of calculating the income tax that must be paid each year, which includes certain additional items of income

and tax preferences and disallows or limits certain deductions otherwise allowable for regular tax purposes. Alternative minimum

tax is payable only to the extent that the alternative minimum tax exceeds "ordinary" federal income tax for the year (computed

without regard to certain credits and special taxes).

Upon a disposition of the shares acquired on exercise of an incentive stock option more than two years after grant of the option

and one year after exercise of the option, the optionee will recognize long-term capital gain or loss equal to the difference

between the sale price and the exercise price. If a disposition occurs before either of the holding periods are satisfied, referred to

as a disqualifying disposition, then (i) if the sale price exceeds the exercise price, the optionee will recognize capital gain equal to

the excess, if any, of the sale price over the fair market value of the shares on the date of exercise and will recognize ordinary

income equal to the difference, if any, between the lesser of the sale price or the fair market value of the shares on the exercise

date and the exercise price; or (ii) if the sale price is less than the exercise price, the optionee will recognize a capital loss equal

to the difference between the exercise price and the sale price. We are not entitled to a federal income tax deduction in

connection with incentive stock options, except to the extent that the optionee has taxable ordinary income on a disqualifying

disposition.

An optionee does not recognize any taxable income when a nonstatutory stock option is granted with an exercise price at least

equal to the fair market value of the stock on the date of grant. Upon the exercise of a nonstatutory option with respect to vested

shares, the optionee has taxable ordinary income (and we are entitled to a corresponding deduction) equal to the option spread

on the date of exercise. Any taxable income recognized in connection with exercise of a nonstatutory option by an employee of

ours is subject to tax withholding. Upon a disposition of stock acquired upon exercise of a nonstatutory option, the optionee

recognizes either long-term or short-term capital gain or loss, depending on how long the stock was held, on any difference

between the sale price and the exercise price, to the extent not recognized as taxable income on the date of exercise. We may

allow nonstatutory options to be transferred subject to conditions and restrictions imposed by the administrator; special tax rules

may apply on a transfer.

In the case of both incentive stock options and nonstatutory options, special federal income tax rules apply if our common stock

is used to pay all or part of the option exercise price, and different rules than those described above will apply if unvested shares

are purchased on exercise of the option.

86 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

Stock Awards

The current federal income tax consequences of other awards authorized under the Plan generally follow certain basic patterns.

An award of restricted stock results in income recognition by a participant in an amount equal to the fair market value of the

shares received at the time the restrictions lapse and the shares vest, unless the participant elects under Code Section 83(b) to

accelerate income recognition and the taxability of the award to the date of grant. Stock unit awards generally result in income

recognition by a participant at the time payment of such an award is made in an amount equal to the amount paid in cash or the

then-current fair market value of the shares received, as applicable. SAR awards result in income recognition by a participant at

the time such an award is exercised in an amount equal to the amount paid in cash or the then-current fair market value of the

shares received by the participant, as applicable. In each of the foregoing cases, the company will generally have a

corresponding deduction at the time the participant recognizes ordinary income.

Cash Awards

Cash awards generally are taxed upon receipt as ordinary income, with the company having a corresponding deduction at the

time the participant recognizes ordinary income.

Section 162(m) of the Code

Code Section 162(m) denies a deduction to any publicly-held corporation for compensation paid to certain "covered employees,"

including our NEOs, in a taxable year to the extent that compensation to the covered employee exceeds $1,000,000.

Section 409A of the Code

The foregoing discussion of tax consequences of awards under the Plan assumes that the award discussed is either not

considered a "deferred compensation arrangement" subject to Section 409A of the Code, or has been structured to comply with

its requirements. If an award is considered a deferred compensation arrangement subject to Section 409A but fails to comply, in

operation or form, with the requirements of Section 409A, the affected participant would generally be required to include in

income when the award vests the amount deemed "deferred," would be required to pay an additional twenty percent (20%)

income tax on such amount, and would be required to pay interest on the tax that would have been paid but for the deferral.

Section 280G of the Code

Under the so-called "golden parachute" provisions of the Code, options that are granted or that vest in connection with a change

in control of the company may be required to be valued and taken into account in determining whether the participant has

received payments in the nature of compensation that are contingent on the change in control in excess of certain limits. If these

limits are exceeded the excess may be subject to an additional 20% federal income tax and may be nondeductible to the

company.

Plan Benefits

The amount, type and timing of awards granted under the Plan are determined in the sole discretion of the Committee and

therefore cannot be determined in advance. The future awards that would be received under the Plan by directors, executive

officers and other employees are discretionary and are therefore not determinable at this time.

 **saic.com** \| 87<br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

Equity Compensation Plan Information

We currently maintain three shareholder-approved equity compensation plans that issue stock-based awards including the 2023

Plan, the Management Stock Compensation Plan ("MSCP"), and the Amended and Restated 2013 Employee Stock Purchase

Plan ("ESPP").

The following table provides the number of shares of our common stock to be issued, the weighted-average exercise price of the

outstanding stock options and the number of shares remaining for future award grants as of January 30, 2026:

---

| | | | |
|:---|:---|:---|:---|
| **Equity Compensation Plan Information** | **Equity Compensation Plan Information** | **Equity Compensation Plan Information** | **Equity Compensation Plan Information** |
| **Plan Category** | **Number of securities** <br>**to be issued upon** <br>**exercise of** <br>**outstanding options,** <br>**warrants and rights**<sup>(1)</sup><br>| **Weighted-average** <br>**exercise price of** <br>**outstanding**<br>**options, warrants**<br>**and rights**<sup>(2)</sup><br>| **Number of securities** <br>**remaining** <br>**available for future** <br>**issuance under** <br>**equity compensation** <br>**plans (excluding** <br>**securities reflected** <br>**in column (a))**<sup>(3)</sup><br>|
|  | (a) | (b) | (c) |
| Equity compensation plans approved by security holders | 1500615 | $— | 3017798 |
| Equity compensation plans not approved by security holders |  |  |  |
| **Total** | 1500615 | $— | 3017798 |

---

(1) This amount includes 41,675 stock options outstanding and 203,748 shares subject to other stock-based awards previously granted but not

yet issued under the 2013 Plan, and 1,255,192 shares issuable for other stock-based awards under the 2023 Plan. This amount does not

include shares to be issued pursuant to purchase rights under the ESPP. Performance share awards under the 2013 Plan and 2023 Plan

assume the maximum payout at the end of the three-year performance period.

(2) Does not include shares to be issued for stock-based awards, other than stock options, which will not require any payment upon issuance of

those shares. The Company did not have stock-based compensation expense for stock options for fiscal 2026 or fiscal 2025.

(3) Includes 1,514,796 shares of our common stock available for issuance under the ESPP and 1,503,002 shares under the 2023 Plan. On

June 7, 2023, the Company's stockholders approved an amended and restated ESPP which limits the total number of shares reserved for

issuance to 2.0 million and extends the ESPP expiration date from September 26, 2023 to the earlier of its termination by the Board or the

issuance of all shares available for issuance. On June 7, 2023, the Company's stockholders approved the 2023 Plan. The 2023 Plan

authorized 2.2 million new shares of the Company's common stock to be issued as various types of stock-based compensation and cash

awards. After June 7, 2023, no new awards may be issued under the 2013 Plan and any awards that subsequently expire, are forfeited or

canceled, are settled in cash, or are used to cover recipient tax obligations, will become available for issuance under the 2023 Plan. Awards

previously issued and outstanding under the 2013 Plan will continue to remain outstanding and be subject to the terms of the 2013 Plan. We

expect that the number of shares actually issued under the 2023 Plan will be significantly less than the number of total awards outstanding

under the plan because (a) a net option exercise results in a smaller portion of the number of award shares being issued when a participant

uses award shares, rather than cash, to pay the exercise price, which historically most participants have elected to do, (b) most participants

historically have elected to let the Company retain award shares to pay for taxes due on the exercise of options and all participants are

required to use award shares to pay for taxes upon the vesting of restricted stock or restricted stock units, (c) some participants may

terminate employment with the Company before the vesting of awards resulting in awards being forfeited and (d) some participants may not

exercise stock options before the expiration date for a variety of reasons, including if the exercise price exceeds the then current market

price of shares.

For additional details for these plans as of January 30, 2026, please see Note 8-Stock Based Compensation to the consolidated

financial statements contained in our Annual Report on Form 10-K for the fiscal year ended January 30, 2026.

88 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 4 - APPROVAL OF AN AMENDMENT TO THE 2023 EQUITY** <br>**INCENTIVE PLAN TO INCREASE THE TOTAL NUMBER OF AUTHORIZED SHARES**<br>

Vote Required

The affirmative vote of a majority of the shares of our common stock present or represented and entitled to vote either in person

or by proxy on Proposal 4 is required to approve Proposal 4. Abstentions have the effect of a vote against the proposal, and

broker "non-votes" have no effect on the outcome of the proposal. Shares of common stock represented by properly executed,

timely received and unrevoked proxies will be voted in accordance with the instructions indicated thereon. In the absence of

specific instructions, properly executed, timely received and unrevoked proxies will be voted "FOR" the proposal. If this proposal

is not approved by our stockholders, the Amendment will not become effective and the current share reserve under the 2023

Plan will apply.

Recommendation of the Board

The Board unanimously recommends a vote FOR Proposal 4 to amend the 2023 Plan to increase the number of authorized

shares.

 **saic.com** \| 89<br>

**PROPOSAL 5 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**<br>

![SectionDividers9.jpg](saic-20260422_g73.jpg)

90 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**PROPOSAL 5 - RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**<br>

**PROPOSAL 5 - RATIFICATION OF** 

**APPOINTMENT OF INDEPENDENT** 

**REGISTERED PUBLIC ACCOUNTING FIRM**

The Board unanimously

recommends a vote **FOR** 

**t**his Proposal.

![Check in Box-01.jpg](saic-20260422_g26.jpg)

The Audit Committee believes that the appointment of Ernst & Young LLP ("EY") is in the best interests of the company and its

stockholders, and proposes and recommends that the stockholders ratify the Audit Committee's appointment of EY as our

independent registered public accounting firm to audit our consolidated financial statements for the fiscal year ending January

29, 2027. Representatives of EY will be present at the virtual annual meeting to respond to appropriate questions and will have

the opportunity to make a statement if they desire to do so.

Stockholders are not required to ratify the appointment of EY as our independent registered public accounting firm. However, we

are submitting the appointment for ratification as a matter of good corporate practice. If stockholders fail to ratify the appointment,

the Audit Committee will consider whether or not to retain EY. Even if the appointment is ratified, the Audit Committee may direct

the appointment of a different independent registered public accounting firm at any time during the year if it determines that a

change in accounting firms would be in our stockholders' best interests.

Vote Required

The affirmative vote of the holders of a majority of the shares of our common stock present or represented and entitled to vote on

Proposal 5 either in person or by proxy is required to approve the proposal. Abstentions have the effect of a vote against the

proposal, and broker "non-votes" have no effect on the outcome of the proposal. Shares of common stock represented by

properly executed, timely received and unrevoked proxies will be voted in accordance with the instructions indicated thereon. In

the absence of specific instructions, properly executed, timely received and unrevoked proxies will be voted "FOR" the proposal.

Recommendation of the Board

The Board unanimously recommends a vote FOR the ratification of the appointment of Ernst & Young LLP as our independent

registered public accounting firm for the fiscal year ending January 29, 2027.

91 \| **saic.com**<br>

**AUDIT MATTERS**<br>

![SectionDividers10.jpg](saic-20260422_g74.jpg)

92 \| Science Applications International Corporation \| **2026 Proxy Statement**<br>

**AUDIT MATTERS**<br>

**AUDIT MATTERS**

Audit Committee Report

The Audit Committee of the Board is responsible for assisting the Board in fulfilling its oversight responsibilities over the

company's accounting, auditing and financial reporting processes, internal controls, and for monitoring compliance with certain

regulatory and legal requirements. The responsibilities of the Audit Committee are described in a written charter that has been

reviewed and approved by the Board. The current Audit Committee charter is available on the company's investor relations

website at investors.saic.com by clicking on the link entitled "Corporate Governance." A summary of the provisions of the Audit

Committee charter, including the responsibilities of the Audit Committee, is set forth in this Proxy Statement under "Corporate

Governance – Audit Committee," beginning on page 27.

Management is responsible for preparing the company's financial statements and for the financial reporting process, including

evaluating the effectiveness of the company's disclosure controls and procedures and internal control over financial reporting.

EY, the company's independent registered public accounting firm since fiscal year 2019, is responsible for performing an

independent audit of the company's annual consolidated financial statements and expressing an opinion on the conformity of the

financial statements with accounting principles generally accepted in the United States of America, and on the effectiveness of

the company's internal control over financial reporting.

Each current Audit Committee member (Carolyn B. Handlon, Paul Eremenko, Yvette M. Kanouff, Timothy J. Mayopoulos, Milford

W. McGuirt, Michael S. Rogers, Steven R. Shane) meets the independence and financial literacy requirements of the SEC and

Nasdaq as well as qualifies as an audit committee financial expert or is financially literate under SEC rules. For a further

description of each Audit Committee member's background and expertise, please refer to the director qualification section of this

Proxy Statement beginning on page 13.

In the course of fulfilling its responsibilities, the Audit Committee has:

• evaluated the qualifications, performance and compensation of the company's independent auditor (EY);

• separately met with the internal auditor and EY to discuss any matters that the internal auditor, EY or the Audit Committee

believed should be discussed privately without members of management present;

• reviewed and discussed with EY the items required to be disclosed under the applicable requirements of the Public

Company Accounting Oversight Board ("PCAOB") and the SEC;

• received written disclosures and the letter from EY regarding its independence required by applicable requirements of the

PCAOB, and discussed with EY its independence;

• reviewed and discussed with management and EY the company's internal control over financial reporting; and

• reviewed and discussed with management and EY the audited consolidated financial statements for fiscal 2026.

Based on the reviews and discussions summarized in this report and subject to the limitations on our role and responsibilities

referred to above and contained in the Audit Committee charter, the Audit Committee recommended to the Board that the

company's audited consolidated financial statements referred to above be included in the company's Annual Report on Form

10-K for fiscal 2026 for filing with the SEC.

Milford W. McGuirt (Chair)

Paul Eremenko

Carolyn B. Handlon

Yvette M. Kanouff

Timothy J. Mayopoulos

Adm. Michael S. Rogers

Steven R. Shane

93 \| **saic.com**<br>

**AUDIT MATTERS**<br>

Independent Registered Public Accounting Firm

The Audit Committee of the Board has appointed Ernst & Young LLP as the independent registered public accounting firm to

audit our financial statements for the company's fiscal year ending January 29, 2027. Stockholders are being asked to ratify the

appointment of Ernst & Young LLP at the annual meeting, as described above.

Audit and Non-Audit Fees

Aggregate fees billed to the company for fiscal 2026 and fiscal 2025 by our independent registered public accounting firm, EY,

were as follows:

---

| | | |
|:---|:---|:---|
| | **January 30, 2026** | **January 31, 2025** |
| Audit Fees<sup>(1)</sup> | $5003000 | $5005000 |
| Audit-Related Fees<sup>(2)</sup> | $— | $7200 |
| Tax Fees<sup>(3)</sup> | $296888 | $241002 |
| All Other Fees | $— | $— |
| **Total Fees** | $5299888 | $5253202 |

---

(1)Audit Fees consist of professional services rendered for the audit of the annual consolidated financial statements, including the audit of

internal controls pursuant to Section 404 of the Sarbanes-Oxley Act of 2002, and the review of quarterly consolidated financial statements.

Audit fees also include services that are normally provided by the accountant in connection with the audit, such as consents and certain

other company filings and submissions with the SEC.

(2)Audit-Related Fees reflect fees for services that are reasonably related to the performance of the audit or review of the company's financial

statements. For fiscal 2025, this included fees for online accounting research access.

(3)Tax Fees include a variety of permissible tax services related to preparation and/or review of statutory tax filings within U.S., foreign, and

state jurisdictions, general tax advisory services (including research and discussions related to tax compliance matters) and assistance with

credits and incentives opportunities in various jurisdictions.

The Audit Committee has considered whether the above services provided by EY are compatible to maintaining the

independence of EY. The Audit Committee has the responsibility to pre-approve all audit and non-audit services to be performed

by the independent registered public accounting firm in advance. Further, the Chair of the Audit Committee has the authority to

pre-approve audit and non-audit services as necessary between regular meetings of the Audit Committee, provided that any of

those services that were pre-approved in that manner will be disclosed to the full Audit Committee at its next scheduled meeting.

All of the Audit Fees, Audit-Related Fees, non-audit Tax Fees, and All Other Fees set forth above were pre-approved by one of

these means.

94 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**OTHER INFORMATION**<br>

![SectionDividers11.jpg](saic-20260422_g75.jpg)

**saic.com** \| 95<br>

**OTHER INFORMATION**<br>

**OTHER INFORMATION**

Stock Ownership of Certain Beneficial Owners

The following table provides information regarding the beneficial ownership of each person known by us to beneficially own more

than five percent of SAIC common stock as of April 6, 2026.<sup>(1)</sup>

---

| | | |
|:---|:---|:---|
| **Name and address of beneficial owner** | **Amount and nature of beneficial ownership** | **Percent of class** |
| **BlackRock, Inc.**<sup>(2)</sup> | 4374758 | 10.1% |
| 55 East 52nd Street<br>New York, NY 10055<br>|  |  |
| **Fuller & Thaler Asset Management, Inc.**<sup>(3)</sup> | 2626951.05 | 6.10% |
| 411 Borel Avenue, Suite 300<br>San Mateo, CA 94402<br>|  |  |

---

(1)Based on information contained in the Schedule 13G/A filed with the SEC on May 7, 2025 by The Vanguard Group, as of April 30, 2025, The

Vanguard Group reported that it beneficially owned 4,777,413 shares of common stock. In the Schedule 13G/A filed with the SEC on March

27, 2026 by The Vanguard Group, it reported beneficial ownership of zero shares of common stock as of March 13, 2026 and noted that

certain subsidiaries or business divisions of subsidiaries of The Vanguard Group that formerly had, or were deemed to have, beneficial

ownership jointly with The Vanguard Group, will report beneficial ownership separately (on a disaggregated basis) from The Vanguard

Group.

(2)Based on a Schedule 13G/A filed with the SEC on April 7, 2026, BlackRock, Inc., a holding company filing on behalf of itself and certain of

its subsidiaries, reported that it beneficially owned 4,374,758 shares as of March 31, 2026, including sole voting power over 4,183,513

shares and sole dispositive power over 4,374,758 shares.

(3)Based on a Schedule 13G/A filed with the SEC on February 17, 2026, Fuller & Thaler Asset Management, Inc., an investment adviser filing

on behalf of itself and certain of its subsidiaries, reported that it beneficially owned 2,626,951.05 shares as of December 31, 2025, including

sole voting power over 2,605,936.05 shares and sole dispositive power over 2,626,951.05 shares.

96 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**OTHER INFORMATION**<br>

Stock Ownership of Directors and Officers

The following table sets forth, as of April 6, 2026, the beneficial ownership of our common stock by our directors, the NEOs, and

all of our directors and executive officers as a group. None of our directors or executive officers beneficially own more than one

percent of our common stock. As a group, our directors and executive officers beneficially own approximately 0.65% of our

common stock. Unless otherwise indicated, each individual has sole investment power and sole voting power with respect to the

shares beneficially owned by that individual, except for any investment or voting power that may be shared with a spouse. No

shares have been pledged.

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Beneficial Owner**  | **Common stock**<sup>(1)</sup> | **Stock units**<sup>(2)</sup> | **Options and RSUs**<sup>(3)</sup> | **Total shares beneficially** <br>**owned**<br>|
| **Non-Employee Directors** | | | | |
| Paul Eremenko |  |  |  |  |
| Garth N. Graham | 7159 |  | 1644 | 8803 |
| Carolyn B. Handlon | 4032 |  | 1644 | 5676 |
| Yvette M. Kanouff | 11169 |  | 1644 | 12813 |
| Timothy J. Mayopoulos | 7927 |  | 1644 | 9571 |
| Katharina G. McFarland | 7094 |  | 1644 | 8738 |
| Milford W. McGuirt | 6841 |  | 1644 | 8485 |
| Donna S. Morea | 32877 |  | 4520 | 37397 |
| Michael S. Rogers |  |  |  |  |
| Steven R. Shane | 36840 |  | 4520 | 41360 |
| John K. Tien, Jr. | 919 |  | 1644 | 2563 |
| David J. Urban |  |  | 1253 | 1253 |
| **Named Executive Officers** |  |  |  |  |
| James C. Reagan<sup>4</sup> | 15955 |  | 1644 | 17599 |
| Prabu Natarajan | 63257 |  |  | 63257 |
| Kathleen T. McCarthy |  |  |  |  |
| Hilary L. Hageman | 15961 |  |  | 15961 |
| Srinivas Attili | 3900 |  |  | 3900 |
| Toni Townes-Whitley<sup>5</sup> | 17407 |  |  | 17407 |
| James J. Jackson<sup>5</sup> | 10302 | 6412 |  | 16714 |
| David C. Ray<sup>5</sup> | 8319 |  |  | 8319 |
| **All directors and executive officers** <br>**as a group (20 persons)**<br>| 249959 | 6412 | 23445 | 279816 |

---

(1)Information in this column includes (a) the approximate number of shares allocated to all directors and officers as a group, 240,175 shares,

and (b) shares held by certain trusts established by the individuals as follows: Mr. Shane, 1,334 shares; Mr. Reagan, 1,450; and Mr.

Natarajan, 7,000 shares.

(2)Represents vested stock units attributable to the individual or the group in the Key Executive Stock Deferral Plan. Shares held in these

plans are voted by the trustee in the same proportion as all other stockholders collectively vote their shares of common stock.

(3)Shares subject to options exercisable or RSUs subject to vesting, both within 60 days following April 6, 2026.

(4) Represents the annual grant of RSUs as a non-employee director from June 4, 2025 that vest on June 3, 2026.

(5)Based solely on information set forth in Ms. Townes-Whitley, Messrs. Jackson and Ray Form 4 filed with the SEC on June 13, 2025,

October 27, 2025 and April 8, 2025, respectively.

**saic.com** \| 97<br>

**OTHER INFORMATION**<br>

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act and the rules of the SEC require our directors and executive officers as well as persons who

beneficially own more than ten percent of our common stock to file reports of their ownership and changes in ownership of

common stock with the SEC. For our directors and executive officers, our personnel generally prepare and file these reports on

the basis of information obtained from each director and officer and pursuant to a power of attorney. Due to an administrative

oversight a Form 4 reporting one transaction for Mr. DiFronzo was filed late during fiscal 2026. Based solely on the information

provided to us, we believe that all other reports for our directors, executive officers and greater than ten percent stockholders

complied with all filing requirements under Section 16(a) of the Exchange Act during fiscal 2026.

Stockholder Proposals and Director Nominations for the 2027

Annual Meeting

Stockholders who, in accordance with Rule 14a-8 of the Exchange Act, wish to present proposals for inclusion in the proxy

materials to be distributed in connection with next year's annual meeting must submit their proposals so they are received by our

Corporate Secretary no later than the close of business (5:00 p.m. ET) on December 23, 2026. As the rules of the SEC make

clear, simply submitting a proposal does not guarantee that it will be included.

In order to be properly brought before the annual meeting of stockholders to be held in 2027 (the "2027 Annual Meeting"), a

stockholder who desires to provide notice of nomination of one or more director candidates to be included in the company's

Proxy Statement and ballot pursuant to Section 3.17 of our bylaws (a "proxy access nomination") must be received by our

Corporate Secretary no earlier than November 23, 2026 and no later than the close of business on December 23, 2026 (not later

than the close of business on the 120th day nor earlier than the close of business on the 150th day prior to the first anniversary

of the date the definitive Proxy Statement was first released to stockholders in connection with the preceding year's annual

meeting of stockholders). If the date of the 2027 Annual Meeting is more than 30 days before or more than 70 days after that

anniversary date, notice of the proxy access nomination by the stockholder to be timely must be received not earlier than the

close of business on the 120th day and not later than the close of business on the later of the 90th day prior to the 2027 Annual

Meeting or the close of business on the 10th day following the day on which the notice of proxy access nomination is mailed or

public announcement of the date of the 2027 Annual Meeting is first made by the company, whichever first occurs.

In addition, in order for a stockholder to propose any matter for consideration at the 2027 Annual Meeting other than by inclusion

in the Proxy Statement, the stockholder must give timely notice to our Corporate Secretary of such stockholder's intention to

bring such business before the meeting. To be timely, notice must be delivered to the Corporate Secretary not later than the

close of business on the 90th day, nor earlier than the close of business on the 120th day, prior to the first anniversary of the

preceding year's annual meeting. Therefore, in connection with the 2027 Annual Meeting, notice must be delivered to the

Corporate Secretary between February 3, 2027 and March 5, 2027. In the event, however, that the date of the 2027 Annual

Meeting is more than 30 days before or more than 70 days after such anniversary date, notice by the stockholder must be

delivered not earlier than the close of business on the 120th day prior to such annual meeting and not later than the close of

business on the 90th day prior to such annual meeting or the 10th day following the day on which public announcement of the

date of such meeting is first made by us, whichever occurs later.

Any stockholder's notice must include additional information about the stockholder and the underlying beneficial owner, if any,

required under our bylaws, as amended from time to time, and SEC rules and regulations, including the information that would

be required to be disclosed in a Proxy Statement soliciting proxies for the election of any proposed nomination of one or more

director candidates. A stockholder's notice must be updated, if necessary, so that the information submitted is true and correct as

of the record date for determining stockholders entitled to receive notice of the meeting.

In addition to the requirements set forth above, stockholders who intend to solicit proxies in support of director nominees other

than the company's nominees must comply with the additional requirements of Rule 14a-19(b) under the Exchange Act.

98 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**OTHER INFORMATION**<br>

Annual Report on Form 10-K

We will provide without charge to any stockholder, upon written or oral request, a copy of our Annual Report on Form 10-K for

fiscal 2026 without exhibits. Requests should be directed to SAIC, 12010 Sunset Hills Road, Reston, Virginia 20190, Attention:

Corporate Secretary, or by calling (703) 676-4008.

By Order of the Board of Directors

![Hilary Hagman Signature.jpg](saic-20260422_g20.jpg)

Hilary L. Hageman

Corporate Secretary

April 22, 2026

 **saic.com** \| 99<br>

![SectionDividers12.jpg](saic-20260422_g76.jpg)

100 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

**APPENDICES**

Appendix A: Non-GAAP Financial Measures

This appendix describes the non-GAAP financial measures included in the Proxy Statement. While we believe that these non-

GAAP financial measures may be useful in evaluating our financial information, they should be considered as supplemental in

nature and not as a substitute for financial information prepared in accordance with GAAP. Other companies may define similar

measures differently.

---

| | | | |
|:---|:---|:---|:---|
|  | **Year Ended** | **Year Ended** | **Year Ended** |
|  | **January 30, 2026** | **January 31, 2025** | **February 2, 2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| **Revenues** | **$7262** | **$7479** | **$7444** |
| **Net income** | 358 | 362 | 477 |
| Interest expense, net and loss on sale of receivables | 140 | 140 | 129 |
| Provision for income taxes | 29 | 66 | 143 |
| Depreciation and amortization | 149 | 140 | 142 |
| **EBITDA**<sup>(1)</sup> | **$676** | **$708** | **$891** |
| *EBITDA as a percentage of revenues* | *9.3%* | *9.5%* | *12.0%* |
| Acquisition, integration, restructuring and impairment costs | 16 | 6 | 24 |
| Depreciation included in acquisition and integration costs and <br>restructuring and impairment costs<br>| (1) | (1) | (1) |
| Recovery of acquisition, integration, restructuring and impairment <br>costs<sup>(2)</sup><br>| (6) | (3) | (6) |
| Executive transition costs, net of recoveries | 16 |  |  |
| Costs related to the settlement of federal tax audits | 7 |  |  |
| Gain on divestitures, net of transaction costs |  |  | (240) |
| **Adjusted EBITDA**<sup>(1)</sup> | **$708** | **$710** | **$668** |
| *Adjusted EBITDA as a percentage of revenues* | **9.7%** | **9.5%** | **9.0%** |

---

(1)EBITDA is a performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables, provision

for income taxes, and depreciation and amortization. Adjusted EBITDA is a performance measure that excludes acquisition, integration,

restructuring, and impairment costs, and any other material non-recurring costs that we do not consider to be indicative of our ongoing

operating performance. Acquisition, integration, restructuring and impairment costs represent costs incurred related to acquisitions,

reorganizations, facilities optimization efforts, and impairments of long-lived assets, along with associated depreciation. Recovery of

acquisition, integration, restructuring and impairment costs represents costs recovered through our indirect rates in accordance with Cost

Accounting Standards. Executive transition costs, net of recoveries, represent costs associated with the departure of our CEO and other

executives in the third quarter of the fiscal year 2026, net of the portion recovered through our indirect rates in accordance with Cost

Accounting Standards. Costs related to the settlement of federal tax audits represent costs related to the IRS audit settlement for fiscal

years 2016 through 2019. We believe that these performance measures provide management and investors with useful information in

assessing trends in our ongoing operating performance and may provide greater visibility in understanding the long-term financial

performance of the company.

(2)Adjustment to reflect the portion of acquisition, integration, restructuring and impairment costs recovered through the company's indirect

rates in accordance with Cost Accounting Standards.

 **saic.com** \| 101<br>

**APPENDICES**<br>

In addition to the above non-GAAP financial measures, the table below describes adjusted performance measures related to the

Performance Stock Units and Short-Term Incentive ("STI") Awards included in the Proxy Statement.

---

| | | | |
|:---|:---|:---|:---|
|  | **Year Ended** | **Year Ended** | **Year Ended** |
|  | **January 30, 2026** | **January 31, 2025** | **February 2, 2024** |
| | **(in millions)** | **(in millions)** | **(in millions)** |
| **Performance Stock Units Adjusted Performance Measures**<br>**Net income** | **$358** | **$362** | **$477** |
| Interest expense, net and loss on sale of receivables | 140 | 140 | 129 |
| Provision for income taxes | 29 | 66 | 143 |
| Depreciation and amortization | 149 | 140 | 142 |
| **EBITDA**<sup>(1)</sup> | **$676** | **$708** | **$891** |
| *EBITDA as a percentage of revenues* | *9.3%* | *9.5%* | *12.0%* |
| Acquisition, integration, restructuring and impairment costs | 25 | 2 | 17 |
| Divestiture impacts |  |  | (240) |
| Tax changes | 15 |  |  |
| Other impacts | 12 |  | 2 |
| **Performance stock units adjusted EBITDA** | **$728** | **$710** | **$670** |
| *Performance stock units adjusted EBITDA as a percentage of revenues* | *10.0%* | *9.5%* | *9.0%* |
| **Cash flows provided by operating activities** | **$609** | **$494** | **$396** |
| Cash paid for acquisition and integration costs and restructuring impacts | 2 | 7 | 4 |
| Platform integration program working capital changes | 27 | 61 | 17 |
| Divestiture impacts |  | 8 | 72 |
| Impact from sale of receivables under Master Accounts Receivable <br>Purchase Agreement ("MARPA")<br>|  | 41 | 45 |
| Tax changes | (89) |  |  |
| Other impacts | 9 | (3) | (6) |
| **Performance stock units adjusted operating cash flow** | **$558** | **$608** | **$528** |
| **Short-Term Incentive Adjusted Performance Measures** |  |  |  |
| **Revenue** | **$7262** | **$7479** | **$7444** |
| Government shutdown impacts | 26 |  |  |
| **STI adjusted revenue** | **$7288** | **$7479** | **$7444** |
| **Net income** | **$358** | **$362** | **$477** |
| Interest expense, net and loss on sale of receivables | 140 | 140 | 129 |
| Provision for income taxes | 29 | 66 | 143 |
| Depreciation and amortization | 149 | 140 | 142 |
| **EBITDA**<sup>(1)</sup> | **$676** | **$708** | **$891** |
| *EBITDA as a percentage of revenues* | *9.3%* | *9.5%* | *12.0%* |
| Acquisition, integration, restructuring and impairment costs | 25 | 2 | 30 |
| Divestiture impacts |  |  | (240) |
| Tax audit fees | 7 |  |  |
| Other impacts | 3 | (5) |  |
| **STI adjusted EBITDA** | **$711** | **$705** | **$681** |
| **Cash flows provided by operating activities** | **$609** | **$494** | **$396** |
| Impact from sale of receivables under MARPA |  | 41 | 45 |
| Acquisition, integration, restructuring and impairment costs | 2 |  | 1 |
| Divestiture impacts |  | 8 | 72 |
| Tax audit fees | 6 |  |  |
| Other impacts | 1 | (5) | (6) |
| **STI adjusted operating cash flow** | **$618** | **$538** | **$508** |

---

(1)EBITDA is a non-GAAP performance measure that is calculated by taking net income and excluding interest and loss on sale of receivables,

provision for income taxes, and depreciation and amortization. We believe that this performance measure provides management and

investors with useful information in assessing trends in our ongoing operating performance and may provide greater visibility in

understanding the long-term financial performance of the company.

102 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

APPENDIX B: SCIENCE APPLICATIONS INTERNATIONAL

CORPORATION 2023 EQUITY INCENTIVE PLAN

**(As Amended by Amendment No. 1 and As Proposed to be Amended by Amendment No. 2)**

1.**Purpose of the Plan.** The purpose of this 2023 Equity Incentive Plan is to enhance the long-term stockholder value of

Science Applications International Corporation and its affiliated companies by offering opportunities to eligible individuals to

participate in the growth in value of the equity of Science Applications International Corporation.

2.**Definitions.** This Plan uses the following defined terms:

a."***Affiliate***" means a "parent" or "subsidiary" (as each is defined in Section 424 of the Code) of the Company and any

other entity that the Board or Committee designates as an "Affiliate" for purposes of the Plan.

b."***Applicable Law***" means any and all laws of whatever jurisdiction, within or without the United States, and the rules of

any stock exchange or quotation system on which Shares are then listed or quoted, applicable to the taking or refraining

from taking of any action under the Plan, including the administration of the Plan and the issuance or transfer of Awards

or Shares.

c."***Award***" means a Restricted Stock Unit, Option, Stock Appreciation Right, Other Stock-Based Award, or Cash Award

granted in accordance with the terms of the Plan.

d."***Award Agreement***" means the document, which may be in paper or electronic form, evidencing the grant of an Award

and its terms and conditions.

e."***Board***" means the Board of Directors of the Company.

f."***Cash Award***" means the right to receive cash as described in Section 10 of the Plan.

g."***Cause***" means employment-related dishonesty, fraud, misconduct or disclosure or misuse of confidential information,

or other employment related conduct that is likely to cause significant injury to the Company, an Affiliate, or any of their

respective employees, officers or directors (including, without limitation, commission of a felony or similar offense), in

each case as determined by the Committee. "Cause" will not require that a civil judgment or criminal conviction has

been entered against or guilty plea will have been made by the Recipient regarding any of the matters referred to in the

previous sentence. Accordingly, the Committee will be entitled to determine "Cause" based on the Committee's good

faith belief. If the Recipient is criminally charged with a felony or similar offense that will be a sufficient, but not a

necessary, basis for such belief.

h."***Change in Control***" means:

1. a merger or consolidation in which the Company is not the surviving corporation (other than a merger or

consolidation with a wholly-owned subsidiary, a reincorporation of the Company in a different jurisdiction, or

other transaction in which there is no substantial change in the stockholders of the Company or their relative

stock holdings and the Awards granted under the Plan are assumed, converted or replaced by the successor

corporation, which assumption will be binding on all participants),

2. a merger in which the Company is the surviving corporation but after which the stockholders of the Company

immediately prior to such merger (other than any stockholder that merges, or which owns or controls another

corporation that merges, with the Company in such merger) cease to own their shares or other equity interest

in the Company,

3. the sale of all or substantially all of the assets of the Company, or

4. the acquisition, sale, or transfer of more than 50% of the outstanding shares of the Company by tender offer or

similar transaction.

i."***Code***" means the Internal Revenue Code of 1986, as amended.

j."***Committee***" means the Human Resources and Compensation Committee of the Board of Directors of the Company.

k."***Company***" means Science Applications International Corporation, a Delaware corporation, or any successor

corporation thereto.

l."***Consultant***" means an individual who, or an employee of any entity that, provides bona fide services to the Company

or an Affiliate not in connection with the offer or sale of securities in a capital-raising transaction, but who is not an

Employee.

m."***Director***" means a member of the Board of Directors of the Company or an Affiliate.

 **saic.com** \| 103<br>

**APPENDICES**<br>

n."***Dividend Equivalent Right***" means, with respect to a Restricted Stock Unit or an Other Stock-Based Award that is a

Full Value Award, a Recipient's right to receive a payment or credit for the account of such Recipient in an amount

equal to the cash dividends that would have been payable on Shares subject to an Award during a period of time had

such Shares been issued to the Recipient. Dividend Equivalent Rights may be settled in the form of cash, Shares, or a

combination of both. Such Dividend Equivalents will be retained by the Company (without interest) and settled when,

and if, to the extent that the RSUs or Other Stock-Based Award to which the Dividend Equivalents relate vests and the

underlying Shares are issued. Dividend Equivalents so credited will be subject to the same terms and conditions as the

RSUs or Other Stock-Based Award to which such Dividend Equivalents relate and will be forfeited in the event that the

RSUs or Other Stock-Based Award with respect to which such Dividend Equivalents were credited are forfeited. If an

Award is in the form of Shares of restricted stock or otherwise involves the grant of actual Shares to Recipients, any

dividends on such Shares will be retained by the Company (without interest) and paid when, and if, to the extent that

the Shares to which the dividends relate vest, and such dividends will be subject to the same terms and conditions as

the Shares to which such dividends relate and will be forfeited in the event that such Shares are forfeited. For the

avoidance of doubt, no dividends or Dividend Equivalents will be paid or granted in respect of Shares subject to Options

or SARs and no holder of an Option or SAR will be entitled to any dividends with respect to the Shares subject to

Options or SARs unless and until such Options or SARs have vested and have been exercised in accordance with the

terms of the Plan and the applicable Award Agreement and such Shares are reflected as issued and outstanding.

o."***Effective Date***" means the date on which the stockholders of the Company approve the Plan <u>and</u> ***<u>"Amendment No. 2</u>***

***<u>Effective Date"</u>*** <u>means the date on which the stockholders of the Company approve Amendment No. 2 to the Plan</u>.

p."***Employee***" means a regular employee of the Company or an Affiliate, including an officer or Director, who is treated as

an employee in the personnel records of the Company or an Affiliate, but not individuals who are classified by the

Company or an Affiliate as: (i) leased from or otherwise employed by a third party, (ii) independent contractors, or (iii)

intermittent or temporary workers. The Company's or an Affiliate's classification of an individual as an "Employee" (or

as not an "Employee") for purposes of the Plan will not be altered retroactively even if that classification is changed

retroactively for another purpose as a result of an audit, litigation or otherwise. A Recipient will not cease to be an

Employee due to transfers between locations of the Company, or between the Company and an Affiliate. Neither service

as a Director nor receipt of a director's fee will be sufficient to make a Director an "Employee."

q."***Exchange Act***" means the Securities Exchange Act of 1934, as amended.

r."***Executive***" means an individual who is subject to Section 16 of the Exchange Act because of the individual's

relationship with the Company or an Affiliate.

s."***Expiration Date***" means, with respect to a Stock Option or Stock Appreciation Right or Other Stock-Based Award, the

date stated in the Award Agreement as the expiration date of the Award or, if no such date is stated in the Award

Agreement, then the last day of the exercise period for the Award, disregarding the effect of a Recipient's Termination or

any other event that would shorten that period.

t."***Fair Market Value***" means, as of any Value Date, the closing sales price as quoted for a Share on the New York Stock

Exchange or The Nasdaq Stock Market LLC (as applicable) for the day before the Value Date, as reported in *The Wall* 

*Street Journal* or a similar publication. If no sales are reported as having occurred on the day before the Value Date,

Fair Market Value will be that closing sales price for the last preceding trading day on which sales of Shares are

reported as having occurred. If no sales are reported as having occurred during the five trading days before the Value

Date, Fair Market Value will be the closing bid for the Shares on the day before the Value Date.

u."***Full Value Award***" means any Award other than an Option, a Stock Appreciation Right, a Cash Award, or any other

Award for which the Recipient pays (or the value or amount payable under the Award is reduced by) an amount less

than the Fair Market Value of the Shares, determined as of the Grant Date.

v."***Good Reason***" means the occurrence of any of the events or conditions described below, without the Recipient's prior

written consent:

1. any material adverse change in the Recipient's authority, duties or responsibilities (including reporting

responsibilities), or (ii) in the case of a Recipient who immediately prior to a Change in Control is an Executive,

the failure of such Recipient following such Change in Control to continue to serve as an Executive, in each

case except in connection with the termination of the Recipient's employment for Cause, disability, as a result

of the Recipient's death, or by the Recipient other than for Good Reason;

2. a material reduction in the Recipient's base salary or target bonus or any failure to pay the Recipient any

compensation to which the Recipient is entitled within 15 days after the date when due;

3. the imposition of a requirement that the Recipient be based (i) at any place outside a 50-mile radius from the

Recipient's principal place of employment immediately prior to such change, or (ii) at any location other than

the Company's corporate headquarters or, if applicable, the headquarters of the business unit in which the

Recipient is employed, except, in each case, for reasonably required travel on Company business which is not

materially greater in frequency or duration than prior to such change.

104 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

Notwithstanding anything to the contrary herein, no termination of the Recipient's employment will be deemed

to be for Good Reason hereunder unless (i) the Recipient provides written notice to the Company identifying

the applicable event or condition within 90 days of the occurrence of the event or the initial existence of the

condition, and (ii) the Company fails to remedy the event or condition within a period of 30 days following such

notice. In the event the Company fails to remedy the event or condition, the Recipient will terminate

employment within 30 days following the cure period.

w."***Grant Date***" means the date the Committee approves the grant of an Award. However, if the Committee specifies that

an Award's Grant Date is a future date or the date on which a condition is satisfied, the Grant Date for such Award is

that future date or the date that the condition is satisfied.

x."***Incentive Stock Option***" means an Option intended to qualify as an incentive stock option under Section 422 of the

Code and designated as an Incentive Stock Option in the Award Agreement for that Option.

y."***Involuntary Termination***" means termination of the Recipient's employment by the Company or an Affiliate, as

applicable, without Cause, or termination by the Recipient for Good Reason.

z."***Nonstatutory Option***" means any Option other than an Incentive Stock Option.

aa."***Officer***" means an officer of the Company as defined in Rule 16a-1 adopted under the Exchange Act.

bb."***Option***" means a right to purchase Shares of the Company granted under the Plan.

cc."***Option Price***" means the price payable under an Option for Shares, not including any amount payable in respect of

withholding or other taxes.

dd."***Other Stock-Based Award***" means an Award granted pursuant to Section 9 of the Plan.

ee."***Performance Condition***" will mean a performance condition upon which the grant or vesting of an Award is contingent

in accordance with Section 11 of the Plan. Measures that may be used in Performance Conditions may be expressed in

absolute terms, in terms of growth or improvement, or relative to the performance of one or more comparable

companies or an index covering multiple companies and that relate to any of the following, as it may apply to an

individual, one or more Affiliates, business unit(s), divisions or the whole of the Company: revenue; earnings per share;

return on assets; return on equity; net order dollars; net profit; operating cash flow; operating income; contract bookings;

contract awards; profit before tax; earnings before interest, depreciation and taxes (EBITDA); return on invested capital;

days working capital; total shareholder return; share price growth; free cash flow; return on sales; operating margin;

book-to-bill; headcount; employee retention; new hires; backlog; objective customer satisfaction indicators; and

efficiency measures; or any other measures selected by the Committee, each with respect to the Company and/or an

Affiliate or individual business unit.

ff."***Plan***" means this 2023 Equity Incentive Plan, as amended from time to time.

gg."***Prior Plan***" means the Company's 2013 Equity Incentive Plan.

hh."***Qualified Domestic Relations Order***" means a "qualified domestic relations order" as defined in, and otherwise

meeting the requirements of, Section 414(p) of the Code, except that reference to a "plan" in that definition will be to the

Plan.

ii."***Restricted Stock Unit***" or "***RSU***" means an Award of an unsecured and unfunded promise to deliver Shares or value

equal to such Shares in the future pursuant to Section 6 of the Plan.

jj."***Recipient***" means: (i) a person to whom an Award has been granted, including a holder of a Substitute Award, or (ii) a

person to whom an Award has been transferred in accordance with all applicable requirements of Section 22 of the

Plan.

kk."***Stock Appreciation Right***" or "**SAR**" means a right to receive cash and/or Shares based on a change in the Fair

Market Value of a specific number of Shares pursuant to an Award Agreement, as described in Section 8 of the Plan.

ll."***Securities Act***" means the Securities Act of 1933, as amended.

mm."***Share***" means a share of the common stock of the Company or other securities substituted for the common stock of

the Company under Section 16 of the Plan.

nn."***Substitute Award***" means an Award granted in substitution for, or upon the conversion of, an award granted by

another entity covering equity securities in the granting entity.

oo."***Ten Percent Stockholder***" is any person who, directly or by attribution under Section 424(d) of the Code, owns stock

possessing more than ten percent of the total combined voting power of all classes of stock of the Company or of any

Affiliate on the Grant Date.

 **saic.com** \| 105<br>

**APPENDICES**<br>

pp."***Termination***" means that the Recipient has ceased to be, with or without any cause or reason, an Employee, Director

or Consultant. However, unless so determined by the Committee, or otherwise provided in the Plan, "Termination" will

not include a change in status from an Employee, Consultant or Director to another such status. An event that causes

an Affiliate to cease being an Affiliate will be treated as the "Termination" of that Affiliate's Employees, Directors, and

Consultants.

qq."***Value Date***" means the value as of which the Fair Market Value of a Share is being determined.

3.**Shares Subject to The Plan; Term of The Plan.**

a.**Number of Shares**. Subject to adjustment pursuant to Section 16 of the Plan and the share counting provisions below,

the aggregate number of Shares authorized for Awards granted under the Plan as of the Effective Date over the term of

the Plan is 2,240,000\*, plus 1,088,000 Shares as of the Amendment No. 2 Effective Date over the then remaining term

of the Plan. After the Effective Date, no awards may be granted under the Prior Plan.

1. If any portion of an outstanding Award for any reason expires or is terminated or canceled or forfeited, the

Shares allocable to the expired, terminated, canceled, or forfeited portion of such Award will again be available

for issuance under the Plan.

2. If any portion of an outstanding Award that was granted prior to the Effective Date under the Prior Plan for any

reason expires or is terminated or canceled or forfeited on or after the Effective Date, the Shares allocable to

the expired, terminated, canceled, or forfeited portion of such Prior Plan award will be available for issuance

under the Plan. Notwithstanding this Section 3(a)(2), the provisions of the Plan will have no effect on awards

granted pursuant to the Prior Plan, which will continue to be governed by the terms and conditions of the

agreements and plan document governing such grants.

3. Shares allocable to an Award that is settled in cash will continue to be available for issuance under the Plan.

Shares issued in settlement of any Dividend Equivalent Rights will be applied against the number of Shares

available for Awards. Shares subject to Substitute Awards and available under a stockholder-approved equity

plan of an acquired company will not be applied against the number of Shares available for Awards.

4. In the event that (i) any Option or other Award granted under the Plan or any other plan maintained by the

Company is exercised through the tendering of Shares or by the withholding of Shares by the Company, or (ii)

withholding tax liabilities arising from such Options or Awards are satisfied by the tendering of Shares or by the

withholding of Shares by the Company, or (iii) Shares are repurchased by the Company using Option exercise

proceeds, then the Shares so tendered or withheld or repurchased will be available for issuance under the

Plan. Awards made in connection with the assumption of, or substitution for, outstanding awards previously

granted to individuals who become Employees of the Company or a Subsidiary as a result of any merger,

consolidation, acquisition of property or stock, or reorganization, will not count against the limitations set forth

in this Section 3.

b.**Source of Shares.** The Shares issuable under the Plan will be authorized but unissued or reacquired Shares, including

Shares repurchased by the Company on the open market. Shares issued under the Plan may be: (i) Shares that have

never been issued, (ii) Shares that have been issued but are no longer outstanding, or (iii) Shares that are outstanding

and are acquired to discharge the Company's obligation to deliver Shares.

c.**Term of the Plan.** The Plan will become effective on the Effective Date (with any amendments to the Plan being

effective on and after the date thereof), and Awards may be granted under the Plan on and after the Effective Date.

Subject to the provisions of Section 19 of the Plan, Awards may be granted under the Plan until the tenth anniversary of

the Effective Date.

\*Consists of (i) the 1,741,168 Shares that were authorized to be issued under the Prior Plan and that were not subject to

awards granted under the Prior Plan and outstanding as of February 3, 2023, plus (ii) an additional 498,832 Shares.

4.**Administration.**

a.**General.** The Board will have ultimate responsibility for administering the Plan. To the extent permitted by Applicable

Law, the Board may delegate certain of its responsibilities to the Committee. The composition of the Committee will at

all times comply with, and will consist of two or more Directors who are "Non-Employee Directors" as defined in Rule

16b-3 under the Exchange Act. To the extent permitted by Applicable Law, the Board or the Committee may delegate

certain of its responsibilities to any Employee or committee consisting of Employees. However, only the Board or the

Committee may approve grants of Awards to Executives and Directors, and an Employee or committee of Employees to

whom the Committee has delegated responsibilities may grant Awards only within the guidelines established by the

Board or the Committee. Moreover, all actions and determinations by the Board or the Committee or any Employee or

committee of Employees are subject to the provisions of the Plan.

b.**Authority of the Committee**. Subject to the other provisions of the Plan, the Committee will have the authority to:

1. grant Awards, including Substitute Awards;

2. determine the Fair Market Value of Shares;

106 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

3. determine the Option Price and the Purchase Price of applicable Awards;

4. select the Recipients;

5. determine the times Awards are granted;

6. determine the number of Shares subject to each Award;

7. determine the type of Shares subject to each Award;

8. determine the methods of payment that may be used to purchase Shares, if applicable under the terms of an

Award;

9. determine the methods of payment that may be used to satisfy withholding tax obligations;

10. to determine the original or amended terms, conditions and restrictions applicable (which need not be identical)

to each Award, including, without limitation,

a.the exercise price of an Option or SAR and the method of payment for Shares purchased upon the

exercise of an Option,

b.whether an Option is a Nonstatutory Option or an Incentive Stock Option,

c.the method for satisfaction of any tax withholding obligations arising in connection with an Award,

including by the withholding or delivery of Shares,

d.the terms and conditions of Awards, including without limitation the timing and other terms and

conditions of the effectiveness, awarding, vesting, exercisability, acceleration, deferral, and

settlement, as applicable, of Awards,

e.the time of the expiration of an Award,

f.the effect of the Grantee's termination of employment or service with the Company on any of the

foregoing, and

g.all other terms, conditions and restrictions applicable to an Award or Shares not inconsistent with the

terms of the Plan;

11. modify or amend any Award, subject to Sections 7(f) and 8(c) of the Plan;

12. authorize any person to sign any Award Agreement or other document related to the Plan on behalf of the

Company and determine the form of any Award Agreement or other document related to the Plan;

13. interpret the Plan and any Award Agreement or document related to the Plan;

14. correct any defect, remedy any omission, or reconcile any inconsistency in the Plan, any Award Agreement or

any other document related to the Plan;

15. prescribe, amend, or revoke rules, guidelines, and policies relating to the Plan, or to adopt supplements to, or

alternative versions of, the Plan, including, without limitation, as the Committee deems necessary or desirable

to comply with non-U.S. Applicable Laws or tax policies or practices or customs, or to take into account or to

mitigate or reduce the burden of taxation and social insurance contributions for Recipients or the Company, or

to meet the goals and objectives of the Plan as they apply to Awards and Shares held by, or granted or issued

to, persons working or resident outside of the United States or employed by Affiliates incorporated outside the

United States;

16. appoint such additional administrators as are necessary to perform various administrative acts and determine

the duties of such administrators; and

17. make all other determinations the Committee deems necessary or advisable for the administration of the Plan.

c.**Scope of Discretion**. Subject to the provisions of this Section 4(c), on all matters for which the Plan confers the

authority, right, or power on the Board, the Committee, or other Committee to make decisions, that body may make

those decisions in its sole and absolute discretion. Those decisions will be final, binding, and conclusive. In making its

decisions, the Board, Committee or other Committee need not treat all persons eligible to receive Awards, all

Recipients, all Awards or all Shares subject to Awards the same way. Notwithstanding anything herein to the contrary,

and except as provided in Section 19(b) of the Plan, the discretion of the Board, Committee or other Committee is

subject to the specific provisions and specific limitations of the Plan, as well as all rights conferred on specific

Recipients by Award Agreements and other agreements.

d.**Minimum Vesting Requirement**. Notwithstanding any other provision of the Plan to the contrary, equity-based Awards

granted under the Plan will vest no earlier than the first anniversary of the date the Award is granted (excluding, for this

purpose, any (i) Substitute Awards, (ii) Shares delivered in lieu of fully vested cash Awards and (iii) Awards to Directors

that vest on the earlier of the one year anniversary of the date of grant or the next annual meeting of stockholders which

is at least 50 weeks after the immediately preceding year's annual meeting); provided, that, the Committee may grant

 **saic.com** \| 107<br>

**APPENDICES**<br>

equity-based Awards without regard to the foregoing minimum vesting requirement with respect to a maximum of five

percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section 3(a) (subject to

adjustment under Section 16); and, provided further, for the avoidance of doubt, that the foregoing restriction does not

apply to the Committee's discretion to provide for accelerated exercisability or vesting of any Award, including in cases

of retirement, death, disability or a Change in Control, in the terms of the Award or otherwise.

5.**Eligibility.**

a.**Eligible Individuals**. Awards (including Substitute Awards) may be granted to, and only to, Employees, Directors, and

Consultants, including to prospective Employees, Directors, and Consultants conditioned on the beginning of their

service for the Company or an Affiliate. However, Incentive Stock Options may only be granted to Employees, as

provided in Section 7(h) of the Plan.

b.**Limits on Awards to Non-Employee Directors**. Notwithstanding any other provision of the Plan to the contrary, the

aggregate Grant Date fair value (computed as of the Grant Date in accordance with applicable financial accounting

rules) of all Awards granted to any non-Employee Director during any single calendar year for service as a Director

(excluding Awards made at the election of the non-Employee Director in lieu of all or a portion of annual and committee

cash retainers) will not exceed $500,000.

6.**Restricted Stock Units**.

a.**General**. The specific terms and conditions of an Award of RSUs granted to a Recipient will be evidenced by an Award

Agreement. The Award Agreement will state (i) the number of Shares subject to the Award (ii) the conditions, if any, that

must be timely satisfied before the Award will be effective, (iii) the conditions, if any, that must be timely satisfied before

the Award will be vested, (iv) the conditions, if any, under which the Recipient's interest in the RSUs will be forfeited,

and (v) and any other terms and conditions of the Award. Any such conditions for effectiveness or vesting will be

determined on the Grant Date, and may be based upon the passage of time and continued service by the Recipient, or

the achievement of Performance Conditions, or the achievement of both time-based conditions and Performance

Conditions.

b.**Dividend Equivalent Rights, Voting, and Other Ownership Rights**. Unless otherwise provided by the Committee in

the Award Agreement, a Recipient will not have any rights as a stockholder with respect to Shares underlying an Award

of RSUs until such time, if any, as the RSUs are settled and the underlying Shares are actually issued to the Recipient.

Subject to Section 2(n) of the Plan, the Committee may provide in the Award Agreement for the payment of Dividend

Equivalents Rights to the Recipient at the time of vesting or other payout of the RSUs. If the payment or crediting of

Dividend Equivalents is in respect of an Award that is subject to Section 409A of the Code, then the payment or

crediting of such Dividend Equivalents will conform to the requirements of Section 409A of the Code.

c.**Deferral of Receipt of Payment.** The Committee may permit or require a Recipient to defer receipt of the delivery of

Shares that would otherwise be due by virtue of the grant of or the lapse or waiver of restrictions with respect to RSUs.

If any such deferral is required or permitted, the Committee will establish such rules and procedures for such deferral,

including rules and procedures implemented pursuant to Section 23 of the Plan for compliance with Section 409A of the

Code.

d.**Termination.** The effect of a Recipient's Termination on their outstanding RSUs will be set forth in the Award

Agreement.

7.**Options.** The specific terms and conditions of an Option granted to a Recipient will be evidenced by an Award Agreement.

In addition, the following rules apply to all Options:

a.**Price**. No Option (other than Substitute Options) may have an Option Price less than the Fair Market Value of the

underlying Share on the Grant Date.

b.**Term**. No Option will be exercisable after its Expiration Date. No Option may have an Expiration Date that is more than

ten years after its Grant Date. Additional provisions regarding the term of Incentive Stock Options are provided in

Sections 7(h)(1) and 7(h)(5) of the Plan.

c.**Vesting**. Options will be exercisable, in whole or in part, at such times as the Committee will specify in the Award

Agreement. The grant or vesting of an Option may be based upon the passage of time and continued service by the

Recipient, or the achievement of Performance Conditions, or the achievement of both time-based conditions and

Performance Conditions. No Option granted to an individual who is subject to the overtime pay provisions of the Fair

Labor Standards Act may be exercised before the expiration of six months after the Grant Date.

d.**Exercise**. An Option will be considered exercised when the Company or its designee receives:

1. written (including electronically pursuant to Section 24(d) of the Plan) notice of exercise from the person

entitled to exercise the Option,

2. full payment, or provision for payment, in accordance with Section 7(e) below in a form and method approved

by the Committee, for the Shares for which the Option is being exercised, and

108 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

3. with respect to any Option the exercise of which triggers any withholding obligation, payment, or provision for

payment, in a form and method approved by the Committee, of all applicable withholding and similar taxes

and/or (if applicable) transaction costs due upon exercise.

An Option may not be exercised for a fraction of a Share.

e.**Form and Method of Payment**. In accordance with Section 4(b) of the Plan, the Committee will have the authority to

determine the acceptable form and method of payment for exercising an Option. Acceptable forms of payment that the

Committee may permit with respect to the exercise of Options include:

1. cash, check or wire transfer, denominated in U.S. dollars except as specified by the Committee for non-U.S.

Employees;

2. other Shares, or the designation of other Shares, which have a Fair Market Value on the date of surrender

greater than or equal to the Option Price of the Shares as to which the Option is being exercised;

3. consideration received by the Company under a procedure under which a licensed broker-dealer advances

funds on behalf of a Recipient or sells Shares issued upon exercise of the Option on behalf of a Recipient (a

"Cashless Exercise Procedure"), provided that if the Company extends or arranges for the extension of credit

to a Recipient under any Cashless Exercise Procedure, no Officer or Director may participate in that Cashless

Exercise Procedure;

4. cancellation of any debt owed by the Company or any Affiliate to the Recipient by the Company (including,

without limitation, waiver of compensation due or accrued for services previously rendered to the Company);

5. payment pursuant to any "cashless net exercise" procedures approved by the Committee; and

6. any combination of the methods of payment permitted by any paragraph of this Section 7(e).

The Committee may also permit any other form or method of payment permitted by Applicable Law. In making its

determination as to the type of consideration to accept, the Committee will consider if acceptance of such consideration

may be reasonably expected to benefit the Company and the Committee may, in its sole discretion, refuse to accept a

particular form of consideration at the time of any Option exercise.

f.**No Repricing.** The Committee may not modify or amend any outstanding Option so as to (i) specify a lower exercise

price, (ii) accept the surrender of an outstanding Option when the Option Price per Share exceeds the Fair Market Value

of one Share and authorize the granting of a new Option or other Award with a lower exercise price in substitution for

such surrendered Option, or buy out, for a payment in cash or Shares, an outstanding Option (other than in connection

with a Change in Control), or (iii) take any other action with respect to an Option that would be treated as a repricing

under the rules and regulations of the principal U.S. national securities exchange on which the Shares are listed, in

each case, without the approval of the Company's stockholders other than in connection with a change in the

Company's capitalization pursuant to Section 16 of the Plan.

g.**Termination.** The effect of a Recipient's Termination on their outstanding Options will be set forth in the Award

Agreement.

h.**Special Rules for Incentive Stock Options.**

1. The Expiration Date of an Incentive Stock Option will not be later than ten years from its Grant Date, with the

result that no Incentive Stock Option may be exercised after the expiration of ten years from its Grant Date.

2. No Incentive Stock Option may be granted after the tenth anniversary of the date the Board most recently

approved the Plan (or such earlier date as required by the Code).

3. Stock options intended to be incentive stock options under Section 422 of the Code that are granted to any

single Recipient under all incentive stock option plans of the Company and its Affiliates, including Incentive

Stock Options granted under the Plan, may not vest at a rate of more than $100,000 in Fair Market Value of

stock (measured on the grant dates of the options) during any calendar year. For this purpose, a stock option

vests with respect to a given Share the first time its holder may purchase that Share, notwithstanding any right

of the Company to repurchase that Share. Unless the administrator of that stock option plan specifies

otherwise in the related agreement governing the stock option, this vesting limitation will be applied by, to the

extent necessary to satisfy this $100,000 rule, treating certain stock options that were intended to be incentive

stock options under Section 422 of the Code as Nonstatutory Options. The stock options or portions of stock

options to be reclassified as Nonstatutory Options are those with the highest option prices, whether granted

under the Plan or any other equity compensation plan of the Company or any Affiliate that permits that

treatment. This Section 7(h)(3) will not cause an Incentive Stock Option to vest before its original vesting date

or cause an Incentive Stock Option that has already vested to cease to be vested.

4. In order for an Incentive Stock Option to be exercised for any form of payment other than those described in

Section 7(e) of the Plan, that right must be stated at the time of grant in the Award Agreement relating to that

Incentive Stock Option.

 **saic.com** \| 109<br>

**APPENDICES**<br>

5. Any Incentive Stock Option granted to a Ten Percent Stockholder, must have an Expiration Date that is not

later than five years from its Grant Date, with the result that no such Option may be exercised after the

expiration of five years from the Grant Date.

6. The Option Price of an Incentive Stock Option will never be less than the Fair Market Value of the Shares at

the Grant Date. The Option Price for the Shares covered by an Incentive Stock Option granted to a Ten

Percent Stockholder will never be less than 110% of the Fair Market Value of the Shares at the Grant Date.

7. Incentive Stock Options may be granted only to Employees. If a Recipient changes status from an Employee

to a Consultant, that Recipient's Incentive Stock Options become Nonstatutory Options if not exercised within

the time period described in Section 7(h)(9) below (determined by treating that change in status as a

Termination solely for purposes of this Section 7(h)(7)).

8. No rights under an Incentive Stock Option may be transferred by the Recipient, other than by will or the laws of

descent and distribution. During the life of the Recipient, an Incentive Stock Option may be exercised only by

the Recipient. The Company's compliance with a Qualified Domestic Relations Order, or the exercise of an

Incentive Stock Option by a guardian or conservator appointed to act for the Recipient, will not violate this

Section 7(h)(8).

9. An Incentive Stock Option will be treated as a Nonstatutory Option if it remains exercisable after, and is not

exercised within, the three-month period beginning with the Recipient's Termination for any reason other than

the Recipient's death or disability (as defined in Section 22(e) of the Code). In the case of Termination due to

death, an Incentive Stock Option will continue to be treated as an Incentive Stock Option if it remains

exercisable after, and is not exercised within, the three month period after the Recipient's death, provided it is

exercised before the Expiration Date. In the case of Termination due to disability (as defined in Section 22(e) of

the Code), an Incentive Stock Option will be treated as a Nonstatutory Option if it remains exercisable after,

and is not exercised within, one year after the Recipient's Termination.

10. An Incentive Stock Option may only be modified by the Committee.

11. Any holder of Shares acquired under an Incentive Stock Option will promptly notify the Committee, following

such procedures as the Committee may require, of the sale or other disposition of any of those Option Shares

if the disposition occurs during: (a) the longer of two years after the Grant Date of the Incentive Stock Option

and one year after the date the Incentive Stock Option was exercised, or (b) such other period as the

Committee has established.

8.**Stock Appreciation Rights.** The following rules apply to SARs:

a.**General**. SARs may be granted either alone, in addition to, or in tandem with other Awards granted under the Plan. The

Committee may grant SARs to eligible participants subject to terms and conditions not inconsistent with the Plan and

determined by the Committee. The specific terms and conditions applicable to the Recipient will be provided for in the

Award Agreement. SARs will be exercisable, in whole or in part, at such times as the Committee will specify in the

Award Agreement. The grant or vesting of a SAR may be based upon the passage of time and continued service by the

Recipient, or the achievement of Performance Conditions, or the achievement of both time-based conditions and

Performance Conditions. The Expiration Date of a SAR will not be later than ten years from its Grant Date, with the

result that no SAR may be exercised after the expiration of ten years from its Grant Date.

b.**Exercise of SARs**. Upon the exercise of a SAR, in whole or in part, a Recipient will be entitled to a payment in an

amount equal to the excess of the Fair Market Value of a fixed number of Shares covered by the exercised portion of

the SAR on the date of exercise, over the Fair Market Value of the Shares covered by the exercised portion of the SAR

on the Grant Date. The amount due to the Recipient upon the exercise of a SAR will be paid in cash, Shares, or a

combination thereof as, and over the period or periods, specified in the Award Agreement. An Award Agreement may

place limits on the amount that may be paid over any specified period or periods upon the exercise of a SAR, on an

aggregate basis or as to any Recipient. If a SAR has been granted in tandem with an Option, upon the exercise of the

SAR, the number of Shares that may be purchased pursuant to the Option will be reduced by the number of Shares

with respect to which the SAR is exercised. A SAR will be considered exercised when the Company or its designee

receives:

1. written (including electronically pursuant to Section 24(d) of the Plan) notice of exercise from the person

entitled to exercise the SAR, and

2. with respect to any SAR the exercise of which triggers any withholding obligation, payment, or provision for

payment, in a form and method approved by the Committee, of all applicable withholding and similar taxes

and/or (if applicable) transaction costs due upon exercise.

A SAR may not be exercised for a fraction of a Share.

c.**No Repricing**. The Committee may not modify or amend any outstanding SAR so as to (i) specify a lower exercise

price, (ii) accept the surrender of an outstanding SAR when the exercise price exceeds the Fair Market Value of one

Share and authorize the granting of a new SAR or other Award with a lower exercise price in substitution for such

surrendered SAR, or buy out, for a payment in cash or Shares, an outstanding SAR (other than in connection with a

110 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

Change in Control), or (iii) take any other action with respect to a SAR that would be treated as a repricing under the

rules and regulations of the principal U.S. national securities exchange on which the Shares are listed, in each case,

without the approval of the Company's stockholders other than in connection with a change in the Company's

capitalization pursuant to Section 16 of the Plan.

d.**Termination.** The effect of a Recipient's Termination on their outstanding SARs will be set forth in the Award

Agreement.

9.**Other Stock-Based Awards**. The Committee may grant Share-based or Share-related awards not otherwise described in

Sections 6, 7, or 8 of the Plan in such amounts and subject to such terms and conditions consistent with the terms of the

Plan as the Committee determines (including Section 2(n)). Without limiting the generality of the preceding sentence, each

such Other Stock-Based Award may:

a.involve the transfer of actual Shares to Recipients, either on the Grant Date or later, or payment in cash or otherwise of

amounts based on the value of Shares;

b.provide for grant or vesting based upon the passage of time and continued service by the Recipient, or the achievement

of Performance Conditions, or the achievement of both time-based conditions and Performance Conditions;

c.be in the form of phantom stock, restricted stock units, performance shares, deferred share units, or share-denominated

performance units, or other awards denominated in, or with a value determined by reference to, a number of Shares

that is specified on the Grant Date; and

d.be designed to comply with applicable laws of jurisdictions other than the United States.

10.**Cash Awards**. Cash Awards may be granted either alone, in addition to, or in tandem with other Awards granted under the

Plan. After the Committee determines that it will offer a Cash Award, it will advise the Recipient, by means of an Award

Agreement or otherwise, of the terms, conditions and restrictions related to the Cash Award. The grant or vesting of a Cash

Award may be based upon the passage of time and continued service by the Recipient, or the achievement of Performance

Conditions, or the achievement of both time-based conditions and Performance Conditions.

11.**Awards Contingent on Performance Conditions**. The Award Agreement for an Option, SAR, RSU, Other Stock-Based

Award, or Cash Award that is contingent on Performance Conditions will specify the Performance Conditions, including the

performance period and the manner in which performance will be measured. The Committee may adjust Performance

Conditions and the related level of achievement if the Committee determines in its discretion that events or transactions that

are unusual in nature or infrequently occurring have occurred after the Grant Date that are unrelated to the performance of

the Recipient and result in distortion of the performance targets or the related level of achievement. The Committee may

provide in the applicable Award Agreement additional rules and procedures relating to the Committee's ability to adjust

aspects of an Award that is contingent on Performance Conditions, the Committee's ability to increase or decrease the

amount of compensation provided by the Award, and the Committee's certification or other determination of the extent to

which Performance Conditions have or have not been attained.

12.**Substitute Awards**. The Committee may cause the Company to grant Substitute Awards in connection with the acquisition

by the Company or an Affiliate of equity securities of any entity (including by merger, tender offer, or other similar

transaction) or of all or a portion of the assets of any entity. Unless and to the extent specified otherwise by the Committee,

Substitute Awards will have the same terms and conditions as the stock awards they replace, except that (subject to the

provisions of Section 16 of the Plan), Substitute Awards will cover Shares rather than equity securities of the granting entity

and will have terms and conditions that, as determined by the Committee in its sole and absolute discretion, properly reflects

the substitution. Any such Substitute Award will be effective on the effective date of the acquisition.

13.**Issuance of Shares**. Subject to Sections 17 and 18 of the Plan, the Company will issue Shares under the Plan in the name

of the Recipient (or to such other person as to whom the Shares may be appropriately and legally issued under procedures

and rules, if any, established from time to time by the Committee). Shares issued by the Company under the Plan may be, at

the Company's option, evidenced by a Share certificate delivered to the Participant, or other physical or electronic evidence

of Share ownership, including, without limitation, deposit of Shares into a stock brokerage account maintained for the

Recipient by the Company's stock transfer agent or its designee. Until Shares are actually issued, as evidenced by the

appropriate entry on the stock register of the Company or its transfer agent, the Recipient will not have the rights of a

stockholder with respect to those Shares, even though the Recipient has completed all the steps necessary for Shares to be

issued. No adjustment will be made for any dividend, distribution, or other right for which the record date precedes the date

the Shares are issued, except as provided in Section 16 of the Plan or in the Award Agreement.

14.**Leave of Absence**. If a Recipient is an Employee of the Company or an Affiliate and is on a leave of absence pursuant to

the terms of the Company's Administrative Policy No. SH-1 "Working Hours and Absences" or similar policy maintained by

an Affiliate, as such policies may be revised or replaced from time to time, the Recipient will not, during the period of such

absence be deemed, by virtue of such absence alone, to have terminated the Recipient's employment. The Recipient will

continue to vest in an outstanding Award during any approved medical or military leave of absence. Medical leave will

include family or medical leaves, workers' compensation leave, or pregnancy disability leave. For all other leaves of

absence, an outstanding Award will fully vest only during active employment and will not vest during a leave of absence,

unless required under local law. However, if a Recipient returns to active employment with the Company or an Affiliate

following such a leave, the Award will be construed to vest as if there had been no break in active employment.

 **saic.com** \| 111<br>

**APPENDICES**<br>

15.**Consulting or Employment Relationship**. Nothing in the Plan or in any Award Agreement, and no Award or the fact that

Shares remain subject to risk of forfeiture, will: (A) interfere with or limit the right of the Company or any Affiliate to terminate

the employment or consultancy of any Recipient at any time, whether with or without cause or reason, and with or without

the payment of severance or any other compensation or payment, (B) confer upon any individual any right to continue in the

employ of, or affiliation with, the Company or a Subsidiary nor constitute any promise or commitment by the Company or a

Subsidiary regarding future positions, future work assignments, future compensation or any other term or condition of

employment or affiliation or (C) interfere with the application of any provision in any of the Company's or any Affiliate's

charter documents or Applicable Law relating to the election, appointment, term of office, or removal of a Director. No

Employee or Director will have any claim or right to be granted an Award under the Plan, or, having been selected for the

grant of an Award, to be selected for a grant of any other Award. Participation in the Plan is a matter separate from any

contract of employment or other agreement and any benefit conferred by the Plan will not be counted for pension or any

other purpose. The rights and obligations of any individual under the terms of their office or employment with the Company

or any Subsidiary will not be affected by their participation in the Plan, and neither the Plan nor any Award form any part of

any contract of employment between any individual and the Company or a Subsidiary. A Recipient will have no entitlement

by way of compensation or damages resulting from termination of the office or employment (for any reason and whether

lawful or not) by virtue of which they are or may be eligible to participate in the Plan or for the loss or reduction of any right or

benefit or prospective right or benefit under the Plan or any Award that they might otherwise have enjoyed whether the

compensation is claimed for wrongful dismissal or otherwise.

16.**Certain Transactions and Events.**

a.**In General**. Except as provided in this Section 16, no change in the capital structure of the Company, merger, sale or

other disposition of assets or of a subsidiary, change in control, issuance by the Company of shares of any class of

securities or securities convertible into shares of any class of securities, exchange or conversion of securities, or other

transaction or event will require or be the occasion for any adjustments of the type described in this Section 16.

b.**Changes in Capital Structure**. In the event of any stock split, reverse stock split, recapitalization, combination or

reclassification of stock, stock dividend, spin-off, extraordinary cash dividend or similar change to the capital structure of

the Company (not including a Change in Control), the Committee will make such adjustments as it concludes are

appropriate in order to preserve the proportionate value of Awards before and after the change in capital structure of the

Company to:

1. the number and type of Awards and Shares that may be granted under the Plan, including (without limitation)

to the number of Shares available for issuance over the term of the Plan as set forth in Section 3(a) of the

Plan,

2. the number and type of Awards that may be granted to any individual under the Plan,

3. the terms of any SAR,

4. the Option Price and number and class of securities issuable under each outstanding Option, and

5. the repurchase price of any securities substituted for Shares that are subject to repurchase rights. The specific

adjustments will be determined by the Committee. Unless the Committee specifies otherwise, any securities

issuable as a result of any such adjustment will be rounded down to the next lower whole security. The

Committee need not adopt the same rules for each Award or each Recipient.

c.**Change in Control**. Subject to the requirements of Section 409A of the Code and any additional terms and conditions

set forth in the applicable Award Agreements, in the event of a Change in Control, the following provisions will apply:

1.**Time-Based Awards.** In the event of an Involuntary Termination within 18 months following the consummation

of a Change in Control for any reason other than death, disability or Cause, each outstanding Award that is

subject to a time-based vesting schedule will become fully vested and nonforfeitable as of the date of such

termination.

2.**Performance-Based Awards.** With respect to each outstanding Award that is contingent on Performance

Conditions, if a Change in Control occurs prior to the end of the Performance Period, the Performance Period

will be terminated, and the Award will become vested and nonforfeitable with respect to the following number

of Shares (or, for a Cash Award, the amount of cash):

a.If the Change in Control occurs following completion of one or more fiscal years in the Performance

Period, the number of Shares (or, for a Cash Award, the amount of cash) earned by the Recipient for

each such completed fiscal year based on the achievement of the applicable Performance Goals as

determined by the Committee; plus

b.If the Change in Control occurs prior to completion of any fiscal year in the Performance Period, a

numb\er of Shares (or, for a Cash Award, the amount of cash) based on the achievement of the

Performance Goals for such fiscal year at the time of consummation of the Change in Control as

determined by the Committee and prorated to reflect the portion of the fiscal year that has elapsed

through the date of consummation of the Change in Control.

112 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

d.**Special Rules for Grants to Non-Employee Directors.**

1. In the event of a Change in Control while the Recipient remains a non-Employee Director, the Shares at the

time subject to each outstanding Award held by such Recipient pursuant to the Plan, but not otherwise vested,

will automatically vest in full and become exercisable for all Shares as fully vested Shares and all repurchase

rights will automatically terminate in full immediately prior to the effective date of the Change in Control.

Immediately following the consummation of the Change in Control, each Award will terminate and cease to be

outstanding, except to the extent assumed by the successor corporation (or Affiliate thereof).

17.**Tax Withholding.**

a.**General**. Whenever Awards are granted or exercised, or Shares are issued or become free of restrictions, as

applicable, the Company may require the Recipient to remit to the Company an amount sufficient to satisfy any

applicable tax withholding requirement, whether the related tax is imposed on the Recipient or the Company. The

Company will have no obligation to deliver Shares or release Shares from an escrow or permit a transfer of Shares until

the Recipient has satisfied those tax withholding obligations. Whenever payment in satisfaction of Awards is made in

cash, the payment will be reduced by an amount sufficient to satisfy all tax withholding requirements.

b.**Method of Payment**. The Recipient will pay any required withholding using such forms of consideration as are

described in Section 7(e) of the Plan and determined appropriate by the Committee. The Committee, in its sole

discretion, may also permit Shares to be withheld or surrendered to pay required withholding or for required withholding

to be paid through payroll deductions. If the Committee permits Shares to be withheld or surrendered, the Fair Market

Value of the Shares withheld or surrendered, as determined as of the date of withholding, will not exceed the number of

Shares having an aggregate Fair Market Value on the date of withholding equal to the aggregate amount of such tax

withholding obligations determined based on an amount that is up to the maximum statutory tax rates in the Recipient's

applicable jurisdiction(s) (or such lesser amount as required by law or applicable accounting standards).

18.**Compliance With Law.** The grant of Awards and the issuance and subsequent transfer of Shares will be subject to

compliance with all Applicable Law, including all applicable securities laws. Awards may not be exercised, and Shares may

not be transferred, in violation of Applicable Law. Thus, for example, Awards may not be exercised unless: (a) a registration

statement under the Securities Act is then in effect with respect to the related Shares, or (b) in the opinion of legal counsel to

the Company, those Shares may be issued in accordance with an applicable exemption from the registration requirements

of the Securities Act and any other applicable securities laws. The failure or inability of the Company to obtain from any

regulatory body the authority considered by the Company's legal counsel to be necessary or useful for the lawful issuance of

any Shares or their subsequent transfer will relieve the Company of any liability for failing to issue those Shares or permitting

their transfer. As a condition to the exercise of any Award or the transfer of any Shares, the Company may require the

Recipient to satisfy any requirements or qualifications that may be necessary or appropriate to comply with or evidence

compliance with any Applicable Law.

19.**Amendment or Termination of the Plan or Outstanding Awards.**

a.**Amendment and Termination**. The Board or the Committee may at any time amend, suspend, or terminate the Plan.

The Company will obtain the approval of the Company's stockholders for any amendment to the Plan if stockholder

approval is necessary or desirable to comply with (i) any Applicable Law, (ii) the requirements applicable to the grant of

Awards intended to be Incentive Stock Options or (iii) if such amendment increases the maximum number of Shares

which may be issued under the Plan, extends the term of the Plan or Awards granted hereunder, changes the eligibility

criteria in Section 5 of the Plan, reduces the exercise price of an Option or SAR below what is permitted under the Plan

or amends the repricing prohibition in Sections 7(f) and 8(c) of the Plan. The Board may also, but need not, require that

the Company's stockholders approve any other amendments to the Plan.

b.**Effect**. No amendment, suspension, or termination of the Plan, and no modification of any Award even in the absence

of an amendment, suspension, or termination of the Plan, will materially impair any existing contractual rights of any

Recipient unless the affected Recipient consents to the amendment, suspension, termination, or modification.

Notwithstanding anything herein to the contrary, no such consent will be required if the Committee determines that the

amendment, suspension, termination, or modification (including an amendment of the designation of the class of

securities to be issued under Awards): (1) is required or advisable in order for the Company, the Plan or the Award to

satisfy Applicable Law, to meet the requirements of any accounting standard or to avoid any adverse accounting

treatment, or (2) in connection with any transaction or event described in Section 16 of the Plan, is in the best interests

of the Company or its stockholders. The Committee may, but need not, take the tax or accounting consequences to

affected Recipients into consideration in acting under the preceding sentence. Those decisions will be final, binding and

conclusive. Termination of the Plan will not affect the Committee's ability to exercise the powers granted to it under the

Plan with respect to Awards granted before the termination of the Plan or with respect to Shares issued under such

Awards even if those Shares are issued after the termination of the Plan.

 **saic.com** \| 113<br>

**APPENDICES**<br>

c.**Recoupment/Clawback**. Notwithstanding anything in the Plan to the contrary, Awards granted under the Plan will be

subject to cancellation, forfeiture and recovery in accordance with the Company's Recoupment Policy, as the same may

be amended from time to time, or any other compensation recoupment policy that may be adopted by the Committee,

including any policies and procedures that the Committee determines to be necessary or appropriate to implement

Section 10D of the Exchange Act and any rules promulgated thereunder or any other Applicable Law. Without limiting

the foregoing, the Committee may provide for such recoupment in Award Agreements or with respect to any Award

granted hereunder (including on a retroactive basis without the Recipient's consent).

20.**Reserved Rights.**

a.**Nonexclusivity of the Plan**. This Plan will not limit the power of the Company or any Affiliate to adopt other incentive

arrangements including, for example, the grant or issuance of stock options, stock, other equity-based rights or cash

bonuses or awards under other plans.

b.**Unfunded Plan**. This Plan will be unfunded. Although bookkeeping accounts may be established with respect to

Recipients, any such accounts will be used merely as a convenience. The Company will not be required to segregate

any assets on account of the Plan, the grant of Awards, or the issuance of Shares. The Company and the Committee

will not be deemed to be a trustee of stock or cash to be awarded under the Plan. Any obligations of the Company to

any Recipient will be based solely upon contracts entered into under the Plan, such as Award Agreements. No such

obligations will be deemed to be secured by any pledge or other encumbrance on any assets of the Company. Neither

the Company nor the Committee will be required to give any security or bond for the performance of any such

obligations.

c.**Compensation.** The value of Awards granted pursuant to the Plan will not be included as compensation, earnings,

salary or other similar terms used when calculating a Recipient's benefits under any other employee benefit plan

sponsored by the Company or any Affiliate except as such other plan otherwise expressly provides.

21.**Escrow of Stock Certificates.** To enforce any restrictions on Shares, the Committee may require the holder to deposit any

certificates (or indicia of ownership) representing Shares, with stock powers or other transfer instruments approved by the

Committee endorsed in blank, with the Company or an agent of the Company to hold in escrow until the restrictions have

lapsed or terminated. The Committee may also cause a legend or legends referencing the restrictions to be placed on any

such certificates.

22.**Nontransferability of Awards.**

a.**In General**. Unless the Committee, in its discretion, determines otherwise at the time an Award is granted, neither an

Award nor the Shares subject to an Award nor any interest or right therein or part thereof will be subject to disposition by

transfer, alienation, anticipation, pledge, encumbrance, assignment or any other means, whether such disposition is

voluntary or involuntary or by operation of law, by judgment, levy, attachment, garnishment or any other legal or

equitable proceedings (including bankruptcy) and any attempted disposition thereof will be null and void and of no

effect; provided, however, that this Section 22(a) will not prevent transfers by will or by the applicable laws of descent

and distribution or by a beneficiary designation in accordance with Section 22(c) below. An Option or SAR may be

exercised during the Recipient's lifetime only by the Recipient or, if permissible under applicable law, by the Recipient's

guardian or legal representative.

b.**Limited Transferability.** To the extent the Committee authorizes the transferability of an Award, in no event will any

transfer be made to any person or persons other than the Recipient's spouse, children or grandchildren, or a trust for

the exclusive benefit of one or more such persons, which transfer must be made as a gift and without any consideration,

and in no event will any transfer be for value. All other transfers and any re-transfer by any permitted transferee are

prohibited and any such purported transfer will be null and void. Each Award that becomes the subject of permitted

transfer (and the Recipient to whom it was granted by the Company) will continue to be subject to the same terms and

conditions as were in effect immediately prior to such permitted transfer. The Recipient will remain responsible to the

Company for the payment of all withholding taxes including but not limited to those incurred as a result of any grant,

vesting, or exercise of such Award, as applicable. In no event will any permitted transfer of an Award create any right in

any party in respect of any Award, other than the rights of the qualified transferee in respect of such Award specified in

the related Award Agreement.

c.**Beneficiary Designations**. The Committee, in its sole discretion, may permit a Recipient to designate a beneficiary or

beneficiaries to exercise any rights or receive any benefits under an Award following the Recipient's death. To be

effective, such designation must be made in accordance with such procedures and in such written or electronic form as

prescribed by the Company (or its designee) for such purpose. If a Recipient fails to designate a beneficiary, or if no

designated beneficiary survives the Recipient's death, the Recipient's estate will be deemed the Recipient's beneficiary.

A beneficiary designation may be changed or revoked by the Recipient's sole action, provided that the change or

revocation is made in accordance with such procedures and in such written or electronic form as prescribed by the

Company (or its designee) for such purpose. Unless otherwise provided in the beneficiary designation, each

designation made will revoke all prior designations made by the same Recipient.

114 \| Science Applications International Corporation \| **2026 Proxy Statement** <br>

**APPENDICES**<br>

23.**Section 409A of the Code**. It is intended that the Plan and all Awards be administered in a manner that will comply with the

applicable requirements of Section 409A of the Code. The Committee is authorized to adopt rules or regulations deemed

necessary or appropriate to qualify for an exception from or to comply with the requirements of Section 409A of the Code.

Without limiting the generality of the foregoing, if any amount will be payable with respect to any Award as a result of a

Recipient's "separation from service" at such time as the Recipient is a "specified employee" (as those terms are defined for

purposes of Section 409A of the Code), and such amount constitutes a deferral of compensation subject to Section 409A of

the Code, then no payment will be made, except as permitted under Section 409A of the Code, prior to the date six months

after the Recipient's separation from service (or the date of their earlier death). The Company may adopt a specified

employee policy that will apply to identify the specified employees for all deferred compensation plans subject to Section

409A of the Code; otherwise, specified employees will be identified using the default standards contained in the regulations

under Section 409A of the Code.

24.**Miscellaneous.**

a.**Governing Law**. This Plan, the Award Agreements and all other agreements entered into under the Plan, and all

actions taken under the Plan or in connection with Awards or Shares, will be governed by the laws of the State of

Delaware without giving effect to principles of conflicts of law.

b.**Rules of Interpretation**. Any reference to a "Section," without more, is to a Section of the Plan. Captions and titles are

used for convenience in the Plan and will not, by themselves, determine the meaning of the Plan. Except when

otherwise indicated by the context, the singular includes the plural and vice versa. Any reference to a statute is also a

reference to the applicable rules and regulations adopted under that statute. Any reference to a statute, rule or

regulation, or to a section of a statute, rule or regulation, is a reference to that statute, rule, regulation, or section as

amended from time to time, both before and after the Effective Date and including any successor provisions.

c.**Electronic Communications**. Any Award Agreement, notice of exercise of an Award, or other document required or

permitted by the Plan may be delivered in writing or electronically. Signatures or acknowledgments may also be

electronic.

d.**Notices**. Unless the Committee specifies otherwise, any notice to the Company under any Award Agreement or with

respect to any Awards or Shares will be in writing or communicated electronically, will be addressed to the Secretary of

the Company, and will only be effective when received by the Secretary of the Company.

![Proxy Card Page 1.jpg](saic-20260422_g77.jpg)

![Proxy Card Page 2.jpg](saic-20260422_g78.jpg)